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Summary 
Colicins are toxins produced under stress conditions by representatives of the 
Enterobacteriaceae family. Released in the environment they target closely related colicin-
sensitive competitors. Thus, colicin-production is a wide-spread example for interference 
competition in complex bacterial ecosystems. Production of colicins is highly costly for the 
producer as the individual bacterium dies upon colicin-release by lysis. Therefore, colicins 
are only synthesized by a fraction of the (genetically identical) population while the remaining 
part of the population survives and can gain a fitness benefit over colicin-sensitive 
competitors. This strategy is termed ‘division of labor’. It was previously shown that the 
enteric pathogen Salmonella enterica serovar Typhimurium SL1344 (S. Tm) produces colicin 
Ib (ColIb) which confers a competitive advantage to S. Tm over commensal, colicin-sensitive 
E. coli strains upon infection. 
In the first part of this thesis, I investigated colicin Ib (cib) regulation of S. Tm at the single 
cell level. To this end a single- and a multi-copy gfp-reporter for the promoter of colicin Ib 
were generated. Comparative analysis revealed that the multi-copy gfp-reporter (pPcib gfp) 
exhibits an optimal GFP signal intensity for a variety of applications. Further characterization 
showed that GFP intensity levels of pPcib gfp correlated well with intrinsic ColIb levels in 
individual bacteria. Cib expression is negatively regulated by the repressors LexA and Fur. 
Only a small fraction of the S. Tm population expressed cib under non-inducing conditions. In 
the course of this thesis the activity of the cib promoter (Pcib) was further characterized in 
response to SOS-response induction and iron-limitation. When applied individually, both 
environmental conditions led to an unimodal increase of the proportion of GFP+ S. Tm, 
however with an overall low GFP signal intensity. In contrast, the simultaneous exposure to 
both conditions resulted in a S. Tm population exhibiting unimodal and high GFP signal 
intensity. In conclusion, this first part of my thesis provided a thorough characterization of 
pPcib gfp which is a prerequisite to investigate the regulation of cib expression and release at 
the single cell level. 
Colicin Ib belongs to colicin subgroup B, which do not encode a cognate lysis gene. Until 
recently, the release mechanism has been unclear. Our group showed that in S. Tm ColIb 
can be released in the course of prophage-mediated cell lysis. To simultaneously investigate 
prophage activity and ColIb release at the single cell level, appropriate gfp-reporter tools 
were generated. I could confirm that individual Col+ bacteria only lyse in the presence of 
intact prophages. Furthermore, single cell analysis revealed that cib expression and 
induction of prophage-lysis genes are co-regulated within individual bacteria. Interestingly, 
only a fraction of ColIb+ S. Tm induces prophage-mediated cell lysis and undergoes lysis. 
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Therefore I could show that S. Tm uses the strategy of ‘division of labor’ for the process of 
colicin release and not as it is the case for other colicins, for colicin production. In conclusion, 
this data reveal the mechanism how S. Tm gains a fitness benefit over competing E. coli in 
the inflamed intestine by ‘division of labor’. 
Generally, colicin-producing bacteria also synthesize a cognate immunity protein, which 
protects the producer population against self-killing. Here, we characterized an E. coli strain 
(Ec252R) that produces ColM (cma) and ColB (cba). Interestingly, the strain was immune to 
ColB but highly susceptible to ColM, despite producing high amounts of this colicin. ColM is a 
peptidoglycan lipid-II-degrading enzyme that interferes with cell wall biogenesis. Cba and 
cma are encoded ‘in tandem’ on the same locus on a large conjugative plasmid. Expression 
of both genes is under control of the same promoter, which is located upstream of cba. In 
addition, the cognate immunity genes (cbi and cmi) are also encoded on the same locus. In 
this part of the thesis I aimed to unravel the underlying reason for ColM sensitivity of Ec252R. 
First, I demonstrated that the immunity protein of Ec252R is fully functional and therefore not 
the underlying reason for lack of ColM immunity of Ec252R. However, cmi overexpression only 
partially protected ColM producers against ‘self-killing’. 
Next, a collection of 36 E. coli strains carrying the cma locus was characterized. Two strains 
could be identified which also exhibited the ‘self-killing’ phenotype. Interestingly, the majority 
of the strains harbor a short version of the cba gene (cba-remnant) and this genotype was 
associated with lack of ColM production. Based on our findings, we hypothesized that 
immunity to ColM is insufficient to protect ColM producers against self-killing. Thus, 
resistance to ColM, as seen in the vast majority of ColM producers must have been gained 
by other mechanisms. In particular, E. coli strains which have just received a ColBM plasmid 
are only partially protected against ColM by the ColM immunity protein and have to ‘further 
evolve’ by accumulating mutations rendering them resistant to ColM or by interfering with 
cma expression. According to this idea, Ec252R might represent an isolate which recently 
acquired a functional ColBM plasmid but has not yet evolved towards ColM tolerance or 
downregulation of ColM production. Finally, a series of in vitro evolution experiments was 
performed to experimentally verify this idea. In conclusion, our data reveal novel insights into 
the biology of ColM, which represents an exceptional case among other colicins, as it shows 
high toxicity despite intact immunity.  
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Zusammenfassung 
Colicine sind Toxine, die unter Stressbedingungen von Mitgliedern der Familie der 
Enterobacteriaceae gebildet werden. Vom Produzenten entlassen richtet sich ihre Toxizität 
gegen nah verwandte, kompetierende und Colicin sensitive Bakterien. Demzufolge ist die 
Produktion von Colicinen eine weitverbreitete Wettbewerbsstrategie zwischen 
Bakteriengruppen in komplexen Ökosystemen. Die Produktion von Colicinen ist für den 
Produzenten mit hohen Kosten verbunden, da die Freisetzung der Colicine die Zell-Lyse und 
somit den Tod des Produzenten zur Folge hat. Auf Grund dieser Tatsache wird das 
Colicingen nur in einem Teil der (genetisch identischen) Population exprimiert. Der 
verbliebende Teil der Population überlebt und erhält einen Fitness Vorteil gegenüber 
anderen kompetierende sensitiven Stämmen. Diese Strategie der „Arbeitsteilung“ dient dem 
Wohle der gesamten Population.  
Vor kurzen wurde gezeigt, dass während einer Darmentzündung der darmpathogene Erreger 
Salmonella enterica serovar Typhimurium SL1344 (S. Tm) durch die Synthese von Colicin Ib 
(ColIb) einen kompetitiven Wachstumsvorteil gegenüber dem Kommensalen und Colicin 
sensitiven E. coli Stamm erlangt. Im ersten Teil dieser Arbeit, wurde die Regulation von ColIb 
(cib) in S. Tm auf Einzelzellebene untersucht. Für diesen Zweck wurden zwei 
unterschiedliche gfp-Reporter („single-copy“ und „multi-copy“ Reporter) hergestellt, mit 
denen sich die ColIb Promoter Aktivität bestimmen lässt. Eine vergleichende Analyse ergab, 
dass der „multi-copy“ gfp-Reporter (pPcib gfp) optimale GFP Intensitäts-Levels erzielt und somit 
für eine Vielzahl von Anwendungen geeignet ist. Des Weiteren zeigten die Untersuchen, 
dass die Bildung von GFP durch den Reporter mit intrinsischen ColIb Proteinmengen in der 
S. Tm Population hervorragend korreliert.  
Frühere Arbeiten unserer Arbeitsgruppe konnten zeigen, dass die Expression von cib durch 
die Repressoren LexA und Fur negativ reguliert wird (Nedialkova et al., 2014). Dieser 
Sachverhalt konnte nun im zweiten Teil dieser Arbeit auf Einzelzellebene bestätigt werden. 
Zunächst konnte gezeigt werden, dass unter nicht induzierten Bedingungen ColIb nur durch 
eine kleine Fraktion der S. Tm Population gebildet wird. Im weiteren Verlauf dieser Arbeit 
wurde mit Hilfe des gfp-Reporters die Aktivität des Colicin Ib Promoters (Pcib) im Bezug auf 
die Induktion der SOS-Antwort, sowie Eisenmangel weiter charakterisiert. Jede Bedingung 
für sich führte zu einer unimodalen Zunahme von GFP+ S. Tm Bakterien, allerdings mit einer 
durchschnittlich geringen GFP Signal Intensität. Im Gegensatz dazu führte die Induktion der 
SOS-Antwort und ein gleichzeitig vorliegender Eisenmangel zu einer unimodalen aber 
insgesamt starken GFP Signal Intensität. Zusammenfassend konnte festgestellt werden, 
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dass im ersten Teil dieser Dissertation eine sorgfältige Charakterisierung des gfp-Reporters 
pPcib gfp gelungen ist. Daraufhin konnte der gfp-Reporter verwendet werden um die Regulation 
der cib Expression, sowie die Freisetzung von ColIb auf Einzelzellebene zu untersuchen.    
Colicin Ib gehört zu der Klasse von Colicinen der Gruppe B und kodiert daher kein 
entsprechendes Gen, welches für die Lyse der Zelle und somit zur Freisetzung von 
intrazellularem Colicin verantwortlich ist. Bislang war daher unklar auf welche Weise ColIb 
aus der Zelle freigesetzt wird. Unsere Gruppe konnte vor kurzem zeigen, dass ColIb von 
S. Tm durch die Zelllyse freigesetzt wird (Nedialkova et al., 2015). Diese Zelllyse wird durch 
Prophagen kodierte Lyse-Proteine verursacht und ColIb im Zuge der Aktivierung von 
Prophagen freigesetzt. Um die Expression von cib, sowie die Induktion von Prophagen 
gleichzeitig untersuchen zu können, wurden entsprechende gfp-Reporter hergestellt. Im 
Laufe meiner Dissertation konnte ich bestätigen, dass einzelne Col+ Bakterien nur in 
Gegenwart von intakten Prophagen lysieren. Des Weiteren konnte ich zeigen, dass innerhalb 
einer Bakterienzelle die Expression von cib und die Induktion der Prophagen kodierten 
Lysegene ko-reguliert sind. Interessanterweise wurde des Weiteren festgestellt, dass nur ein 
kleiner Teil von ColIb+ S. Tm Bakterien die Expression von Prophagen kodierten Lysegene 
induziert und im Anschluss lysiert. Basierend auf den Ergebnissen meiner Dissertation 
konnte nun erstmals gezeigt werden, dass S. Tm die Strategie der „Arbeitsteilung“ für die 
Freisetzung von ColIb verfolgt, jedoch aber nicht, wie bei anderen Colicinen, für die 
Produktion des Colicins. Dies deutet erstmals auf den Mechanismus hin, wie S. Tm im 
entzündeten Darm durch „Arbeitsteilung“ einen Fitnessvorteil gegenüber kompetierende 
E. coli Stämme erlangt.  
Gewöhnlich bildet ein Colicin produzierendes Bakterium ein entsprechendes 
Immunitätsprotein, um sich vor der Toxizität des Colicins, und somit vor einem „Selbstmord“ 
zu schützen. Im letzten Teil der Arbeit habe ich einen Colicin B (ColB) sowie Colicin M 
(ColM) produzierenden E. coli Stamm (Ec252R) charakterisiert. Dieser Stamm ist zwar immun 
gegenüber ColB, aber zeigt eine sehr hohe Sensitivität gegenüber ColM. ColM ist nicht nur 
eines der kleinsten Colicine, es hat auch eine einzigartige Wirkungsweise. Im Gegensatz zu 
den derzeit bekannten Colicinen inhibiert ColM die Peptidoglycan Biosynthese. Dieses 
erfolgt im Periplasma durch die Hydrolyse des Phosphatesters zwischen dem Lipidcarrier 
Undecaprenol und der Mureinvorstufe N-Actelymuramyl-(Pentapeptid)-N-Acetylglucosamin. 
ColM (cma) sowie ColB (cba) sind hintereinander auf einem großen, konjugativen Plasmid 
kodiert (pColBM). Die Expression beider Gene wird von ein und demselben Promoter 
reguliert, welcher sich stromaufwärts von cba befindet. Entsprechende Immunitätsgene (cbi 
und cmi) sind ebenfalls auf demselben Lokus kodiert, werden aber in die entgegengesetzte 
Richtung transkribiert. Ziel war es in diesem Teil der Dissertation die Ursachen für die 
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Sensitivität von Ec252R gegenüber dem selbstgebildeten ColM aufzuklären. Zunächst habe 
ich belegt, dass das von Ec252R produzierte ColM Immunitätsprotein funktionell ist und daher 
nicht die Ursache für den durch ColM verursachten „Selbstmord“ von Ec252R ist. Darüber 
hinaus konnten die Ergebnisse dieser Arbeit zeigen, dass die Produktion des ColM 
Immunitätsproteins im Allgemeinen den Produzenten nur teilweise gegenüber der Toxizität 
von ColM schützt. Im Anschluss wurde eine Sammlung bestehend aus 36 verschiedenen 
E. coli Stämmen, welche den cma Lokus tragen, charakterisiert. Zwei dieser Stämme zeigten 
ebenfalls einen ähnlichen „Selbstmord“ Phänotyp. Auffällig war, dass die Mehrheit dieser 
Stämme ein verkürztes cba Gen aufweist („cba-remnant“). Eine genauere Untersuchung 
ergab, dass die Verkürzung des cba Gens eine Inhibition der ColM Produktion zur Folge hat. 
Basierend auf diesen Ergebnissen stellte ich die Hypothese auf, dass die Immunität 
gegenüber ColM unzureichend ist und daher ColM Produzenten nicht ausreichend 
gegenüber einem „Selbstmord“ geschützt sind. Aus diesem Grund muss eine ColM-
Resistenz, welche in der großen Mehrheit der ColM Produzenten beobachtet wurde, durch 
andere Mechanismen entstanden sein. Vor allem E. coli Stämme, welche gerade erst ein 
ColBM Plasmid aufgenommen haben, sind durch das ColM Immunitätsprotein gegenüber 
ColM nur partiell geschützt. Diese „neuen“ ColBM Produzenten müssten infolgedessen 
Mutationen anhäufen, welche eine ColM-Resistenz vermitteln oder mit der cma Expression 
interfrieren. In Anlehnung an diese Idee habe ich vermutet, dass Ec252R eventuell ein Isolat 
repräsentiert, welches vor kurzem ein funktionales ColBM Plasmid aufgenommen hat. Dieser 
Stamm hat sich bisher jedoch noch nicht genügend angepasst, so dass sich eine ColM-
Resistenz entwickeln konnte oder die Reduzierung der ColM Produktion bewirkt wurde. Um 
diese Idee experimentell zu verifizieren wurde schließlich eine Serie an in vitro 
Evolutionsexperimenten durchgeführt. Zusammenfassend lässt sich sagen, dass die Daten 
dieser Dissertation neue Erkenntnisse und Einblicke in die Biologie von ColM liefern. Laut 
meiner Ergebnisse repräsentiert ColM nicht nur ein Ausnahmefall im Bezug auf seine 
einzigartige Wirkungsweise innerhalb der Colicine, sondern auch ein Ausnahmefall im Bezug 
auf seine ungewöhnlich hohe Toxizität gegenüber seinem Produzenten, trotz eines intakten 
und funktionellen Immunitätsproteins.  
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1 Introduction 
1.1 Colicin biology 
Bacteria are found in all kind of environments such as e.g. soil, water or the human gut, were 
they form complex communities and interact with each other. Competition between 
microorganisms is one example of bacterial interaction (Hibbing et al., 2010). Competition 
between microorganisms (interspecies competition) has an important role in microbial 
interactions as it drives community dynamics and thereby shapes biodiversity (Little et al., 
2008, Foster and Bell, 2012). It is also important for pathogens for the establishment of 
infections (Stecher et al., 2007). Interspecies competition can occur in two different 
scenarios, by exploitative and interference competition (Little et al., 2008). In case of 
exploitative competition, bacteria compete with other bacteria by consuming their resource 
(space and nutrients) and thus banish competitors from the captured ecological niche (Little 
et al., 2008). In contrast to this, using interference competition bacteria compete directly with 
other bacteria and harm competitors by production of toxic compounds like antimicrobials 
(Cornforth and Foster, 2013). These produced compounds also include bacteriocins such as 
colicins (Majeed et al., 2011). 
 
1.1.1 Main characteristics of colicins  
Colicins were first discovered in the name-giving species Escherichia coli (E. coli) by André 
Gratia in 1925  (Gratia, 1925) and since then have been also found in other species of 
Enterobacteriaceae like Salmonella spp., Shigella spp. and Citrobacter spp. (Cascales et al., 
2007). Colicins are small proteinaceous toxins and are classified as bacteriocins (Jacob et 
al., 1953). In fact, the colicin is released by the producing bacterium, and kills susceptible 
closely related target bacteria (usually of the same species) (Riley and Wertz, 2002a). They 
are generally found with a high molecular mass ranging in size from around 42 to 75 kDa, 
with the exceptions of colicin M (~30 kDa) and colicin Js (11 kDa) (Šmarda and Šmajs, 1998, 
Šmajs and Weinstock, 2001). Colicins display a high killing efficiency, as only one molecule 
of the colicin, if successfully translocated, is sufficient to kill a sensitive target bacterium. 
These toxins are usually harmless for the producer if the cognate immunity protein is 
simultaneously synthesized. Colicins are mostly abundant in the mammalian gut and play an 
important role as competition factors for intestinal colonization by new strains including 
enteric pathogens (Cascales et al., 2007).  
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According to the translocation machinery used to enter the target bacterium, colicins are 
classified in two groups (A and B). Group A colicins (e.g. colicin A, E1-E9) are translocated in 
a Tol-dependent manner, whereas group B colicins (e.g. colicin B, Ia, Ib, M) are imported into 
the target bacterium by the TonB-translocation machinery (Davies and Reeves, 1975a, 
Davies and Reeves, 1975b). More than 20 different colicins have been discovered so far. 
They do not only differ in size and in the dependency on the translocation machinery, but 
also display a wide range of killing mechanisms (Table 1.1). Colicins with nuclease activity 
(DNase or RNase), colicin M which comprises the ability to disrupt the peptidoglycan 
biosynthesis, and pore-forming ionophore colicins have been described (Cascales et al., 
2007). The latter are able to depolarize the bacterial cell membrane followed by an efflux of 
intracellular ions and death of the bacterium (Weaver et al., 1981a). 
 
Table 1.1: Characteristics of the most studied colicins: import and mode of action. 
Colicin 1
st
 
receptor 
2nd receptor 
(translocator) 
Translocation 
system Mode of action 
Group A 
    
A BtuB OmpF TolA, TolB, TolQ, TolR  Pore formation 
E1 BtuB TolC TolA, TolR Pore formation 
E2 BtuB OmpF TolA, TolB, TolQ, TolR DNase 
E3 BtuB OmpF TolA, TolB, TolQ, TolR 16S-RNase 
E4 BtuB OmpF TolA, TolB, TolQ, TolR 16S-RNase 
E5 BtuB OmpF TolA, TolB, TolQ, TolR t-RNase 
E6 BtuB OmpF TolA, TolB, TolQ, TolR 16S-RNase 
E7 BtuB OmpF TolA, TolB, TolQ, TolR DNase 
E8 BtuB OmpF TolA, TolB, TolQ, TolR DNase 
E9 BtuB OmpF TolA, TolB, TolQ, TolR DNase 
K Tsx OmpF TolA, TolB, TolQ, TolR Pore formation 
N LPS OmpF TolA, TolQ, TolR Pore formation 
S4 OmpW OmpF TolA, TolB, TolQ, TolR Pore formation 
U OmpA OmpF, LPS TolA, TolB, TolQ, TolR Pore formation 
Group B 
    
B FepA unknown TonB, ExbB, ExbD Pore formation 
D FepA unknown TonB, ExbB, ExbD t-RNase 
Ia  CirA CirA TonB, ExbB, ExbD Pore formation 
Ib CirA CirA TonB, ExbB, ExbD Pore formation 
M FhuA FhuA TonB, ExbB, ExbD Inhibition of peptidoglycan 
biosynthesis 
5 Tsx TolC TonB, ExbB, ExbD Pore formation 
10 Tsx TolC TonB, ExbB, ExbD Pore formation 
BtuB: vitamin B12 transporter; CirA: colicin I receptor; FepA: ferrienterobactin receptor; FhuA: 
ferrichrome-iron receptor; Omp: outer membrane protein; Tsx: nucleoside specific channel-forming 
protein. Table modified from (Kim et al., 2014).  
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All colicins have in common a tripartite domain structure consisting of the amino-terminal 
translocation domain (T), the receptor domain (R) and the carboxy-terminal cytotoxic domain 
(C) (Figure 1.1A). The initial step of colicin import is also similar to all colicins. First, the 
central R-domain binds with high affinity to its specific outer-membrane receptor, thus 
explaining the narrow-spectrum of colicin activity. Receptors for colicins can be either trimeric 
outer membrane porins (OmpF, OmpW, OmpA), or outer membrane transporters usually 
used to transport iron-chelate complexes (FhuA, FepA, Tsx, CirA), or vitamin B12 (BtuB), or 
lipopolysaccharides (LPS) in case of colicin N (Kleanthous, 2010, Johnson et al., 2014). After 
binding, group A colicins recognize a translocator protein with their T-domain (e.g. OmpF), 
subsequently recruit the Tol- translocation system to the translocon and the T-domain 
passes through the outer membrane (OM). The Tol-translocation system consists of the 
inner membrane proteins TolA, TolQ, TolR, the periplasmic protein TolB and the 
peptidoglycan-associated lipoprotein Pal. The proteins TolQ and TolR are responsible for the 
proton-motive-force (PMF)-dependent activation of TolA (Figure 1.1B). However, group B 
colicins bind with the T-domain a second copy of the R-domain-bound receptor (e.g. ColIa 
uses two copies of CirA) followed by the recruitment of proteins of the TonB-dependent 
system (Jakes and Finkelstein, 2010). The TonB-machinery consists of the inner membrane 
proteins TonB, ExbB, ExbD, whereas ExbB and ExbD provide the required energy from the 
inner membrane PMF to energize TonB for the uptake of group B colicins (Figure 1.1C). 
After receptor-binding, the C-domain of the colicin crosses the OM by a yet unknown 
mechanism. Depending on the mode of action, the C-domain is integrated into the inner 
membrane (IM) (pore formers) while in case of colicin M it stays in the periplasm or is further 
translocated into the cytoplasm (nucleases). In case of nuclease colicins, the C-domain is 
cleaved off in a FtsH-dependent manner (ATP-dependent metalloprotease) in the IM and is 
further passaged through the IM into the cytoplasm (Kim et al., 2014). 
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Figure 1.1.: Schematic view of Tol- and TonB-dependent import pathways for colicins. (A) The 
tripartite domain structure of colicins, consisting of an amino-terminal translocation domain [T], a 
central receptor binding domain [R] and a carboxy-terminal cytotoxic domain [C]. (B) Example of the 
import of a group A nuclease colicin (e.g. colicin K) using the Tol-dependent import machinery (TolA, 
TolB, TolQ, TolR and the peptidoglycan-associated lipoprotein Pal). At first the colicin binds with its 
central R-domain to its specific receptor [Rc]. In the next step the T-domain recognizes the 
translocator protein [Tl], followed by the recruitment of the Tol-import machinery and its transfer 
through the outer membrane [OM] in the periplasm (indicated as purple dots). After this, the C-domain 
is also imported in the periplasm by a yet unknown mechanism, cleaved from the other domains in an 
FtsH-dependent manner and further translocated (indicated as red dots). (C) Example of the import of 
a group B pore-forming colicin by the TonB-translocation system (TonB, ExbB, ExbD). The colicin 
binds with its R-domain its specific receptor and with the T-domain a second copy, of this receptor, 
thereby recruiting the TonB-machinery. After this the T-domain is translocated through the OM in the 
periplasm (indicated as purple dots). As a consequence the C-domain is imported in the periplasm by 
a yet unknown mechanism and integrated in the IM to form a voltage gated ion channel (indicated as 
red dots). Both import machineries are energy-dependent and receive this energy from the proton 
motive force [PMF] by either TolR/TolQ (Tol-dependent translocation) or ExbB/ExbD (TonB-dependent 
translocation). Adapted by (Kim et al., 2014).  
 
1.1.2 Genetic organization and regulation of colicins  
Colicin operons are encoded on colicinogenic plasmids and can be subdivided into two 
classes: type I and type II. Type I plasmids mostly encode operons of group A colicins and 
are small (6-10 kb), multi-copy (~20 copies/cell) and mobilizable. Type II plasmids generally 
encode operons of the group B colicins and are usually large (>40 kb), mono-copy and 
conjugative (Hardy et al., 1973). Type II plasmids can also encode two different colicins, as 
for example pColBM, which encodes genes for colicin B and M (Köck et al., 1987, Ölschläger 
et al., 1984).  
The genetic organization of nuclease colicins differ from that of pore-forming colicins. The 
colicin gene (= activity gene) of nuclease colicins is followed by the gene encoding for a 
cognate immunity protein that protects the colicin-producer against self-killing. The immunity 
gene is regulated by the promoter of the activity gene and, additionally, by its own 
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constitutive promoter, located within the activity gene. This allows constitutive expression of 
the immunity gene. For pore-forming colicins the immunity gene is not encoded on the same 
operon but on the opposite DNA strand downstream of the colicin activity gene, and is 
regulated by its own constitutive promoter. The operon of group A colicins also encodes a 
third gene downstream of the activity gene (pore-formers) or immunity gene (nucleases), 
which encodes for a lysis gene and ensures the release of colicins by the producing cell 
(Figure 1.2). In contrast, group B colicins usually do not encode for a lysis gene, except 
colicin 5, 10 and D. In general, all colicins are negatively regulated by a strong SOS-inducible 
promoter in a LexA (locus for X-ray sensitivity A)-dependent manner (Singh and Ghosh, 
2012) and SOS-induction can yield a 1000-fold increase in colicin gene expression (Zgur-
Bertok, 2012). 
 
 
Figure 1.2: Gene structure of colicin operons. Colicin operons are generally regulated by the SOS-
inducible promoter PSOS. The operon of group A nuclease-type colicins encodes the colicin X activity 
gene (cxa), its cognate immunity gene (cxi) and the lysis gene (cxl). In contrast, group B, colicin 
operons (except colicin D, 5, 10) lacking the cxl gene. The operons of pore-forming colicins do not 
encode for the immunity gene cxi. They either encode the genes cxa and cxl (group A) or only the cxa 
gene (group B). In general, the immunity gene of pore-forming colicins is located on the opposite DNA 
strand and regulated by its own constitutive promoter (Pim). The immunity genes of nuclease-type 
colicins are additionally regulated by the PSOS promoter. Transcription terminators are indicated as ●. 
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The SOS-response comprises a pathway for controlling DNA repair and is responsible for the 
regulation of more than 50 genes (Zgur-Bertok, 2013). For the regulation of the SOS-
response two key regulator proteins are needed: the repressor protein LexA and the inducer 
protein RecA (recombinase A) (Butala et al., 2009). Repression of SOS-inducible genes 
takes place by a LexA dimer binding to a short (20 bp) palindromic consensus sequence 
which is termed SOS-box and is located downstream of the Pribnow box. The SOS-response 
can be induced by exogenous factors (e.g. UV-radiation, chemical or oxidative compounds or 
antibiotics (like mitomycin C and ciprofloxacin) or by endogenous factors as stalled 
replication forks or metabolic by-products as reactive oxygen species (ROS) (Zgur-Bertok, 
2013).  
Concerning the main SOS-response pathways in general, upon SOS-induction (e.g. by UV 
irradiation) double stranded DNA breaks occur and are recognized by the RecBCD complex. 
This complex generates with its helicase and nuclease activity single stranded DNA (ssDNA) 
the substrate for RecA. Thereafter, ssDNA accumulates in the cell and is recognized and 
bound by RecA, which is thereby converted in its active form as a nucleoprotein filament. 
This induces auto-cleavage of free LexA dimers and lead to the dissociation of LexA from the 
SOS-box. As a consequence, this leads to de-repression of SOS-inducible promotors 
(Baharoglu and Mazel, 2014).    
In case of colicin regulation two overlapping SOS-boxes are generally involved except for 
colicin Ia and Ib, which are regulated only by a single SOS-box differing from SOS-box 
consensus sequences of other colicins of E. coli (Gillor et al., 2008). Recently it has been 
shown that colicin synthesis is additionally regulated by nutrient-responsive regulators such 
as ferric uptake regulator Fur (colicin Ib) (Nedialkova et al., 2014), the transcription regulator 
IscR (iron–sulphur cluster regulator) (colicin E1, K, N) (Butala et al., 2012) or transcription 
regulator AsnC (ColE2, ColE6, ColE8) (Kamenšek et al., 2015) or the RNA-binding protein 
CsrA (carbon storage regulator protein) which post-transcriptionally regulates synthesis of 
colicin E7 and E2 lysis genes (Yang et al., 2010, Hol et al., 2014). Due to these additional 
regulators induction of colicin gene expression exhibits a short lag phase between SOS-
induction and the induction of colicin gene expression (Herschman and Helinski, 1967, Salles 
et al., 1987). Therefore, colicin synthesis occurs only upon severe and persistent SOS-
response induction and additional regulator proteins ensure a tight repression of colicin and 
colicin lysis genes (Zgur-Bertok, 2012).  
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1.1.3 Colicin release mechanisms  
The release mechanism of group A colicins and some colicins of group B (colicin D, 5 and 
10) depends on production of the lysis protein. Colicin lysis proteins are small lipoproteins 
(27-35 amino acids), which are synthesized as precursor in the cytoplasm and further 
processed by lipid-modification events, resulting in a mature lysis protein anchored to the 
periplasmic leaflet of the IM or OM. This leads to membrane perturbation, so that the outer 
membrane phospholipase A (OmpLA) is activated (OmpLA*). OmpLA* permeabilizes the OM 
by hydrolyzing the OM-phospholipids and generates thereby fatty acids and 
lysophopholipids, promoting the release of colicins (Snijder and Dijkstra, 2000, Pugsley and 
Schwartz, 1984, Cavard, 1997). For colicin E7 release it was further shown that the mature 
lysis protein, anchored in the IM, activates OmpLA cooperatively with its cleaved stable 
signal peptide (Chen et al., 2011). 
The release mechanism of group B colicins, which do not encode a cognate lysis gene had 
been unclear for a long time (Cascales et al., 2007). Recently another colicin lysis gene 
independent release mechanism has been described. Group B colicin Ib, which does not 
encode a colicin lysis gene, is released from the producing bacteria by prophage-mediated 
bacterial cell lysis (Nedialkova et al., 2015) (section 1.5.7).     
 
1.1.4 Immunity to colicins 
Protection against self-killing due to colicin synthesis is usually circumvented by the 
simultaneous production of a cognate immunity protein. To neutralize the lethal toxicity of the 
colicin its immunity protein has to bind to the C-domain of the colicin (Cascales et al., 2007). 
Immunity proteins of nuclease-type colicins (DNase- and RNase-type) have a molecular 
weight of about ~10 kDa and bind directly to their cognate colicin after their synthesis. This 
occurs either to the nuclease activity site directly, in case of immunity proteins of tRNase-
type colicins (e.g. Im5 and ImD), or by binding the adjacent region of the active site, in case 
of DNase and rRNase colicins (e.g. colicins E2, E7, E9, E3, E4, E6) (Kleanthous et al., 1999, 
Kleanthous and Walker, 2001, Luna-Chávez et al., 2006). Both blocking mechanisms inhibit 
colicin binding to its substrate. Hence, the nuclease-type colicin, once synthesized, is bound 
directly to its cognate immunity protein, to prevent its lethal toxicity already inside the 
producer, and is released by the producer as an inactive complex. The immunity protein is 
released from this complex after the colicin has bound its receptor, but the mechanism is still 
unclear (Kim et al., 2014). The immunity proteins of pore-forming colicins, having a molecular 
weight of about 13-21 kDa (Harkness and Ölschläger, 1991), are integral proteins located in 
the IM and are classified as A-type (for colicins A, B, N, and U) or E1-type (for colicins E1, 5, 
K, 10, Ia, and Ib) immunity proteins. The immunity proteins of both groups diffuse laterally in 
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the IM to bind their cognate colicin cytotoxic domain right before the colicin-formed channel 
opens. Therefore it does not prevent formation of the channel but the depolarization of the 
membrane. The integral embedded immunity proteins either bind the voltage-gated region of 
the colicin channel (E1-type e.g. colicin Ib) or to the adjacent region (A-type e.g. colicin B) 
(Espesset et al., 1996, Nardi et al., 2001, Zhang et al., 2010).  
The immunity protein of the enzymatically active colicin M has a calculated molecular weight 
of about 14 kDa (Harkness and Ölschläger, 1991, Usón et al., 2012), but showed a 
molecular weight of 16 kDa determined by polyacrylamide gels (Olschläger and Braun, 
1987). It is anchored in the IM similarly to the immunity proteins of pore-forming colicins and 
binds colicin M in the periplasm (Usón et al., 2012), which is in contrast to the immunity 
proteins of the enzymatic nuclease-type colicins. However, colicin M is only lethal to a 
bacterium if translocated from the outside into the periplasm. Therefore colicin M does not 
need to be bound to its immunity protein the entire time (Harkness and Braun, 1990). 
 
1.1.5 Colicin Ib in Salmonella enterica serovar Typhimurium 
Salmonella enterica serovar Typhimurium (S. Tm) is a Gram-negative and facultative 
anaerobic bacterium which belongs to the family of Enterobacteriaceae. As intracellular 
pathogen of humans and warm-blooded animals, it causes self-limiting diarrhea (in humans) 
or a systemic typhoid-like disease (in mice) (Coburn et al., 2007). Usually in the healthy 
intestine Enterobacteriaceae as S. Tm and E. coli are only present in low abundance (~0.1%) 
and are taken over by the residing obligate anaerobic microbiota (homeostasis) (Eckburg et 
al., 2005). However, in response to inflammatory conditions, for instance when induced by 
enteropathogenic S. Tm (Stecher et al., 2007), the ecology of the microbiota is altered, which 
in turn leads to a high increase (“bloom”) of facultative anaerobic Enterobacteriaceae as 
S. Tm and E. coli (Stecher et al., 2013). For instance, induction of inflammation causes 
neutrophil transmigration, which produce lipocalin-2 that sequesters bacterial siderophores 
(e.g. enterochelin) (Raffatellu et al., 2009), and stress-inducing reactive oxygen and nitrogen 
species (ROS and RNS) (Fialkow et al., 2007, Winter et al., 2013a). Furthermore, this leads 
to generation of anaerobic electron acceptors by the inflamed mucosa (e.g. NO3-, 
tetrathionate) which are used for anaerobic respiration by facultative anaerobic bacteria 
(Winter et al., 2010a, Winter et al., 2013b). Intriguingly, under inflammatory conditions S. Tm 
(S. TmSL1344) is not only able to outcompete the resident anaerobic microbiota but also 
commensal E. coli. This ability of S. Tm is conferred by the large (86.9 kb) low-copy, 
conjugative colicinogenic plasmid pColIB9 (further named as p2) which encodes, among 
other genes, for colicin Ib and its cognate immunity protein (Kröger et al., 2012, Stecher et 
al., 2012a, Clewell and Helinski, 1970). Colicin Ib production is induced by SOS-response 
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and Fe2+-limitation (see section 1.1.2). Killing occurs by the binding of colicin Ib to its 
receptor CirA, followed by the TonB-dependent translocation (as for group B colicins) across 
the OM and the formation of pores in the IM, a process that leads to ion-leakage and cell 
death of a sensitive bacterium (Weaver et al., 1981b). Additionally, it has been shown in in 
vivo studies that S. TmSL1344 up-regulates colicin Ib gene expression in the inflamed mouse 
gut. This confers S. TmSL1344 a strong growth advantage over competing, commensal and 
colicin Ib-sensitive E. coli in inflammation-induced Enterobacterial blooms (Figure 1.3) 
(Stecher et al., 2013, Nedialkova et al., 2014).   
 
 
Figure 1.3: Inflammation induced colicin-dependent competition in Enterobacterial blooms. (A) 
In the healthy intestine, and thus upon homeostatic conditions, Enterobacteriaceae (red and blue) are 
low in numbers and suppressed by high numbers of the obligate anaerobic microbiota (green). (B) As 
a consequence of intestinal inflammation, induced for instance by enteropathogenic S. Tm (e.g. 
S. TmSL1344) the immune system of the host responds with e.g. neutrophil transmigration into the gut 
lumen. Iron-depleting agents as lipocalin-2 and reactive oxygen and nitrogen species (ROS, RNS) are 
produced and secreted which result in iron-limited conditions and activation of the SOS-response. 
Such environmental cues induce colicin Ib (red star) production and are thereby a trigger for colicin-
dependent competition in Enterobacterial blooms. Adapted from (Nedialkova et al., 2014).  
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1.1.6 Colicin M in E. coli 
As a member of the Enterobacteriaceae family, E. coli is a Gram-negative and facultative 
anaerobic bacterium and closely related to S. Tm. It is primarily found in the gastrointestinal 
tract as commensal of vertebrates like mammals, birds and reptiles. In addition a variety of 
E. coli pathovars exist, causing intestinal (diarrhea) or extraintestinal (bacteraemia, 
meningitis or urinary tract infections) diseases (Donnenberg, 2002, Dozois and Curtiss, 1999, 
Hartl and Dykhuizen, 1984). Strains of the species E. coli are the main reservoir of 
colicinogenic plasmids, which serve competition for ecological niches (Cascales et al., 2007). 
Colicin M is unique among the colicins produced by E. coli. It has a molecular weight of only 
~30 kDa and is therefore one of the smallest colicins known so far. Usually, it is encoded 
together with colicin B (~55 kDa) and their cognate immunity proteins on large (~80-180 kb) 
conjugative colicin BM plasmids further named as pColBM (Johnson et al., 2006, 
Christenson and Gordon, 2009, Ölschläger et al., 1984). Among all known colicins, colicin M 
displays a unique cytotoxicity, as it interferes with the peptidoglycan synthesis (El Ghachi et 
al., 2006). Notably, colicin M is only toxic for the cell if imported from the surrounding 
environment (Harkness and Braun, 1990). To this end, colicin M binds to the OM receptor 
FhuA, probably partially unfolds and, as a group B colicin, it is further translocated into the 
periplasm, using the TonB-dependent machinery (Zeth et al., 2008). Once it is in the 
periplasm it is bound by FkpA (a peptidyl prolyl cis-trans isomerase/chaperone) which refolds 
the colicin M protein (Helbig et al., 2011). Active colicin M cleaves lipid II, the undecaprenyl-
phosphate-linked precursor, of the growing peptidoglycan layer resulting in undecaprenol 
and 1-pyrophospho-(N-Acetylmuramic-acid)-(pentapeptide). These products cannot be used 
further for the murein biosynthesis, resulting in cell wall damage and bacterial lysis (El 
Ghachi et al., 2006). 
 
1.2 Ecology of colicinogeny  
Colicinogeny can shape microbial community diversity and dynamics, as shown by 
mathematical modeling, in in vitro and in vivo studies (Riley and Wertz, 2002b, Czárán et al., 
2002, Nedialkova et al., 2014, Kirkup and Riley, 2004). About 10-50% of natural E. coli 
strains are colicin-producers, whereas an average of about 70% are resistant to at least one 
colicin and an average of 30% are resistant to all investigated colicins, with only a small 
fraction of colicin-sensitive bacteria (Riley and Gordon, 1999).  
Interestingly, although colicin-producers comprise a high-killing potential, the three different 
species (sensitive, producer, resistant) can coexist, but only in a spatially structured 
environment (e.g. growth on agar plates or in biofilms) according to a “rock-paper-scissor” 
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game (Kerr et al., 2002). This system is also designated as “non-transitive-interaction 
network” (Figure 1.4). The producer strain beats the sensitive strain, but in turn the producer 
bears the cost for colicin production and thus is beaten by the resistant strain. The resistant 
strain in turn is beaten by the sensitive strain as the sensitive strain does not bear the costs 
for colicin resistance. For instance, colicin resistance can be achieved by mutation of the 
receptor which can result, in case of mutation of the receptor CirA (ColIb receptor) in 
suboptimal iron-acquisition. In a well-mixed environment (e.g. liquid culture), the resistant 
strain would outcompete both the sensitive strain and the producer strain, therefore 
preventing coexistence of all phenotypes (Kerr et al., 2002, Hibbing et al., 2010).  
 
 
Figure 1.4: Rock-paper-scissors interplay in a non-transitive competition network. A colicin 
producing strain kills the colicin-sensitive strain due to colicin-mediated killing. The colicin-sensitive 
strain does not pay the costs for resistance and gain a competitive growth advantage over the colicin-
resistant strain. The colicin-resistant strain in turn outcompetes the producer strain, as it does not pay 
the cost for colicin production. Adapted from (Hibbing et al., 2010). 
 
 
1.3 Evolution of colicin diversity 
Evolutionary processes (e.g. mediated by mutations) are also common among colicins and 
contribute to the diversity of colicinogenic-bacterial population. It is assumed that colicins 
evolve by two different possibilities depending on the environmental abundancy. In an 
environment of less abundant colicins, as it would be in general the case for nuclease-type 
colicins (less abundant than pore-forming colicins), mutations are highly likely to appear in 
the colicin immunity region. This would result in a strain broadened in its immunity capacity 
against its own and relative colicins. This might be followed by an additional mutation in the 
colicin region close to the immunity gene. This generated novel colicin is able to kill the 
ancestral colicin producing strain and thus, outcompetes the yet more abundant ancestral 
colicin-producer. Upon conditions of high colicin-abundance, thus very likely for pore-forming 
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colicins, “domain-swapping” of protein-sequence with high similarities occurs by 
recombination. Interestingly, this domain-swapping was also shown for nuclease-type 
colicins (e.g. E2), demonstrating that colicin diversity, as a result of the occurrence of 
mutations, is dependent on colicin-abundance and sequence similarity rather than the mode 
of action (Riley and Wertz, 2002a). Another mechanism which contributes to the diversity of 
bacterial populations is the acquisition of additional colicin genes (e.g. pColBM). This confers 
a competitive advantage against single-colicin producer and a broadened killing capacity 
against sensitive cells, as these strains can produce colicins which bind to a variety of 
receptors (Gordon and O'Brien, 2006, Gordon et al., 2007, Ölschläger et al., 1984).       
 
1.4 Heterogeneous gene expression in bacteria 
Based on experimental bulk assays, it was assumed that a population of bacteria, derived 
from a common ancestor bacterium, consists of isogenic bacterial cells, which should all 
exhibit the same phenotype. Due to microscopy based single cell analysis techniques, it was 
discovered that in a population of isogenic bacteria, individuals can exhibit different 
phenotypic traits (e.g. gene expression, growth rates, cell-size), even if grown under the 
same environmental conditions. This phenomenon is designated as “phenotypic 
heterogeneity” (Raj and van Oudenaarden, 2008). Bistable (or bimodal) gene expression can 
lead to phenotypic heterogeneity in an isogenic population, e.g. due to feedback loops. For 
instance, changing nutrient concentrations in the surrounding environment can be sensed by 
the bacterial signaling network. In case the corresponding network comprises a bistable gene 
expression, the population is split into two phenotypically distinct subpopulations. It is also 
possible that the network comprises a multistable gene expression pattern, which results in 
more than two phenotypically distinct subpopulations (Smits et al., 2006). For an isogenic 
population phenotypic heterogeneity can lead to an increase in the overall fitness of a 
population by two different scenarios, called “bet-hedging” and “division of labor” 
(Figure 1.5). Both can increase fitness of the genotype (Ackermann, 2015). The bet-hedging 
strategy can promote the fitness of a population in fluctuating environments. For instance, an 
isogenic population of bacteria can be composed of a fast growing subpopulation and a 
subpopulation with a phenotype reduced or inhibited in growth. The latter exhibits a 
detrimental phenotype compared to the other subpopulation, but it might be better adapted to 
other environments. This has been shown for E. coli persister cells which can tolerate 
antibiotic-exposure (Balaban et al., 2004). Another example of bet-hedging is explained by 
variation in gene expression of metabolic pathways generated by a positive feedback loop, 
as shown for the lac-operon in E. coli (Elowitz et al., 2002, Ozbudak et al., 2004). 
Interestingly, the lysis-lysogeny life cycle switch of bacteriophage lambda (generated by 
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double-negative feedback loop; section 1.4) depends as well on environmental conditions 
(e.g. nutrient or phage particle concentrations) and thus was shown to follow the bet-hedging 
strategy (Toman et al., 1985, Arkin et al., 1998).   
The fitness of a population can also be increased by division of labor. In contrast to bet-
hedging, this second strategy depends on the interaction between subpopulations. Here, 
subpopulations can fulfill simultaneously different functions which are otherwise costly or 
impossible to be fulfilled by a single bacterium. Therefore, in case of division of labor, a 
subpopulation sacrifices its fitness as “common good” to increase the fitness of the overall 
population (Ackermann, 2015). Formation of biofilms by Bacillus subtilis is one example of 
division of labor, as this process depends on the production of the major matrix protein EPS 
(extracellular polymeric substance), which is costly and reduces the bacterial fitness. EPS is 
only produced by a subpopulation of Bacillus subtilis and, therefore, EPS-production by the 
subpopulation serves as common good for the fitness of the remaining population (van 
Gestel et al., 2014). Another example is the expression of virulence genes for the Type III 
secretion system encoded on Salmonella pathogenicity island I (ttss-1) of S. Tm. Upon 
infection of the gut S. Tm bifurcates into two subpopulations consisting of bacteria either 
expressing ttss1 or not. Ttss-1 expressing bacteria invade the intestinal mucosa, thus 
initiating an immune response of the host, and are killed by immune defenses. The other 
subpopulation which does not express ttss1 stays in the gut lumen and benefits from gut 
inflammation, as this enables S. Tm to outcompete the intrinsic gut microbiota (Stecher et al., 
2007, Ackermann et al., 2008). Colicin production is also a form of division of labor. As 
known, colicins are only produced by a fraction of the population (Mrak et al., 2007, 
Kamensek et al., 2010) and this is costly because the producers need to lyse in order to 
release colicins (Cascales et al., 2007). In fact, this suicidal behavior is disastrous for the 
individual colicin-producing bacteria but beneficial for the remaining population. For example, 
in inflammation-induced Enterobacterial blooms in the gut, S. Tm outcompetes colicin Ib 
sensitive commensal E. coli by colicin Ib-dependent killing (Nedialkova et al., 2014) 
(section1.1.5).  
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Figure 1.5: Phenotypic heterogeneity in bacterial populations. Phenotypic heterogeneity can 
increase the fitness of a bacterial population by bet-hedging (upper panel) or division of labor (lower 
panel). The bet-hedging strategy is of advantage in fluctuating environments. For instance, phenotypic 
heterogeneity achieved by bet-hedging can result in at least two phenotypically distinct 
subpopulations, consisting of nutrient A-adapted bacteria (pink) and bacteria with a phenotype suited 
for growth in nutrient B (green), and thus showing a reduced fitness in nutrient A conditions. If 
environmental conditions changes to nutrient B the survival of the overall population is rescued by the 
green subpopulation. Phenotypic heterogeneity by division of labor depends on bacterial-cooperation. 
This strategy can increase the fitness of a population for example by colicin-production. Therefore, 
only a fraction of producers actually synthesizes colicin (colicin+; purple), release the toxin by lysis and 
thus kill sensitive bacteria. Due to the suicidal behavior of individual bacteria, the remaining population 
(light blue) can gain a fitness benefit over the colicin sensitive population (blue).        
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1.5 Bacteriophages 
1.5.1 Main characteristics 
Bacteriophages (or phages) were first discovered in the early 20th century and named by 
D’Herelle according to the observations that phages infect bacteria and lyse or devour 
(greek: phagein) the bacteria (Twort, 1915, d’Herelle, 1917). They are defined as obligate 
intracellular parasites (= virus), because they need to infect bacterial (or archeae) host cells 
to propagate (Madigan et al., 2009). Phages are highly abundant in the environment (>1031 
phage particles are present in the biosphere) and are found ubiquitously just like their 
bacterial host cells (Comeau et al., 2008).  
 
1.5.2 Phage life cycle  
Phages infect and replicate inside the host either by the lytic or the lysogenic life cycle 
(Figure 1.6). In both cases, phage-infection of the bacterial host is generally initiated by the 
highly specific attachment of phages to a specific surface structure of the host cell. These 
receptors are outer membrane structures presented at the bacterial surface such as 
lipopolysaccharides, teichoic acids, pili and flagella (Heller, 1992). Subsequently, the phage 
genome is injected into the host cell and circularizes as protection mechanism against 
degradation by the host exonucleases (Campbell, 2003). Depending on the phage type, 
different mechanisms are employed for replication. Virulent phages (e.g. phage T4), which 
undergo a lytic life cycle, redirect directly the host cell metabolism, resulting in the inhibition 
of all cellular processes not needed for phage synthesis. Subsequently, phage particles are 
assembled and mature phages are released by cell lysis. Temperate phages, which 
reproduce via a lysogenic life cycle, can either directly follow the lytic life cycle or undergo 
lysogeny. Lysogeny is a result of the integration of the phage-genome as prophage in the 
host chromosome (e.g. phage λ). Alternatively, the phage-genome stays in the cytoplasm as 
plasmid-like structure (e.g. phage P1). As a result, temperate phages replicate together with 
the host genome and its replication machinery (Salmond and Fineran, 2015). At any time 
prophages can be induced to excise from the host chromosome and switch to the lytic life 
cycle. Phage particles are synthesized and finally the mature phage particles are released by 
cell lysis. For instance, induction of the host SOS-response (e.g. by UV-radiation, oxidative 
stress, antibiotics, and starvation) can result in prophage induction (Oppenheim et al., 2005, 
Zgur-Bertok, 2013). Filamentous phages (e.g. M13) are the exception as instead of lysing the 
host cell to release mature phage particle, they secrete mature phage particles. Thus 
filamentous phages do not kill but slow down the growth of the host cell (Russel, 1995).   
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Figure 1.6: Exemplary life cycle of a temperate phage. The phage life cycle starts by the 
attachment of the phage to a specific receptor, presented on the host outer membrane. Subsequently, 
the phage genome is injected into the host cell, were it directly circularizes. At this step the phage 
decides weather it will follow the lytic or the lysogenic cycle. In case it decides for the lysogenic cycle it 
will integrate its genome in the host chromosome as prophage. Thus, it is replicated together with the 
host cell. Upon stressful bacterial growth conditions (e.g. SOS-response induction) the phage genome 
exits the host chromosome and starts the lytic cycle. The phage genome is replicated and phage 
particles are synthesized and assembled. This is followed by the host lysis and release of mature and 
infectious phage particles, which are able to infect new host cells. Adapted from (Campbell, 2003).    
 
 
1.5.3 Induction of temperate phages 
In case of the temperate phage λ, the genetic switch between the lysogenic and the lytic 
state depends on the phage-encoded strong repressor protein cI. CI represses the promoters 
PR and PL of the lytic genes and regulates its own expression (PM). Thus the phage remains 
in the dormant state (Wegrzyn et al., 2012). As mentioned in section 1.1.2, upon induction of 
the SOS-response, e.g. by UV irradiation, RecA is activated (Rec*), inducing, among SOS-
regulated genes like LexA, also the auto-cleavage of cI dimers (Sauer et al., 1982).  
However, in contrast to LexA, the cleavage of cI is less efficient, suggesting that prophages 
are only induced upon a severe and permanent DNA damage (Slilaty et al., 1986). 
Additionally, Liu and co-workers could show a delay in the expression of the prophage late 
genes, after the genetic switch to the lytic cycle (Liu et al., 2013). After the cleavage of cI, the 
prophage genes of the lytic cycle are no longer repressed. Subsequently, the repressor 
protein cro is produced and represses cI-expression via the promotor PM and also other 
genes needed for maintenance of lysogeny (Court et al., 2007, Wegrzyn et al., 2012). 
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1.5.4 Evolutionary aspects of temperate phages 
It is well known that phages contribute to shape the bacterial community dynamics. For 
instance, temperate phages integrate into the host genome as prophages and thus increase 
the fitness of the host cell (lysogenic conversion). Lysogenic conversion implies that the host 
cell acquires prophage-encoded genes, which are usually worthless for the phage itself, but 
e.g. encode for antibiotic resistance genes (Quirós et al., 2014), virulence factors or 
superinfection exclusion systems (Brüssow et al., 2004). The latter protect the host against 
phage superinfection by blocking the DNA-injection of other phages (e.g. lytic phages) 
(McGrath et al., 2002, Bebeacua et al., 2013). Examples for prophage encoded virulence 
factors are the shiga toxin of E. coli O157:H7 (O'Brien et al., 1989, O'Brien et al., 1984), the 
cholera toxin of Vibrio cholerae (Waldor and Mekalanos, 1996) and the effector protein SopE 
of S. Tm (Friebel et al., 2001). Bacterial fitness can also be negatively influenced by 
integration of prophages in virulence genes of the host cell, thereby causing insertion 
mutations (Coleman et al., 1989, Lee and Iandolo, 1985). Furthermore, bacterial community 
dynamics can be shaped by phage-dependent horizontal gene transfer (HGT), by 
transduction (Zinder and Lederberg, 1952, Modi et al., 2013) or by phage-mediated cell lysis 
causing the release of bacterial genetic material which can be acquired by surrounding 
competing bacteria (e.g. transformation) (Kloos et al., 1994). Therefore, bacteriophages are 
able to promote the spread of antibiotic resistances by several mechanisms (Modi et al., 
2013, Huddleston, 2014, Quirós et al., 2014). 
 
1.5.5 Phage release by bacterial host lysis  
Phage-dependent cell lysis needs to be very tightly regulated, as cell lysis should occur at 
the right time to ensure completion of synthesis and maturation of the phage particles. 
Icosahedral phages with ssDNA and ssRNA encode for a single lysis protein, which is 
thought to inhibit the biosynthesis of the peptidoglycan layer (PGL). Disruption at the 
developing septum of the cell is suggested to cause the lysis (Bernhardt et al., 2001a, 
Bernhardt et al., 2001b, Bernhardt et al., 2002). In contrast, host cell lysis mediated by 
dsDNA phages (e.g. phage λ or phage 21) depends on several phage lysis genes (S, R, Rz 
and Rz1), which are usually encoded in a cassette regulated by the late gene promoter pR’ 
(Figure 1.7A) (Young, 2013). The cell lysis of Gram negative bacteria mediated by dsDNA 
phages involves 3 steps: (i) permeabilization of the cytoplasmic membrane (CPM), (ii) 
degradation of the peptidoglycan layer and (iii) fusion of the inner (IM) and outer membrane 
(OM) (Rajaure et al., 2015, Young, 2013). Two fundamentally different phage-dependent 
lysis pathways exist: (i) the canonical holin-endolysin model and (ii) the pinholin-SAR  
(signal-anchor-release) endolysin model (Young, 2013). Phages using the canonical holin-
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endolysin lysis model (e.g. phage λ; Figure 1.7B) produce the small membrane protein holin, 
encoded by the S gene, which accumulates in the CPM as an inactive complex with its 
cognate antiholin protein. In the meantime the active muralytic enzyme endolysin, encoded 
by the R gene, is produced and accumulates in the cytoplasm. At a certain time the holins 
are triggered to form aggregates, called “rafts” (1-3 per cell) consisting of hundreds of holin 
molecules. It is thought that the formation of these holin-“rafts” depolarizes the CPM, which 
can activate the holin-antiholin complex. This in turn causes the arrangement of holes (0.34-
1 µm) which allow the passage of endolysins and the endolysin-dependent degradation of 
the PGL (Young, 2013). In contrast, the pinholin-SAR endolysin model (e.g. by phage 21) 
produces the protein pinholin together with its cognate antipinholin protein and the muralytic 
SAR (signal-anchor-release) endolysin (Young, 2013). SAR endolysins are translocated by 
the Sec-transport machinery of the host and anchored in the periplasmic leaflet of the IM. In 
the meantime inactive pinholin-antipinholin complexes are produced and accumulate in the 
CPM. After triggering, pinholins are activated, a process followed by the arrangement of 
rafts, causing the formation of ~103 “pinholes” with a diameter of about 2 nm. This in turn 
results in the depolarization of the CPM. The muralytic SAR endolysins are released from the 
CPM and change to their enzymatically active form, which leads to the degradation of the 
PGL (Young, 2013, Young, 2014). In the last step of the host cell lysis, two additional 
proteins are needed to form a complex that spans the entire periplasm (= spanin complex). 
One of these is the type II integral inner membrane protein Rz (= i-spanin) and the other one 
is the outer membrane lipoprotein Rz1 (= o-spanin). After the PGL is degraded the spanin 
complex disrupts the OM by mediating the fusion of the inner and outer membrane (Rajaure 
et al., 2015, Berry et al., 2008).    
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Figure 1.7: The canonical holin-endolysin lysis model of phage λ. (A) Linearized genome of 
phage λ, flanked by the cohesive (cos) sites used for circularization inside of the host. Control region 
encodes among others the transcription regulators cI and cro. Adapted from (Rajagopala et al., 2011). 
Gene cassette organization of the lambdoid prophage lysis genes (S, R, Rz and Rz1) is shown as 
inset. The expression of S (holin), R (encodes endolysin), Rz (i-spanin) and Rz1 (o-spanin) is 
regulated by the phage late gene reporter pR´. (B) Schematic process of the host cell lysis by a 
lambdoid phage. Initially, phage lysis starts with the accumulation of the phage lysis proteins. Holins 
accumulate in the inner membrane (IM), endolysins in the cytoplasm and spanins in the IM (i-spanins) 
and outer membrane (OM; o-spanins) and form periplasmic spanning complexes. Upon “triggering”, 
holins form “rafts” which mediates hole-formation. Using these holes the muralytic endolysins can 
transit into the periplasm and degrade the peptidoglycanlayer (PG). This results in the oligomerization 
of the PG-liberated spanins. Subsequently conformational changes of the spanins lead to the 
disruption of the OM by the IM-OM fusion. Adapted from (Rajaure et al., 2015, Young, 2014). 
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1.5.6 Prophages encoded by S. TmSL1344  
As already mentioned in section 1.5.4, phages shape the community dynamics of their host 
strains by several mechanisms. This could also been shown for S. Tm strains, which differ in 
the number and type of their prophages (Porwollik and McClelland, 2003, Figueroa-Bossi 
and Bossi, 2004, Bossi et al., 2003). Phage typing is thereby a very useful tool to support 
global Salmonella surveillance (Baggesen et al., 2010). S. TmSL1344 harbors four different 
prophages, which are inducible upon SOS-response activated by the antibiotic mitomycin C: 
the P2-like prophage SopEφ and the lambdoid prophages Gifsy-1, Gifsy-2 and ST64B (Mirold 
et al., 1999, Figueroa-Bossi and Bossi, 2004, Figueroa‐Bossi et al., 1997, Frye et al., 2005) 
(Figure 1.8). 
 
 
Figure 1.8: Genetic organizations of the prophage genomes in S. TmSL1344. Depicted are the open 
reading frames (ORF) of the Gifsy-1, Gifsy-2, SopEφ and ST64B phage-genome, respectively. The 
ORFs encodes for excision/integration proteins (orange), regulation proteins (light blue), virulence 
factors (purple), phage structure proteins (capsid= blue; neck= brown; tail= green) proteins, lysis 
proteins and for proteins with unknown functions (grey). The direction of the gene-transcription is 
shown by arrows. From (Nedialkova et al., 2015). 
 
The P2-like prophage SopEφ encodes the effector protein SopE an important virulence factor 
of S. Tm. The effector protein SopE is exported by the Type III secretion system encoded on 
Salmonella pathogenicity island I (T3SS-1) and promotes invasion of epithelial cells and thus 
enhances S. Tm-induced intestinal inflammation by triggering the release of pro-inflammatory 
cytokines. Furthermore it supports nitrate respiration upon inflammatory conditions (Lopez et 
al., 2012, Müller et al., 2009, Mirold et al., 1999). Lambdoid prophages Gifsy-1 and Gifsy-2 
also encode for different virulence genes which contribute to the pathogenicity and fitness of 
the strain required for efficient infection. Gifsy-1 encodes for instance for effector proteins 
SseI and GipA  which are needed for intracellular survival of Salmonella and exported by the 
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Type III secretion system encoded on Salmonella pathogenicity island II (T3SS-2) (Miao and 
Miller, 2000, McLaughlin et al., 2009, Fàbrega and Vila, 2013), (Stanley et al., 2000). 
However, prophage Gifsy-2 encodes for [Cu, Zn] superoxide dismutase SodCI. By this, 
S. Tm is able to convert superoxide radicals to hydrogen peroxide and is thus protected 
against reactive oxygen species (ROS) (Figueroa-Bossi et al., 2001). Prophage ST64B was 
first isolated from S. TmDT64 strain, and it was shown to produce tailless non-infectious 
phages due to a reversible frameshift mutation in the tail genes (Mmolawa et al., 2003, 
Figueroa-Bossi and Bossi, 2004). Although it was demonstrated that S. Tm strains harboring 
the prophage ST64B have a slight benefit for surviving in the blood, its contribution to 
virulence is not clear yet (Herrero-Fresno et al., 2014).  
 
1.5.7 Contribution of temperate phages to colicin Ib release from S. TmSL1344 
It has been recently discovered that temperate phages are the key mediators of ColIb 
release in S. TmSL1344 (Nedialkova et al., 2015). Therefore S. TmSL1344 gains a fitness benefit 
over colicin-sensitive bacteria in the inflamed gut (Nedialkova et al., 2014). Lysis proteins 
encoded by prophage ST64B seem to be the main contributors for ColIb release by 
S. TmSL1344, but interestingly prophages Gifsy-1 and Gifsy-2 do also contribute to the release 
of ColIb (Nedialkova et al., 2015). Furthermore, in the same study it has been shown that 
prophage-mediated ColIb release is not only restricted to Salmonella but is also true for 
E. coli strains carrying functional prophages. For instance an originally sensitive E. coli strain 
(e.g. EcMG1655), harboring ColIb plasmid p2, expresses cib in a similar way as S. TmSL1344, but 
is not able to release ColIb. In contrast to this, p2-harboring strain EcMG1655 lysogenic for 
phage 933W (EcStx p2) is able to express cib and to release ColIb due to prophage-mediated 
cell lysis. Furthermore, it has been shown that upon SOS-inducing conditions (using 
mitomycin C), the expression of ST64B lysis genes is delayed (~60 min) compared to the cib 
expression. This enables S. Tm to produce and accumulate sufficient amounts of colicin Ib 
before the cells lyse and release the toxin (Nedialkova et al., 2015).  
   
Aims of the Thesis 
22 
 
2 Aims of the Thesis 
Colicins are protein toxins commonly produced by Enterobacteriaceae family-members. 
Once released into the environment, colicins are able to kill sensitive closely-related target 
bacteria, whereas the producing bacteria are protected by a simultaneously synthesized 
immunity protein. Colicin production is highly costly as the producer needs to lyse and, thus, 
to die to release colicins. Hence, colicins are only produced by a fraction of the bacterial 
population (division of labor). 
Aim 1. It was previously shown that colicin Ib (ColIb)-production confers a fitness benefit to 
Salmonella Typhimurium strain SL1344 (S. Tm) over sensitive E. coli upon inflammation-
induced Enterobacterial “blooms” in the gut. Based on this data it was hypothesized that 
heterogeneous colicin Ib (cib) gene expression increases the fitness of S. Tm against 
commensal and colicin-sensitive E. coli. In the first part of this thesis, reporter tools shall be 
generated and characterized to analyze cib expression in vitro under different environmental 
conditions at the single cell level. This will shed light on the question if heterogeneous cib 
expression increases the fitness of the pathogen against a sensitive-competitor. 
Aim 2. Group A colicins are usually released by the synthesis of a cognate lysis protein. In 
contrast, in case of group B colicins cognate lysis genes are absent and release can be 
mediated by prophage-mediated cell lysis (e.g. ColIb; (Nedialkova et al., 2015)). The second 
part of this thesis aims at analyzing regulation of cib expression and prophage activation at 
the single cell level in S. Tm. To this end, reporter tools shall be generated to analyze 
prophage lysis gene expression in individual cells. Together with the cib reporter established 
in the first part of this thesis, these reporters shall be employed to determine the fraction of 
bacteria which produce ColIb and are prone to lysis due to prophage-mediated cell lysis. 
Aim 3. In the course of the current work an E. coli strain (Ec252R) was found to produce and 
release a bacteriocin against which it is insufficiently protected (‘self-killing’ phenotype). A 
transposon library screen revealed that ColM production is responsible for this phenotype. 
This was highly surprising, as colicin-producers are thought to be sufficiently protected 
against self-killing by cognate immunity. Based on this result, it was hypothesized that (i) 
Ec252R may not harbor or produce a functional immunity protein, or (ii) after acquisition of a 
colicin plasmid, the production of a cognate immunity protein alone is insufficient to protect 
the producer against self-killing. The third aim of the thesis was to validate these hypotheses 
and shed light on the ‘self-killing’ phenotype of ColM producers. 
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 Materials 3.1
 Strains and plasmids 3.1.1
Table 3.1: Strains 
Strains Strain ID Relevant characteristics Antibiotic 
resistance Reference 
S. Tm strains 
 
 
  
S. Tmwt SB300 S. Tm wild type strain 
SL1344 
Sm50 (Hoiseth and 
Stocker, 1981)  
S. Tm p2∆cib M990-2 SB300, cib imm::aphT Sm50, Kan30 (Stecher et al., 
2012a) 
S. Tm p2cib-HA M1400 SB300, cib::HA aphT Sm50, Kan30 Spriewald et 
al.,2015 
S. TmWT MA6118 S. Tm wild type strain 
SL1344 
Sm50 (Figueroa-Bossi 
et al., 2001) 
S. Tm∆Ph ∆pRSF1010 MA7891 MA6118, ∆Gifsy-1 ∆Gifsy-2 
ST64B::aphT, SopEΦ::cat, 
∆pRSF1010-SL1344 
Kan30, Cm30 (Alonso et al., 
2005) 
S. Tm∆Ph  LPN27-1 MA7891, pRSF1010-
SL1344 
Sm50, Kan30, 
Cm30 
(Nedialkova et 
al., 2015) 
S. Tm p2cib::sfgfp SJB15-2 SB300, cib imm::sfgfp aphT, 
pWKS30 
Sm50, Kan30, 
Amp100 
Spriewald et 
al.,2015 
S. TmlysST::T7 pol SJB34 SB300, ST64B 
(SL1344_1955-
SL1344_1957)::T7 gene1 
aphT 
Sm50, Kan30 This study 
S. TmlysST::sfgfp p2cib-HA SJB36-1 SB300, cib::HA aphT; 
ST64B (SL1344_1955-
SL1344_1957)::sfgfp 
Sm50, Kan30 This study 
 
E. coli (Ec) strains 
    
EcDH5α DH5α F -, Φ80lacZ∆M15, 
∆(lacZYA-argF), U169, 
recA1, endA1, hsdR17(rk-, 
mk
+), phoA, supE44, thi-1, 
gyrA96, relA1, λ- 
- Invitrogen 
EcMG1655 MG1655  E. coli K-12 wild type strain 
MG1655, F-, λ-, ilvG-, rfb-50, 
rph-1 
Sm50 (Moller et al., 
2003) 
EcBL21(DE3)  BL21 
(DE3) 
BL21(DE3), B F - dcm ompT 
hsdS (rB- mB-) gal l (DE3), 
- Stratagene 
Ec SM10 SM10  
(λ- pir) 
thi-1, leu, tonA, lacY, supE, 
recA::RP4-2-Tc::Mu, λ-pir  
Kan30 (Simon et al., 
1983) 
Ec252R 252R E. coli mouse isolate, 
pColBM 
Rif45, Sm50 This study 
Ec252R Tn10 MAD3 252R, pColBM::Tn10  Rif45, Sm50, 
Kan30 
This study 
EcP13C5 P13C5 252R, virE::Tn10  Rif45, Sm50, 
Kan30 
This study 
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Strains Strain ID Relevant characteristics Antibiotic 
resistance Reference 
EcP10A10 P10A10 252R, cma::Tn10 Rif45, Sm50, 
Kan30 
This study 
Ec252R pColBMcba::cat MAD4-1 252R, cba::cat; Rif45, Sm50, 
Cm10 
This study 
Ec252R pColBMcma::cat MAD5-1 252R, cma::cat Rif45, Sm50, 
Cm10 
This study 
Ec252R pColBMcmaHA SJB3 252R, cma::HA cat Rif45, Sm50, 
Cm10 
This study 
Ec252R pColBMcmiHA SJB4 252R, cmi::HA cat Rif45, Sm50, 
Cm10 
This study 
EcCl139 Cl139 pColBM-Cl139 
leu, lac, thi, λr  
unknown Prof. Klaus 
Hantke, 
Tübingen 
Ec252R pColBM∆cba SJB5 252R, ∆cba Rif45, Sm50 This study 
Ec252R pColBM∆cma SJB6 252R, ∆cma Rif45, Sm50 This study 
EcBL21(DE3) ∆fhuA SJB7 BL21(DE3), B F - dcm ompT 
hsdS (rB- mB-) gal l (DE3), 
fhuA::cat 
Cm30 This study 
EcDH5α ∆fhuA SJB8 DH5α, fhuA::cat Cm30 This study 
EcMG1655 ∆fhuA SJB20 MG1655, fhuA::cat Sm50, Cm30 This study 
EcStx MBK13 MG1655 lysogenized with 
933W phage, stx2A::luc 
aphT 
NalAc60, 
Sm50, Kan30 
(Nedialkova et 
al., 2015) 
EcStx∆SR MBK14 MG1655 lysogenized with 
933W phage, stx2A R S::luc 
aphT 
NalAc60, 
Sm50, Kan30 
(Nedialkova et 
al., 2015) 
EcMG1655 pColBMB1144 SJB21-2 MG1655, pColBMB1144 
 
NalAc60, 
Sm50, 
Amp100 
This study 
EcStx pColBMB1144 SJB22-2 MBK13, pColBMB1144 NalAc60, 
Sm50, 
Amp100, 
Kan30 
This study 
EcStx∆SR pColBMB1144 SJB23-2 MBK14, pColBMB1144 NalAc60, 
Sm50, 
Amp100, 
Kan30 
This study 
EcMG1655 
pColBMB1144 S6 
SJB21-2- 
Set6 
clone 
derivative of SJB21-2 NalAc60, 
Sm50, 
Amp100 
This study 
EcStx pColBMB1144  S6 SJB22-2- 
Set6 
clone 
derivative of SJB22-2 NalAc60, 
Sm50, 
Amp100, 
Kan30 
This study 
EcStx∆SR 
pColBMB1144 S6 
SJB23-2- 
Set6 
clone 
derivative of SJB23-2 NalAc60, 
Sm50, 
Amp100, 
Kan30 
This study 
EcMG1655 
pColBMB1144 G5 
SJB21-2-
G5 
derivative of SJB21-2 NalAc60, 
Sm50, 
Amp100 
This study 
EcStx pColBMB1144  G5 SJB22-2-
G5 
derivative of SJB22-2 NalAc60, 
Sm50, 
Amp100, 
This study 
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Strains Strain ID Relevant characteristics Antibiotic 
resistance Reference 
Kan30 
EcStx∆SR 
pColBMB1144 G5 
SJB23-2-
G5 
derivative of SJB23-2  NalAc60, 
Sm50, 
Amp100, 
Kan30 
This study 
E. coli clinical isolates 
EcB2025 B2025 ColM unknown D. Šmajs and J. 
Bosák, Brno 
EcB411 B411 ColM unknown D. Šmajs and J. 
Bosák, Brno 
EcB516 B516 ColM unknown D. Šmajs and J. 
Bosák, Brno 
EcB522 B522 ColM unknown D. Šmajs and J. 
Bosák, Brno 
EcB526 B526 ColM unknown D. Šmajs and J. 
Bosák, Brno 
EcB537 B537 ColM unknown D. Šmajs and J. 
Bosák, Brno 
EcB593 B593 ColM unknown D. Šmajs and J. 
Bosák, Brno 
EcB1216 B1216 ColM unknown D. Šmajs and J. 
Bosák, Brno 
EcB1218 B1218 ColM unknown D. Šmajs and J. 
Bosák, Brno 
EcB1311 B1311 ColM unknown D. Šmajs and J. 
Bosák, Brno 
EcB459 B459 ColM unknown D. Šmajs and J. 
Bosák, Brno 
EcB1314 B1314 ColM unknown D. Šmajs and J. 
Bosák, Brno 
EcB1327 B1327 ColM unknown D. Šmajs and J. 
Bosák, Brno 
EcB1688 B1688 ColM unknown D. Šmajs and J. 
Bosák, Brno 
EcB3253 B3253 ColM unknown D. Šmajs and J. 
Bosák, Brno 
EcB7 B7 ColB, ColM, micV unknown D. Šmajs and J. 
Bosák, Brno 
EcB54 B54 ColE1, ColM unknown D. Šmajs and J. 
Bosák, Brno 
EcB72 B72 ColE1, ColM unknown D. Šmajs and J. 
Bosák, Brno 
EcB147 B147 I2*, ColM, micV unknown D. Šmajs and J. 
Bosák, Brno 
EcB195 B195 ColB, ColM unknown D. Šmajs and J. 
Bosák, Brno 
EcB1011 B1011 ColB, ColM NalAc30, 
Kan30, 
Amp100 
D. Šmajs and J. 
Bosák, Brno 
EcB1069 B1069 ColB, ColM unknown D. Šmajs and J. 
Bosák, Brno 
EcB1144 B1144 ColB, ColM NalAc60, 
Kan30, 
D. Šmajs and J. 
Bosák, Brno 
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Strains Strain ID Relevant characteristics Antibiotic 
resistance Reference 
Amp100 
EcB1156 B1156 ColB, ColM, micM unknown D. Šmajs and J. 
Bosák, Brno 
EcB1161 B1161 ColB, ColM, micH47 unknown D. Šmajs and J. 
Bosák, Brno 
EcB202 B202 ColE1, ColM unknown D. Šmajs and J. 
Bosák, Brno 
EcB203 B203 ColB, ColM unknown D. Šmajs and J. 
Bosák, Brno 
EcB236 B236 ColM unknown D. Šmajs and J. 
Bosák, Brno 
EcB255 B255 ColM, ColN unknown D. Šmajs and J. 
Bosák, Brno 
EcB338 B338 ColM unknown D. Šmajs and J. 
Bosák, Brno 
EcB358 B358 ColM unknown D. Šmajs and J. 
Bosák, Brno 
EcB383 B383 ColE1, ColB, ColM, micV unknown D. Šmajs and J. 
Bosák, Brno 
EcB805 B805 ColM unknown D. Šmajs and J. 
Bosák, Brno 
EcB848 B848 ColE1, ColM unknown D. Šmajs and J. 
Bosák, Brno 
EcB852 B852 ColE1, ColM unknown D. Šmajs and J. 
Bosák, Brno 
Amp: ampicillin; Cm: chloramphenicol; Kan: kanamycin; NalAc: nalidixic acid; Rif: Rifampicin; Strep: 
streptomycin; mic: microcin; *: bacteriocin-like 
 
 
Table 3.2: Plasmids 
Plasmids Plasmid ID 
Copy 
number Relevant characteristics 
Antibiotic 
resistance Reference 
p2795 p2795 high pSK, ori F1 and ori pUC Amp100, Kan30 (Husseiny and 
Hensel, 2005) 
pWKS30 pWKS30  pSC101 origin of 
replication;  
Amp100 (Wang and 
Kushner, 
1991) 
pJA1 pJA1 low R6K γ-origin, Tn10, 
lacIq, Ptac-ATS 
transposase 
Amp100, Kan30 (Alexeyev and 
Shokolenko, 
1995), 
(Badarinaraya
na et al., 2001) 
pKD46 pKD46 low λ Red-expression under 
control of pBAD, 
temperature-sensitive 
Amp100 (Datsenko and 
Wanner, 2000) 
pWRG7 pWRG7 medium Promoterless sfgfp-aphT 
lambda red template 
vector 
Kan30 (Spriewald et 
al., 2015)  
pSU315 pSU315 low R6K oriV, FRT-flanked 
HA-aphT, lambda red 
template vector 
Amp100, Cm30 (Uzzau et al., 
2001) 
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Plasmids Plasmid ID 
Copy 
number Relevant characteristics 
Antibiotic 
resistance Reference 
pCP20 pCP20 low FLP+, λ cI857+, λ pR 
Repts 
Amp100, Cm30 (Cherepanov 
and 
Wackernagel, 
1995) 
pSJB4 pSJB4 high cma-6x-his Kan30 This study 
pcontrol pSJB17 high ori pBR322, 
ori F1, control plasmid 
Amp100 (Spriewald et 
al., 2015) 
pPcib pSJB16 high ori pBR322, ori F1, cib 
promoter (Pcib) 
Amp100 (Spriewald et 
al., 2015) 
pgfp pM968 high ori pBR322, ori F1, 
carrying gfpmut2 coding 
region without promoter 
Amp100 (Stecher et al., 
2004) 
pPcib gfp pM1437 high ori pBR322, ori F1, 
Pcib::gfpmut2 
Amp100 (Nedialkova et 
al., 2014) 
pPrpsM gfp pM979 high ori pBR322, ori F1, 
constitutive gfpmut2-
reporter plasmid; PrpsM 
(ribosomal rpsM 
promoter)  
Amp100 (Stecher et al., 
2004) 
pPT7 sfgfp pJLG1 low pM955, PT7::sfgfp Amp100 This study 
pT7 Pol pJLG2 low p2795, T7 gene 1 aphT Amp100, Kan30 This study 
pM946 pM946 low ori pSC101, pWKS30 
cured of Plac , 
PT7 gfpmut3b 
Amp100 (Stecher et al., 
2004) 
pempty pM955 low ori pSC101, pWKS30 
cured of Plac 
Amp100 This study 
pPsicA gfp pM974 high ori pBR322, ori F1, 
PsicA::gfpmut2 
Amp100 (Stecher et al., 
2004), 
(Stecher et al., 
2007) 
pcmi 252R pMAD7 low pM955, 252R Pcmi cmi Amp100 This study 
pcmi Cl139 pMAD8 low pM955, Cl139 Pcmi cmi Amp100 This study 
Amp: ampicillin; Cm: chloramphenicol; Kan: kanamycin  
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 Oligonucleotides 3.1.2
All oligonucleotides used in this study were synthesized by Metabion (Martinsried). 
Table 3.3: Oligonucleotides 
Designation Sequence (5’ → 3’) 
Ampli4_Fwd TGAGATAGGTGCCTCACTG 
Ampli4_Rev ACAGGGCGCGTAAATCAATC 
CBA CBI Primer For ATGACCAGCAATAAAGATAAG 
CBA complete Rev ATCTTGGAGATAAATACAAGG 
CBA remnant Pri. Rev GATGAGTTGAATCACAAGATC 
cba-check-down GCGTAATTTTTGATCTGTAC 
cba-check-up CATGACATATGCGATTTTAC 
cba-fwd-ko TGGTTATGTGTACAGTATTTAATTTTAATTGATTGTTTTTAAAG
TCAAAGAGGTTTTCTATATGAATATCCTCCTTAGTT 
cba-rev-ko ATGCCATTACTTGTCATTAAATATTTTAAAGGGAGGCAGTAAC
ACTGCCTTCCTTTTAATGTGTAGGCTGGAGCTGCTTC 
Check up_ SFGFP /RFP _rev CATGCTGGAGTTCTTCGCC 
Check up_ SFGFP_fwd GTGGCTCAGTTCTGTAACT 
check up_pSJB16 AGGTTTTCACCGTCATCA 
check_ST64_for CTGTTTGGCGGCCTTTTC 
check_ST64_rev GGA TAT AAA AAC GCC CCG 
cma-check-down TCTCTCATGGGGTTTGTTCG 
cma-check-up TTGTGAGGAGGGATATGTTG 
cma-fwd-ko GAATGACTAATACACTGTTATAAAGGCTGCATAAAAAGGCCG
GAACCCCGGCCCTTATAATATGAATATCCTCCTTAGTT 
cma-HA-fwd CTGGTAAAGAGTACCAGATACTGCTTCCTGGTGAAATTCACA
TTAAAGAAAGTGGTAAGCGATATCCGTATGATGTTCCT 
cma-HA-rev GCGAATGACTAATACACTGTTATAAAGGCTGCATAAAAAGGC
CGGAACCCCGGCCCTTATAATATGAATATCCTCCTTAG 
cma-rev-ko GGCGGAGGCGTTAGCCAGCGGCGAACTCTGTTATCTTGTTA
ACTTATAAGGAGTTATGTTGTGTAGGCTGGAGCTGCTTC 
cmi check down rev ACTGCTTCCTGGTGAAATTC 
cmi check up forward CCGATGCTGTCACAATGCTG 
cmi-HA-fwd GTAAGAGAATGTATTATGGCATGTACCATTGTGAGGAGGGAT
ATGTTGAATATGCGAATGACTATCCGTATGATGTTCCT 
cmi-HA-rev GGTAAGCGATAATATAAGGGCCGGGGTTCCGGCCTTTTTATG
CAGCCTTTATAACAGTGTAATATGAATATCCTCCTTAG 
cmi-histag_fwd ATAGCTAGCATGGAAACCTT 
cmi-histag_rev2 CGCAAGCTTTCGCTTACCACT 
cmi-pro-fwd-XbaI CCCGGATCCACTGCTTCCTGGTGAAATTC 
cmi-pro-rev-BamHI CCCTCTAGACCGATGCGGTCACAATGCTG 
Colicin-HA-fwd GTTAATGATAAGTTTATTGAGCAGGTCAATAAACTTATTGGTA
TCTATCCGTATGATGTTCCTGA 
Colicin-HA-rev ACTTAATTTTTATATTCTGCAAAGCCCTTTCAGGAAAATGAATA
TGAATATCCTCCTTAG 
Col-lux_check_for GACATGCCATTTTCTCCT 
Col-lux_check_rev GATGTAAACGTGACACAG 
Col-ÜE-XbaI CCCTCTAGACCTCAGAGGATGAAGGAGATAC 
Col-ÜE-XhoI CCCCTCGAGGATGTAAACGTGACACAGCT 
FhuA_sequ-fwd1 GGATGGCGAGTTGCCATC 
FhuA_sequ-fwd2 GACAGCCTGTTCCAGAC 
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Designation Sequence (5’ → 3’) 
FhuA_sequ-rev CGTGTATTCCTGCATAAC 
FhuA-KO_fwd CTTTATAATAATCATTCTCGTTTACGTTATCATTCACTTTACAT
CAGAGATATACCATGTGTAGGCTGGAGCTGCTTC 
FhuA-KO_rev CCTGCATAACAGCCAACTTGTGAAATGGGCACGGAAATCCGT 
GCCCCAAAAGAGAAAATATGAATATCCTCCTTAGTT 
hp-F* GAATTACGATGAAAATAACG 
hp-R2* TCATTCTGGCGATTTCAATA 
InsideT7 TAGCATCTTGACGACGCGGTG 
pJLG2 seq Fw GCTCTGAAGTTCCTATACT 
pJLG2 seq Rev GCTATGACCATGATTACG 
pJLG1proof fwd GGGGATGTGCTGCAAGG 
pJLG1proof rev GAGCTGACTGGGTTGAAG 
pJLG1 SFGFP SD BamHI Fw GATCCTAAGGAGGGTAAGCATGCGCAAAGGCGAAG 
pJLG1 SFGFP EcoRI Rev GTAGAATTCTTATTATTTATACAGTTCATCCATGCCA 
PsicA_2_fwd GGCAAAGACGTTATTCAGCC 
PsicA_2_rev GCCCAATGAATACATCGCTAC 
R/S outside Rev GAGATGCGCAGAAATGACAA 
SFGFP_cib_fwd TATACGTAAGCAGTTAATTCATTTGTTTTCCTCAGAGGATGAA
GGAGATACCGAATGCGCAAAGGCGAAGAACTGTTTAC 
SFGFP_cib_rev TGTGATTATGTTATCACGCACCGGTACACGATAACAATAAAG
GAGAAAACAGCGTGTAGGCTGGAGCTGCTTC 
SFGFP-fwd GATAAGCTTATGCGCAAAGG 
SFGFP-rev CTTTCTAGAGAATAGGAACTTC 
ST64B-sfgfp-fwd TCCACTCACCCGATACCCGGGTAAACAGTCTCCCGGACAGG
GGGAGGTCATGCGCAAAGGCGAAGAACTGTTTAC 
ST64B-sfgfp-rev ACGAGGCATTTTCATGAAAGTCACTTGTCAAATTTCTATGTGA
TGGAAACGTGTAGGCTGGAGCTGCTTC 
Stx2 Operon Fw GATCGGTATGTTGAGCGTGA 
Stx2 Operon Rev TGCTCAGTCTGACAGGCAAC 
Stx2A outside Fw AGACGGTCAGGGAAGTTCAG 
T7 TAATACGACTCACTATAGGG 
T7 pol FW NotI  CATGCGGCCGCATGAACACGATTAACATCGCTAAG 
T7 pol Rev XhoI TCACTCGAGTTACGCGAACGCGAAGTC 
T7 seq left 2 CTAAGGGTCTACTCGGTGGC 
T7 seq right 2 TCACGCTCACAGATTCCCAA 
T7_ST64B_fwd TCCACTCACCCGATACCCGGGTAAACAGTCTCCCGGACAGG
GGGAGGTCATGAACACGATTAACATCGCTAAGAA 
* from (Christenson and Gordon, 2009) 
 
 
 
 
Materials and Methods 
30 
 
 Chemicals 3.1.3
Table 3.4:Sources of the used chemicals and enzymes. 
Chemicals and enzymes Source 
Acrylamide mix 30% Serva (Heidelberg) 
Agar bactoTM Becton, Dickinson and Company (BD) (Heidelberg) 
Ammonium persulfate (APS) Roth (Karlsruhe) 
Benzonase nuclease (Novagen) Merck Chemicals (Schwalbach) 
Bovine serum albumin fraction 
(BSA), PAA 
GE Healthcare (Munich) 
Bromphenolblue Roth (Karlsruhe) 
CaCl2 Merck Chemicals (Schwalbach) 
Chloroform Roth (Karlsruhe) 
Cetyltrimethylammoniumbromid 
(CTAB) 
Roth (Karlsruhe) 
4',6-diamidino-2-phenylindole (DAPI) Roth (Karlsruhe) 
D-glucose
 
Roth (Karlsruhe) 
Diethylenetriamine Pentaacetic Acid 
(DTPA) 
Sigma-Aldrich Chemie (Munich) 
dNTP Set Thermo Fisher Scientific Biosciences (St. Leon-Rot) 
DreamTaq PCR Master Mix (2 x) Thermo Fisher Scientific Biosciences (St. Leon-Rot) 
Dithiothreitol (DTT) Roth (Karlsruhe) 
ECL detection system GE Healthcare (Munich) 
Immobilion Western 
Chemoluminescent HRP substrate 
Merck Chemicals (Schwalbach) 
Ethylenediaminetetraacetic acid 
(EDTA) 
Roth (Karlsruhe) 
Ethylene glycol tetraacetic acid 
(EGTA) 
Roth (Karlsruhe) 
Ethanol ROTIPURAN® ≥99,5 %, p.a Roth (Karlsruhe 
FastStart Taq DNA Polymerase Kit Roche (Mannheim) 
Glycerol Roth (Karlsruhe) 
Glycine MP Biomedicals 
High-fidelity PCR enzyme Thermo Fisher Scientific Biosciences (St. Leon-Rot) 
Immobilion Western 
Chemoluminescent HRP substrat 
Merck Chemicals (Schwalbach) 
K2HPO4 Roth (Karlsruhe) 
KCl
 
Fluka, Sigma-Aldrich Chemie (Munich) 
KH2PO4 Roth (Karlsruhe) 
L-(+)-Arabinose Sigma-Aldrich Chemie (Munich) 
Lysozyme from chicken egg white Sigma-Aldrich Chemie (Munich) 
MacConkey agar Oxoid, Thermo Fisher Scientific Biosciences (St. Leon-Rot) 
MacConkey agar Roth (Karlsruhe) 
Methanol ROTIPURAN® ≥99,5 %, 
p.a 
Roth (Karlsruhe) 
Milk powder Roth (Karlsruhe) 
Mitomycin C (MitC) Roth (Karlsruhe) 
Na2HPO4 unhydrated Roth (Karlsruhe) 
Na2HPO4 x 2H2O Roth (Karlsruhe) 
NaAcetate Roth (Karlsruhe) 
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Chemicals and enzymes Source 
NaCl Roth (Karlsruhe) 
NH4Cl Sigma-Aldrich Chemie (Munich) 
Peptone Oxoid, Thermo Fisher Scientific Biosciences (St. Leon-Rot) 
Phenol/chloroform/isoamylalcohol Roth (Karlsruhe) 
Phenylmethylsulfonyl fluoride 
(PMSF), 
Serva (Heidelberg) 
Propidium iodide Sigma-Aldrich Chemie (Munich) 
ProteinaseK Roth (Karlsruhe) 
Restriction enzymes Thermo Fisher Scientific Biosciences (St. Leon-Rot) 
Sodium dodecyl sulfate (SDS) Serva (Heidelberg) 
Sodium Azide Merck Chemicals (Schwalbach) 
T4 DNA ligase Thermo Fisher Scientific Biosciences (St. Leon-Rot) 
Tergitol Sigma-Aldrich Chemie (Munich) 
Tetramethylethylenediamine 
(TEMED) 
Biomol Feinchemikalien (Hamburg) 
Tissue-Tek Optimal Cutting 
Temperature  
(O.C.T.) compound 
Sakura Finetek, (Torrance) 
Tris MP Biomedicals (Eschwege) 
Triton X-100 Roth (Karlsruhe) 
Tryptone Roth (Karlsruhe) 
Tween 20 Roth (Karlsruhe) 
VECTASHIELD(R) Mounting Medium Biozol (Eching) 
Yeast extract MP Biomedicals (Eschwege) 
Zebra Spin desalting columns (5 ml) Thermo Fisher Scientific Biosciences (St. Leon-Rot) 
β –D-thiogalactopyranoside (IPTG) Roth (Karlsruhe) 
 
Table 3.5: Antibiotics 
Antibiotics Final concentration Source 
Ampicillin sodium salt 100 µg/ml Roth (Karlsruhe) 
Chloramphenicol 30 µg/ml 
10 µg/ml (E. coli 252R derivatives) 
Roth (Karlsruhe) 
Kanamycin sulphate 30 µg/ml Roth (Karlsruhe) 
Nalidixic acid 60 µg/ml Roth (Karlsruhe) 
Rifampicin 45 µg/ml, dissolved in ddH2O Roth (Karlsruhe) 
Streptomycin sulphate 50 µg/ml Roth (Karlsruhe) 
 
Table 3.6: DNA and protein standards 
Item Source 
Page ruler prestained protein ladder  Thermo Fisher Scientific Biosciences (St. 
Leon-Rot) 
GeneRuler 1 kb DNA ladder Thermo Fisher Scientific Biosciences (St. 
Leon-Rot) 
 
Materials and Methods 
32 
 
Table 3.7: Sources of purification kits 
Kit Source 
NucleoSpin Gel and PCR clean-up kit Macherey-Nagel (Düren) 
NucleoSpin Plasmid kit Macherey-Nagel (Düren) 
NucleoSpin Tissue Macherey-Nagel (Düren) 
Plasmid Plus Midi Kit QIAGEN (Hilden) 
 
Table 3.8: Consumables 
Consumables Source 
Microscope slides, SuperFrost® Thermo Fisher Scientific Biosciences (St. Leon-
Rot) 
TC-Platten Orange 96-well (F-well) Orange Scientific (Braine-l'Alleud, Belgium) 
Filter Millex 0.22 µm Merck Chemicals (Schwalbach) 
Cryotubes Thermo Fisher Scientific Biosciences (St. Leon-
Rot) 
Cultube sterile culture tubes, tube with cap, 
polystyrene; 17 mm x 95 mm H 
Simport (Beloeil, Canada) 
Nitrocellulose membrane GE Healthcare (Munich) 
HisTrap column (5 ml) GE Healthcare (Munich) 
HiTrap desalting column (5 ml) GE Healthcare (Munich) 
Electroporation Cuvette LE (1 mm) PAQlab (VWR International GmbH 
Life Science Competence Center, Erlangen) 
 
 
 
 Buffers, media and supplements 3.1.4
If not otherwise stated, components of media, buffers and solutions are solved in ddH20. 
Table 3.9: Media for bacterial growth and for cryostorage 
Media Component Final concentration  
Luria-Bertani (LB) medium NaCl 
Yeast extract 
Tryptone  
85.6 mM 
0.5% (w/v) 
1% (w/v) 
 
LB-agar NaCl 
Yeast extract 
Tryptone   
Agar 
85.6 mM 
0.5% (w/v) 
1% (w/v) 
1.5% (w/v) 
 
LB-softagar NaCl 
Yeast extract 
Tryptone 
Agar 
85.6 mM 
0.5% (w/v) 
1% (w/v) 
0.7% (w/v) 
 
Peptone-glycerol (P/G) 
broth 
Peptone 
Glycerol 
             2% (w/v) 
5% (v/v) 
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Table 3.10: Buffers for multiple applications 
Buffers Component Final concentration 
 
Phosphate Buffered Saline 
(PBS) 10x 
KCl 
Na2HPO4 anhydrous 
KH2PO4 
26.8 mM 
43 mM 
17.6 mM 
 
 
Table 3.11: Buffers for affinity purification of recombinant proteins  
Buffers Component Final concentration  
Loading buffer (pH 7.8) Na2HPO4 
NaCl 
Imidazol 
40 mM 
300 mM 
5 mM 
 
Lysis buffer (pH 7.8) Na2HPO4 
NaCl 
Imidazol 
PMSF 
Benzonase nuclease 
40 mM 
300 mM 
5 mM 
2 mM 
0.0125 U/µl 
 
Elution buffer (pH 7.8) Na2HPO4 
NaCl 
Imidazol 
40 mM 
300 mM 
500 mM 
 
 
Exchange buffer 1  
(pH 7.4) 
Na2HPO4 
NaCl 
20 mM 
100 mM 
 
 
Table 3.12: Buffers for SDS-polyacrylamide gel preparation 
 Components Final concentration   
5% stacking gel  Acrylamide mix 30% 
Tris (pH 6.8) 
SDS 
APS 
TEMED 
17% (v/v) 
125 mM 
1.73 mM 
4.4 mM 
0.1% (v/v) 
 
12% resolving gel  Acrylamide mix 30% 
Tris (pH 8.8) 
SDS 
APS 
TEMED 
40% (v/v) 
5700 mM 
3.5 mM 
4.4 mM 
0.04% (v/v) 
 
15% resolving gel  Acrylamide mix 30% 
Tris (pH 8.8) 
SDS 
APS 
TEMED 
50% (v/v) 
5700 mM 
3.5 mM 
4.4 mM 
0.04% (v/v) 
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Table 3.13: Buffers for SDS-PAGE and western blot  
Buffer Components Final concentration 
 
Protein loading buffer (5x) Tris-Cl (pH 6.8) 
DTT 
SDS 
Bromphenolblue 
Glycerol 
250 mM 
500 mM 
346.8 mM 
7.5 mM 
50% (v/v) 
 
Running- buffer (10x) Tris 
Glycine 
SDS 
249.3 mM 
2500 mM 
34.7 mM 
 
Transfer-buffer Tris 
Glycine 
Methanol 
25 mM 
191.8 mM 
5% (v/v) 
 
Blocking solution in 1X PBS Tween 20 
Milkpowder (Roth) 
0.1% (v/v) 
5% (w/v) 
 
 
Table 3.14: Solution for coomassie staining of SDS-polyacrylamide gels 
Solution Components Final concentration  
 
Coomassie staining solution Coomassie Brilliant Blue 
R250 
Methanol 
Acetic acid (100%) 
0.3% (w/v) 
45% (v/v) 
10% (v/v) 
 
Coomassie fixing solution Methanol 
Acetic Acid (100%) 
50% (v/v) 
10% (v/v) 
 
 
 
Table 3.15: Buffers for genomic DNA extraction 
Buffer Components Final concentration 
TE buffer (pH 8.0) Tris/HCl 
EDTA 
10 mM 
1 mM 
 
CTAB/NaCl NaCl 
CTAB 
0.7 M 
10% 
 
 
Table 3.16: Permeabilization buffers for intrabacterial staining 
Buffer Components Final concentration 
Permeabilization buffer A  
(pH 8.0) 
Tris 
EDTA 
TritonX-100 
Glucose 
20 mM 
50 mM 
0.1% (v/v) 
99.9 mM 
 
Permeabilization buffer B  
(pH 8.0) 
Tris 
EDTA 
Glucose 
25 mM 
10 mM 
99.9 mM 
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3.1.1. Antibodies 
Table 3.17: Antibodies 
Name of antibody  Recognized antigen Origin Final dilution Source 
Primary antibody     
ADI-SPA-880 (Hsp 70) DnaK (E. coli)* Mouse 1:200 (IF) 
1:500 (WB) 
Enzo Life 
Sciences 
(Lörrach) 
HA probe (Y11) Influenza 
hemagglutinin (HA) 
Rabbit 1:200 (IF) 
1:500 (WB) 
Santa Cruz 
Anti-ColM (rabbit polyclonal) His(6x)-tagged ColM 
(recombinant) 
Rabbit 1:5000 (WB) This study 
Anti-GFP  Green Fluorescent 
Protein (GFP) 
Rabbit 1:200 (IF) antibodies-
online.com 
Secondary antibody (and label)    
Anti-mouse IgG (Rhodamine 
RedTM-X)  
Mouse IgG Goat 1:200 (IF) Invitrogen 
Anti-rabbit IgG (HRP) Rabbit IgG Goat 1:10,000 (WB)  GE-
Healthcare 
(Munich) 
Anti-mouse IgG (HRP) Mouse IgG Goat 1:10,000 (WB) Sigma-
Aldrich 
Chemie 
(Munich) 
Anti-rabbit IgG (DyLightTM549) Rabbit IgG Goat 1:400 (IF) Jackson 
Anti-rabbit IgG (DyLightTM649) Rabbit IgG Goat 1:400 (IF) Jackson 
*Also recognizes S. Tm DnaK; HRP: horseradish peroxidase; IF: immunofluorescence; WB: western 
blot 
 
 Methods 3.2
 Bacterial growth  3.2.1
 Bacterial growth conditions 3.2.1.1
If not otherwise stated bacteria (from –80 °C cryostocks) were streaked on LB agar 
(Table 3.9) supplemented with appropriate antibiotic(s) and incubated o.n. at 37 °C. 
Afterwards, a bacterial colony was used to inoculate liquid LB media (Table 3.9) 
supplemented with the selective antibiotic(s) and incubated over night (o.n.) in the rotor 
wheel at 37 °C.  
 Long-term storage of bacterial strains  3.2.1.2
Initially, bacteria were grown o.n. at 37 °C on LB agar. A single colony was used to inoculate 
5 ml LB media (supplemented with or without selective antibiotics) and incubated o.n. at 
37 °C and 180 rpm. Afterwards this o.n. culture was spun down at 4 °C and 4030 g for 
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20 min. The pellet was resuspended with 1 ml P/G broth (Table 3.9) and stored in 1 ml 
cryotubes (Table 3.8) at -80 °C.  
 Generation of samples for the intracellular immunofluorescence staining  3.2.1.3
Bacteria were streaked from -80 °C cryostocks on LB agar containing 100 µg/ml Ampicillin 
and incubated o.n. at 37 °C. The next day three individual colonies were picked and 
transferred in 100 µl 1x PBS (Table 3.10). The bacterial suspension were mixed and 20 µl 
was used to inoculate 2 ml liquid LB medium supplemented with 100 µg/ml Ampicillin, 
followed by incubation for 12 h at 37 °C in the rotor wheel in test tubes (Cultube sterile 
culture tubes, tube with cap, polystyrene; 17 mm x 95 mm H; Table 3.8). This o.n. culture 
was used to inoculate (1:20) 2 ml LB subcultures supplemented with 100 µg/ml Ampicillin, 
without any further supplements, or with mitomycin C (MitC; 0.25 µg/ml or 0.5 µg/ml), or with 
diethylenetriamine pentaacetic acid (DTPA; 100 µM), or supplemented with both. These 
subcultures were incubated for 4 h at 37 °C in the rotor wheel. Generation of samples for the 
intracellular immunofluorescence staining in section 4.2.2 was done without 
supplementation of ampicillin.  
 Bacterial growth conditions for immunoblot and flow cytometry  3.2.1.4
A single bacterial colony was used to inoculate 3 ml LB medium (supplemented with 
appropriate antibiotics) and incubated for 12 h at 37 °C in the rotor wheel. This (o.n.) culture 
was diluted 1:20 in 2 ml LB (supplemented with the appropriate antibiotics) and subcultured 
for further 4 h at 37 °C in the rotor wheel. If required, subcultures were additionally 
supplemented with 0.25 µg/ml, or 0.5 µg/ml MitC, and/or 100 µM DTPA. 
 Growth in 96-well plates 3.2.1.5
Bacteria were streaked from -80 °C cryostocks on LB agar containing appropriate antibiotics 
and incubated o.n. at 37 °C. The following day a single bacterial colony was used to 
inoculate 3 ml LB medium and incubated for 12 h at 37 °C in the rotor wheel in test tubes 
(Cultube sterile culture tubes, tube with cap, polystyrene; 17 mm x 95 mm H; Table 3.8). This 
o.n. culture was diluted and normalized to an OD600 of 0.025 in 3 ml fresh LB medium. After 
an incubation time of 2 h at 37 °C in the rotor wheel, this subculture was diluted to an OD600 
of 0.25 in fresh LB medium only or with fresh LB supplemented with 0.5 µg/ml MitC or 
100 µM DTPA or both (final concentration). From each culture condition 200 µl/well were 
transferred in a sterile 96-well plate and incubated in total for 4 h at 37 °C while shaking.    
 Growth for live cell microscopy 3.2.1.6
Bacteria were streaked from -80 °C cryostocks on LB agar containing appropriate antibiotics 
and incubated o.n. at 37 °C. The following day a single bacterial colony was used to 
inoculate 3 ml LB medium and incubated for 12 h at 37 °C in the rotor wheel in test tubes 
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(Cultube sterile culture tubes, tube with cap, polystyrene; 17 mm x 95 mm H; Table 3.8). This 
o.n. culture was used to inoculate 2 ml LB medium in a ratio 1:20 and incubated for 2 h at 
37 °C (in the rotor wheel). From this subculture a bacterial sample of 106 cells/ml in 1x PBS 
was prepared for live cell microscopy using the CellASIC® ONIX Microfluidic Platform 
(Millipore).  
 
 Molecular biological methods 3.2.2
 Polymerase Chain Reaction (PCR) 3.2.2.1
In general a final volume of 50 µl was prepared. The reaction mixture contained 10-100 ng 
DNA template, 0.6 µM oligonucleotides and 1x Dream Taq Mastermix (Fermentas, St. Leon 
Roth). For amplicons >1.5 kb, the reaction mix contained 2 U FastStartTm Taq DNA 
Polymerase and 1x FastStartTm buffer supplemented with 20 mM MgCl2 (Roche, Mannheim) 
as well as 0.2 mM dNTPs (Roche, Mannheim). Oligonucleotides used in this thesis are listed 
in Table 3.3.  
In order to verify the specificity and yield of the reaction, 1/10 of the reaction mix was loaded 
on a 1% agarose gel and separated by gel electrophoresis according to their size. The 
following standard PCR program was used (Table 3.18). 
 
Table 3.18: Standard PCR protocol 
        Standard PCR protocol: 
95 °C 5 min 
95 °C 30 sec 
X °C 30 sec 
72 °C ~1 min/1 kb 
72 °C 10 min 
8 °C ∞ 
 
 Restriction hydrolysis  3.2.2.2
The restriction hydrolysis of DNA was done by restriction enzymes obtained from Thermo 
Fisher Scientific Biosciences (St. Leon-Rot) and the reaction was performed according to the 
manufacturer instructions. 
 
x 35 
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 Purification and gel extraction of DNA   3.2.2.3
The Purification of PCR-amplicons as well as the extraction of hydrolyzed DNA from 1% 
agarose gels was performed using the NucleoSpin® Gel and PCR Clean up kit (Table 3.7) 
according to the manufacturer’s instructions. 
 DNA-Ligation 3.2.2.4
Ligation of DNA fragments, which had previously been purified from a 1% agarose gel, was 
performed with the T4 ligase (Table 3.4) and conducted according to the manufacturer 
instructions. The protocol was adjusted to a final reaction volume of 18 µl.  
 Sequencing  3.2.2.5
DNA was sent for sequencing to GATC-Biotech (Munich), according to the company 
requirements.  
 Generation of electro-competent bacterial cells 3.2.2.6
To generate electro-competent bacterial cells, 20 ml LB media (supplemented with 
appropriate antibiotic(s)) were inoculated using an o.n. culture in a 1:20 ratio and incubated 
at 37 °C and 180 rpm until OD600 of ~ 0.5-0.8 was reached. Subsequently, this subculture 
was washed and concentrated with ice cold ddH20 two times (1 volume and ½ volume) by 
centrifugation (4030 x g, 4° C, 15 min). Afterwards, bacterial cells were washed with 1/10 
culture volume ice cold 10% glycerol by a further centrifugation step (4030 x g, 4° C, 15 min). 
After a final centrifugation step, bacterial cells were resuspended in 1/50 volume ice cold 
10% glycerol and transferred in collection tubes in aliquots of 80 µl. These aliquots were 
shock frozen in liquid nitrogen and stored at -80 °C.   
 Transformation 3.2.2.7
Frozen electro-competent bacterial cells (80 µl) were thawed on ice and 1-6 µl of plasmid, 
linear DNA, or DNA ligation mix was added to the cells, mixed, transferred into an ice cold 
electroporation cuvette (1 mm) and pulsed at 1800 V/cm for 5 ms using the Gene Pulser 
Xcell (Bio-Rad). Subsequently, bacterial cells were suspended with 900 µl LB medium, 
transferred into a new collection tube and incubated for 1 h at 37° C and 950 rpm. 
Afterwards, bacterial cells were spun down at RT (6297 x g, 1 min). The cell pellet was 
resuspended with 100 µl LB medium and plated on LB agar containing the appropriate 
antibiotic(s) and incubated o.n. at 37 °C.  
 Conjugation 3.2.2.8
Donor and acceptor strains were grown individually at 37 °C o.n. in 3 ml liquid LB medium 
(supplemented with appropriate antibiotic(s)). The next day, 1 ml of each o.n culture was 
washed 3 times in LB medium by centrifugation at RT (1 min at 6297 x g). Then, the pellet of 
the donor strain was resuspended with 100 µl LB medium and this cell suspension was used 
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to resuspend the pellet of the acceptor strain. The mixture of acceptor and donor cells was 
transferred as a big spot (2 x 2 cm) on a LB agar without any antibiotics and incubated o.n. at 
37 °C. The next day, the conjugation mixture was washed from the plate with 2 ml LB 
medium and transferred into a collection tube. This cell suspension was serially diluted 10-
fold up to 10-4. 50 µl of each dilution was plated on LB agar supplemented with the 
antibiotic(s) needed to select for successful conjugation events and the plates were 
incubated o.n. at 37 °C. 
 Transduction 3.2.2.9
Transduction (Schmieger, 1972) was used, to transfer a new generated allele containing an 
antibiotic resistance cassette, generated by lambda Red recombination, into a clean S. Tm 
background strain (Datsenko and Wanner, 2000); section 3.2.2.14). For this purpose, a P22 
phage lysate of the donor strain was generated. In a second step, this phage lysate was 
used to transduce the allele of interest into a new bacterial background strain. 
Generation of P22 phage lysate    
At first, 3 ml LB medium supplemented with the appropriate antibiotic(s) and 5 mM CaCl2 
was inoculated with the donor strain and incubated o.n. at 37 °C in the rotor wheel. The next 
day, 103 pfu of a P22-phage lysate (stock solution: 106 pfu/ml) (Schmieger, 1972) were used 
to infect 1 ml o.n. bacterial culture, mixed and incubated for 15 min at 37 °C. Subsequently, 
the suspension was transferred to a baffled flask containing 10 ml LB medium and incubated 
o.n. at 37 °C and 180 rpm. After this, 100 µl chloroform were added to this phage containing 
culture and incubated at RT for 15 min while shaking. Afterwards, the culture was spun down 
(4 °C, 4030 x g and 15 min), 1 ml of the supernatant was filtered (0.45 µM) and transferred 
into a new 1.5 ml screwcap tube and stored at 4 °C. To confirm sterility of the phage lysate, 
50 µl were plated on LB agar and incubated o.n. at 37 °C.  
P22 transduction       
3 ml LB medium supplemented with the appropriate antibiotic(s) and 5 mM CaCl2 was 
inoculated with the acceptor strain and incubated o.n. at 37 °C in the rotor wheel. The next 
day, 10 µl of the generated donor phage lysate were added to 100 µl of the o.n. culture, 
mixed and incubated for 15 min at 37° C. Subsequently, 900 µl of LB supplemented with 
10 mM EGTA were added. After incubation of 1 h at 37 °C and 850 rpm, cells were spun 
down (1 min, 10000 x g, RT). The pellet was resuspended in 100 µl LB and plated on LB 
agar supplemented with 10 mM EGTA and the appropriate antibiotics to select for 
transduction events. Plates were incubated o.n. at 37 °C. Colonies were streaked on fresh 
LB agar containing 10 mM EGTA and the appropriate antibiotics for in total three times.     
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 Extraction of plasmid DNA from bacterial cells 3.2.2.10
The extraction of plasmid DNA from bacterial cells was done using the NucleoSpin® Plasmid 
Quick-Pure kit (Table 3.7) following the instruction of the manufacturer for low copy 
plasmids. If higher amounts of plasmid DNA were needed, plasmids were extracted using the 
QIAGEN Plasmid Plus Midi-Kit Table 3.7 according to the manufacturer instructions following 
the protocol for low copy plasmids.  
 Determination of DNA concentration 3.2.2.11
A NanoDrop Spectrophotometer ND-1000 (PEQLAB Biotechnology) was used to measure 
spectrophotometrically the DNA concentration at 260 nm absorbance (A260) as well as the 
A260/A280 ratio.  An A260/A280 ratio of about 1.8-2.0 was considered as pure DNA. 
 Isolation of chromosomal DNA 3.2.2.12
For the isolation of bacterial chromosomal DNA 1 ml of an o.n. culture was harvested by 
centrifugation for 2 min at 19283 x g. Bacterial cell pellet was resuspended in 567 µl TE-
buffer (Table 3.15), 30 µl 10% SDS and 3 µl Proteinase K (20 mg/ml). After the incubation for 
1 h at 55 °C, 100 µl of 5 M NaCl and 80 µl CTAB/NaCl (Table 3.15) were added. The 
suspension was further incubated for 10 min at 65 °C. Subsequently, an equal volume of 
phenol/chloroform/isoamylalcohol (Roth, Karlsruhe) was added and the suspension was 
mixed by vortexing for 10 sec and spun down for 5 min at 19283 x g at RT. The supernatant 
containing chromosomal DNA was transferred into a new 1.5 ml collection tube and DNA 
was precipitated by adding 2.5 volume of 100% EtOH and 1/10 volume of 3 M NaAcetate, 
mixed by inverting and spun down for 30 min at 4 °C and 19283 x g. The supernatant was 
removed carefully and the DNA pellet was washed using 2.5 volume of 70% EtOH. After the 
last centrifugation step for 15 min at 4 °C and 19283 x g, the DNA pellet was air-dried at RT 
and finally resuspended with 20-50 µl of TE buffer or ddH20 and stored at 4 °C, or for long 
time storage at -20 °C. Chromosomal DNA isolation for the transposon mutagenesis assay 
(section 3.2.2.16) was done using the Kit NucleoSpin Tissue (Table 3.7), following the 
instructions of the protocol “support protocol for bacteria” of the manufacturer.   
 PCR on bacterial lysates 3.2.2.13
To verify generated bacterial mutants a single bacterial colony was transferred into a 1.5 ml 
collection tube containing 100 µl ddH20. This bacterial suspension was mixed an incubated at 
95 °C for 10 min. Immediately after, the tube was cooled down on ice and 8 µl was added to 
the PCR reaction mix (final volume of 20 µl) containing: 1 µM oligonucleotides and  1x 
DreamTaq PCR Master Mix. PCR was conducted using the standard PCR protocol (Table 
3.18).      
Materials and Methods 
41 
 
 Generation of bacterial mutant strains by lambda Red recombination 3.2.2.14
Amplification and purification of the insert: 
Bacterial mutant strains were generated using lambda Red recombination (Datsenko and 
Wanner, 2000). At first, oligonucleotides for the amplification of the reporter genes or 
antibiotic resistance cassettes have been designed. The forward oligonucleotide included a 
homologous region of about 50 bp upstream from the start codon of the target gene(s) and 
the reverse oligonucleotide included a homologous region of about 50 bp downstream from 
the stop codon of the gene(s), respectively. To control the correct insertion oligonucleotides 
were designed, which bind about 20 bp up- and downstream of the insertion site. For the 
amplification of the insert a standard PCR mix (200 µl) was assembled (section 3.2.2.1) 
including 50-100 ng linearized template plasmid DNA followed by a standard PCR program 
as described previously in section 3.2.2.1.  
Recombination:         
At first, the respective Salmonella or E. coli background strain, in which the recombination 
should take place, was transformed with the plasmid pKD46 (Table 3.2) and grown o.n. at 
30 °C. After this, an o.n. culture of these bacteria was prepared in 3 ml LB medium 
supplemented with 100 µg/ml ampicillin and incubated at 30 °C o.n. in the rotor wheel. The 
following day, 10 ml LB subcultures supplemented with 100 µg/ml ampicillin were inoculated 
using this o.n. cultures (ratio 1:20). To induce the recombinase of the pKD46 plasmid, the 
subcultures were additionally supplemented with 7 mM and 10 mM L (+)-arabinose. Bacterial 
cultures were incubated at 30 °C and 180 rpm until an OD600 of 0.5-0.8 was reached. 
Subsequently, bacterial cells were washed in ice cold ddH2O and concentrated to 1/50 of the 
culture volume by four centrifugation and washing steps (10 min, 4 °C and 7000 x g). 
Between the centrifugation steps, bacterial cells were chilled on ice for 10 min. After the last 
centrifugation step an aliquot of 80 µl electro-competent bacteria was transformed (section 
3.2.2.7) with ~4-6 µg of the prior amplified and purified (by precipitation, section 3.2.2.12) 
insert and grown o.n. on LB agar supplemented with the appropriate antibiotic(s) at 37 °C. To 
verify the success of the lambda Red recombination, a standard PCR (section 3.2.2.1) was 
conducted using the designed control oligonucleotides (Table 3.3). 
 Site specific recombination using Flp-recombinase 3.2.2.15
To eliminate antibiotic resistance cassettes flanked by FRT-sites, the Flp-recombinase 
system (Cherepanov and Wackernagel, 1995) encoded on plasmid pCP20 (Table 3.2) was 
used. Therefore, bacteria were transformed with 50-100 ng pCP20 (section 3.2.2.7). 
Bacteria harboring pCP20 were plated on selective LB agar and incubated at 30 °C o.n.. 
About 20 transformants were re-streaked on LB agar and incubated o.n. at 43 °C to induce 
the Flp-mediated recombination. Antibiotic sensitive colonies were then identified by double 
picking on LB agar with and without selective antibiotic(s) and incubation at 37°C o.n. 
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Antibiotic sensitive bacteria were re-streaked again on fresh LB agar and incubated o.n. at 
37 °C in order to cure the strain from pCP20 plasmid.    
 Transposon mutagenesis assay 3.2.2.16
A transposon (Tn10) insertion library was constructed in E. coli 252R (Ec252R) (Table 3.1) by 
using the suicide plasmid pJA1 (Table 3.2). For this purpose pJA1 carrying Tn10 and the 
transposase was transformed at first into E. coli SM10 λ-pir (EcSM10) (Table 3.1) and then 
transferred to Ec252R by conjugation. Transconjugants were selected on LB plates 
supplemented with 100 µg/ml kanamycin, 45 µg/ml rifampicin and 10 µM IPTG (Isopropyl-β-
D-thiogalactopyranosid) to induce transposase-dependent random insertion of Tn10 into the 
chromosome of Ec252R at 37 °C o.n.. Single colonies were transferred into 96-well plates filled 
with LB (180 µl/well) and supplemented with 100 µg/ml kanamycin and incubated at 37°C 
o.n. while shaking for long time storage.  
 Single Primer PCR 3.2.2.17
For the identification of Tn10 insertion sites by single primer random PCR, a protocol was 
followed as previously described (Karlyshev et al., 2000). To this end, a PCR mix was 
prepared for a volume of 50 µl. This reaction mix included ~100 ng genomic DNA, 1 µM of 
the oligonucleotide T7 (Table 3.3) as well as 1x Dream Taq Mastermix (Table 3.4). 
Oligonucleotide T7 targeting the T7 transcriptional promoter, located adjacent to the 
kanamycin resistance cassette of the Tn10, and directed outside of Tn10. The standard PCR 
protocol was modified and consists of three different stages (Table 3.19). In the first stage a 
stringent annealing temperature is chosen to ensure specific binding of the single 
oligonucleotide T7. In the next stage a low annealing temperature is used to facilitate 
unspecific binding of the oligonucleotide to the chromosomal DNA in the adjacent region of 
Tn10, to generate with subsequent oligonucleotide extension an amplicon flanked with at 
both ends with sequences derived from the oligonucleotide T7. Finally in the last stage, using 
again a stringent annealing temperature, transposon specific amplicons, generated in the 
second stage, are exponential amplified.  
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Table 3.19: Single primer PCR protocol 
Step 1 Step 2 Step3 
94 °C 1 min     
20 cycles 30 cycles 30 cycles 
94 °C 30 sec 94 °C 30 sec 94 °C 30 sec 
50 °C 30 sec 30 °C 30 sec 50 °C 30 sec 
72 °C 3 min 72 °C 2 min 72 °C 2 min 
    final extension 
    72 °C 7 min 
 
PCR amplicons were loaded on a 1% agarose gel and a single DNA band with an 
appropriate size was extracted as described in section 3.2.2.3. Using the oligonucleotide 
InsideT7, which binds downstream of the oligonucleotide T7 promoter with a region of 18 bp, 
purified DNA was sent for sequencing (section 3.2.2.5). 
 qPCR to determine plasmid copy number and stability of pPcib gfp 3.2.2.18
The qPCR was performed using the FastStart Essential DNA Green Master reaction mix for 
SYBR Green I-based real-time PCR (Roche) on a LightCycler® 96 Instrument (Roche). Each 
reaction was run in triplicates in a reaction mix of 20 µl volume containing 10 µl of 2x 
FastStart Essential DNA Green Master, 0.3 µm forward primer, 0.3 µm reverse primer, 5-
10 ng/µl of extracted total DNA from bacterial cultures of S. Tmwt pPcib gfp (passages 1-5; 
section 3.2.3.4) and RNase-free water.  
To determine the copy number of pPcib gfp per S. Tm bacteria oligonucleotides 
Ampli4_Fwd/Ampli4_Rev (amplicon: 86 bp) (Table 3.3), targeting the plasmid, and 
oligonucleotides PsicA_2_fwd/PsicA_2_rev (amplicon: 79 bp) (Table 3.3), targeting the 
S. Tm chromosome, were used. To determine qPCR reaction efficiency plasmid DNA was 
linearized, purified and quantified using Quant-IT Picogreen dsDNA assay kit (Life 
Technologies). The linear dynamic range and reaction efficiency was determined from a 
standard curve using a 1:10 dilution series of the linearized plasmid pPcib gfp or linearized 
plasmid pPsicA gfp (encoding PsicA) ranging from 2.5x107 - 2.5x102 copies. The optimal qPCR 
efficiency (97% for pPcib and 93% for pPsicA gfp) was obtained using the following cycling 
protocol: pre-incubation step of 1 cycle 95° C for 10 min, following a 3-step amplification for 
45 cycles at 95 °C for 10 s, 53 °C for 10 s and 72 °C for 10s. After each run a melting curve 
analysis was performed using the following cycling parameters: 95 °C for 10 s, 65 °C for 60 s 
and 5 °C temperature changes to the end temperature of 97 °C. Standard curves were taken 
for absolute quantification of genome (pPsicA gfp) as well as for plasmid copy numbers (pPcib gfp) 
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and consequential relative plasmid copy number was calculated (plasmid copy 
number/genome copy number). 
 
 In vitro assays 3.2.3
 Colicin killing-assay (halo-assay) 3.2.3.1
To test colicin production and sensitivity, a colicin producer strain was grown for 12 h in 3 ml 
liquid LB medium and 3 µl (to an OD600 of 0.25) were spotted (Ø 5 mm) on a LB agar 
containing 0.25 µg/ml MitC and grown o.n. at 37 °C. The next day, the plate was overlayed 
with 6 ml LB softagar containing 100 µl (to an OD600 of 1) of a sensitive tester strain grown for 
12 h in 3 ml liquid LB. The plate was incubated for 24 h at 37 °C, following inspection and 
quantification of an inhibition zone (halo) around the colony of the producer strain. For halo-
size the diameter of the colony is substracted from the total diameter (halo+colony). 
 Flow Cytometry 3.2.3.2
Bacteria were grown as described in section 3.2.1.4. For FACS, the culture was diluted in 
1x PBS to a concentration of ~106 CFU. FACS data were recorded by a FACS Canto II 
running the FACSDiva software (Aria Becton Dickinson). Data analysis was done using the 
FlowJo software 8.8.4 (Tree Star, Inc.). 
 In vitro evolution assay 3.2.3.3
For the in vitro evolution assay the plasmid pColBM of EcB1144 (pColBMB1144) was transferred 
in EcMG1655, EcStx and EcStx∆SR (Table 3.1) by conjugation, respectively. Successful conjugation 
of pColBMB1144 was verified by PCR on bacterial lysates (section 3.2.2.13) using the 
oligonucleotides CBA CBI Primer For/CBA complete Rev and cma-check-up/cma-check-
down (Table 3.3). Colicin production and sensitivity was confirmed using a colicin killing 
assay (section 3.2.3.1). To test for colicin BM production, transconjugants were overlayed 
with the colicin sensitive strain EcMG1655.  
Evolution experiment I: 
Strains (EcMG1655 pColBMB1144, EcStx pColBMB1144, EcStx∆SR pColBMB1144; Table 3.1) were streaked 
from –80 °C on LB agar containing 100 µg/ml ampicillin (to select for maintenance of 
pColBMB1144) and incubated o.n. at 37 °C. The next day, 10 individual colonies were picked 
and used to inoculate 10 ml LB medium supplemented with 100 µg/ml ampicillin (to select for 
maintenance of pColBMB1144) and incubated ~15 h at 37 °C and 180 rpm. Cultures were 
diluted and plated on LB agar containing 0.25 µg/ml MitC to select for colicin resistant 
bacteria and incubated o.n. at 37 °C. Additionally, the o.n. culture was prepared for long-term 
storage and stored at -80 °C (section 3.2.1.2). Next, 10 re-grown colonies were picked and 
used to inoculate 10 ml LB media supplemented with 100 µg/ml ampicillin and incubated for 
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~15 h at 37 °C and 180 rpm. Again, 5 ml of this o.n. culture were prepared for long-term 
storage and stored at -80 °C. The rest from this o.n. culture was diluted as before and plated 
on LB agar containing 0.25 µg/ml MitC and incubated o.n. at 37 °C. This whole procedure 
was repeated five times in total. 
After the last time a bacteria from the last set (Set 6; EcMG1655 pColBMB1144 S6, EcStx pColBMB1144 
S6, EcStx∆SR pColBMB1144 S6; Table 3.1) were streaked on LB agar containing 100 µg/ml 
ampicillin and incubated o.n. at 37 °C. The next day, clones were tested for colicin production 
(overlay with EcMG1655). Additionally the presence of pColBMB1144, and possible mutations in 
the cma gene were controlled by PCR using oligonucleotides CBA CBI Primer For/CBA 
complete Rev (Table 3.3) and cma-check-up/cma-check-down (Table 3.3). 
Evolution experiment II: 
EcMG1655 pColBMB1144, EcStx pColBMB1144, EcStx∆SR pColBMB1144 (Table 3.1) were streaked 
from -80 °C on LB agar containing 100 µg/ml ampicillin and incubated o.n. at 37 °C. The 
procedure was conducted as before however only one colony was used to inoculate the 15 h 
o.n. culture. After five times repeating the selection, the last bacteria of the generation G5 
(EcMG1655 pColBMB1144 G5, EcStx pColBMB1144 G5, EcStx∆SR pColBMB1144 G5) were streaked from -
80 °C on LB agar containing 100 µg/ml ampicillin and incubated o.n. at 37 °C. Strains were 
tested for colicin as before. Additionally the presence of pColBMB1144, and possible mutations 
in the cma gene were controlled by PCR using oligonucleotides CBA CBI Primer For/CBA 
complete Rev (Table 3.3) and cma-check-up/cma-check-down (Table 3.3). 
 Test for plasmid stability  3.2.3.4
S. Tmwt pPcib gfp was streaked on LB agar containing ampicillin (100 µg/ml) from -80 °C 
cryostock and incubated o.n. at 37 °C. The following day, a single colony was used to 
inoculate 10 ml LB liquid medium without antibiotics (flask). This culture was incubated o.n. 
at 37 °C with 180 rpm shaking. Subsequently, a sample of 1 ml to an OD600 of 0.4 was taken 
and used to set up a subculture in 10 ml LB liquid media (flask) in a ratio of 1:10. This 
subculture was incubated for about 3 h at 37 °C with 180 rpm. Passaging was then repeated 
for additional 4 times. 
From each culture, samples were taken (OD600 of 1), diluted 10-6, and plated on LB agars. 
After incubating o.n. at 37 °C a minimum of 100 colonies were picked and tested for 
presence of pPcib gfp. To check the variation of plasmid copy number of pPcib gfp
 
1 ml of each 
culture was spun down (2 min, 19283 x g) and total DNA was extracted as described in 
section 3.2.2.12. Total DNA was used as template for qPCR (section 3.2.2.18) to determine 
plasmid stability and the copy number per genome. 
 
Materials and Methods 
46 
 
 Biochemical methods 3.2.4
 Generation of samples for the immunoblot (western blot) 3.2.4.1
To extract total bacterial protein and bacterial proteins from the supernatant for immunoblot, 
bacteria were grown as described previously in section 3.2.1.4. 
Extraction of total bacterial proteins 
For the extraction of total bacterial proteins, a sample of 250 µl (to an OD600 of 1) was taken 
from the subculture and spun down for 10 min at 4 °C and 9838 x g. The pellet was 
resuspended in 1x protein loading buffer (Table 3.13), incubated for 10 min at 95 °C and 
immediately after this chilled on ice.  
Extraction of bacterial proteins from the supernatant 
Bacterial proteins from the supernatant were harvested by transferring 500 µl sample into a 
collection tube followed by a centrifugation at 9838 x g and 4 °C for 10 min. 400 µl of the 
supernatant were transferred into a new collection tube containing 100 µl of 5x protein 
loading buffer. The suspension was mixed, incubated for 10 min at 95 °C and immediately 
chilled on ice. 
 SDS-polyacrylamide gel electrophoresis (PAGE) and immunoblot 3.2.4.2
SDS-PAGE was used to separate proteins (Laemmli UK, 1970). For this purpose, a 
polyacrylamide gel was generated consisting of a 5% stacking gel (Table 3.12) and, 
depending the size of the protein of interest, a 10-15% resolving gel (Table 3.12). Proteins 
were separated using the Mini-PROTEAN® Tetra System and the Power Pac 200 (Biorad). 
Subsequently, separated proteins were transferred onto a nitrocellulose membrane (GE 
Healthcare), using the PerfectBlue Semi-Dry Electro Blotter (PEQLAB Biotechnology) at 
300 mM for 2 h. The membrane was blocked, in blocking solution (Table 3.13). The 
membrane was incubated with polyclonal primary antibody HA probe (Y11) [1:200] (Santa 
Cruz) or anti-ColM (rabbit polyclonal) [1:5000] (this study) diluted in blocking solution, and 
washed three times 5 min in 1x PBT (1X PBS and 0.1% Tween20). The membrane was then 
incubated for 30 min with the secondary anti-rabbit IgG (HRP) antibody [1:5000] (GE 
Healthcare) diluted in blocking solution. At last, the membrane was washed three times 5 min 
in 1x PBT, followed by detection with the ECL detection system or Immobilon Western 
Chemiluminescent HRP substrate (Table 3.4). 
 Coomassie Brilliant Blue R250 staining of SDS-polyacrylamide gels  3.2.4.3
After SDS-PAGE the polyacrylamide gel was transferred into a plastic box containing the 
fixing solution (Table 3.14) and heated in a microwave for 30 sec by avoiding boiling of the 
gel. Subsequently, the Coomassie Brilliant Blue R250 staining solution (Table 3.14) was 
applied and the gel was heated again for 30 sec in the microwave and further incubated for 
3 min at RT while shaking. Next, the gel was de-stained by rinsing with ddH2O, heating for 
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30 sec in the microwave and another incubation step at RT on a shaker. This washing 
procedure was repeated until an optical signal noise ratio was reached. 
 Generation and affinity purification of recombinant His(6x)-tagged proteins 3.2.4.4
For the extraction and purification of His(6x)-tagged ColM (ColM-His(6x)), EcBL21(DE3) ∆fhuA (Table 
3.1) electro-competent cells were transformed with pSJB4 to generate EcBL21(DE3) ∆fhuA pSJB4 
(Table 3.2 and Table 3.1, respectively).  
A single bacterial colony of EcBL21(DE3) ∆fhuA pSJB4 was used to inoculate 50 ml LB medium 
supplemented with 30 µg/ml kanamycin and 30 µg/ml chloramphenicol. The bacterial culture 
was incubated o.n. at 37 °C and 180 rpm. Using this o.n. culture, 1 L LB media 
supplemented with 30 µg/ml kanamycin and 30 µg/ml chloramphenicol was inoculated in a 
ratio of 1:20. When the subculture reached an OD600 of about 0.9, the culture was induced 
with 0.1 mM IPTG. After an incubation of 4 h at 180 rpm and 37 °C, bacterial cells were 
harvested by centrifugation (4030 x g, 4 °C, 30 min). The cell pellet was washed one time 
with 30 ml 1x PBS and an additional centrifugation step (4030 x g, 4 °C, 30 min). The 
supernatant was discarded and the bacterial cell pellet was stored at -80 °C. To test for 
production of ColM-His(6x) samples of 250 µl to an OD600 of 1 were taken before induction 
with IPTG and each hour after induction with IPTG, and further processed for immunoblot as 
described in section 3.2.4.1. Total bacterial protein was separated by SDS-PAGE and 
stained with Coomassie (section 3.2.4.2 and 3.2.4.3). The bacterial cell pellet was thawed 
and resuspended at RT with 25 ml lysis buffer (Table 3.11) and then lysed using the French 
Pressure Cell Press (SLM Aminco Instruments) at 1000 PSI. Afterwards, the bacterial lysate 
was spun down at 4030 x g, 4 °C, 30 min and a sample of 250 µl of the supernatant was 
taken and processed for immunoblot as described in section 3.2.4.1. Subsequently, the 
supernatant was filtered (0.22 µm filter) and loaded on a 5 ml HisTrap column equilibrated 
with loading buffer (Table 3.11). The purification and the later desalting steps were 
performed on an ÄKTA system (GE Healthcare). ColM-His(6x) were eluted with elution buffer  
(Table 3.11) and fractions containing the ColM-His(6x) were desalted by loading them on a 
5 ml HiTrap desalting column and the application of the exchange buffer 1 (Table 3.11). 
Antisera against ColM-His(6x) were obtained from immunized rabbits. Immunization was 
performed using standard protocols of Pineda Antibody-Service (Berlin, Germany).  
Rabbit antisera were received from day 61, 90, 120 and 150 post immunization and checked 
for specificity by SDS-PAGE and immunoblot using ColM producer strain Eccba::cat, parental 
strain Ec252R (ColMB producer) and EcMG1655 as negative control. 
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 Microscopy methods 3.2.5
 Immunofluorescence staining of intrabacterial proteins 3.2.5.1
In order to stain intrabacterial proteins, bacteria were grown as described in section 3.2.1.3. 
Samples of 250 µl from an OD600 of 1 were taken, spun down for 5 min, at 4 °C and 6297 x g 
and cell pellets were resuspended and fixed in 1 volume icecold  1x  PBS and three volume 
icecold 4% paraformaldehyde (PFA) in  1x PBS for 1 h. After fixation, bacteria were washed 
three times in icecold 1x PBS. Next, bacteria were immobilized on poly L-lysine coated glass 
slides (Superfrost Plus, Thermo Scientific). For this purpose, samples of 10 µl bacterial cell 
solution were spotted on the glass slides and dried o.n. at RT. Immobilized bacteria were 
additionally fixed for 5 min with 4% PFA in 1x PBS and bacterial cells were washed three 
times in 1x PBS. The next steps of the immunostaining of intrabacterial proteins were 
conducted as previously described (Schlumberger et al., 2005). Bacteria were permeabilized 
at first for 5 min in icecold permeabilization buffer A (Table 3.16). Then, pre-permeabilized 
bacteria were equilibrated with icecold permeabilization buffer B (Table 3.16) and further 
permeabilized with 5 mg/ml lysozyme solved in icecold permeabilization buffer B for 30 min 
at 4°C. Bacteria were washed three times for 5 min in 1x PBS. Next, bacteria were incubated 
in blocking solution (10% normal goat serum diluted [Biozol] in 1x PBS) for 1 h at RT. 
Afterwards, bacteria were incubated for 1 h with the primary antibody (HA probe (Y11) 
[1:200] (Table 3.17), ADI-SPA-880 (Hsp70) [1:200] (Table 3.17), or anti-GFP [1:200] 
(Table 3.17)) diluted in blocking solution. Thereafter, bacteria were washed three times for 
5 min in 1x PBS and incubated for 30 min with the respective secondary antibody (anti-rabbit 
IgG (DyLightTM549) [1:400] (Table 3.17), anti-rabbit IgG (DyLightTM649) [1:400] (Table 3.17), 
or anti-mouse IgG (Rhodamine RedTM-X) [1:200] (Table 3.17)) diluted in blocking solution. 
Nucleic acids were stained with 4’6-Diamidin-2-phenyl (DAPI [1 µg/ml], Roth). Finally 
bacteria were washed three times with 1x PBS, dried at RT in the dark, mounted with 
Vectashield (Vector) and sealed with nail polish.    
 Confocal microscopy and image analysis 3.2.5.2
For microscopic image analysis a minimum of three images (corresponding to >100 bacteria 
counted) were taken using the Leica TCS SP5 confocal microscope (HCX PL APO CS, Leica 
Microsystems, Mannheim) and a 63x oil objective and a magnification of 1 or 2.4, 
respectively. ImageJ software, version 1.48v (Wayne Rasband, National Institute of Health, 
USA) (Schneider et al., 2012) was used for image analysis. Initially, a mask was created 
using the DAPI channel. With this mask the bacterial shape was defined. The mask was 
superimposed to the channel of interest like the green (GFP-signal of the multicopy reporter 
or the prophage lysis gene reporter) and red (ColIb-HA- or anti-GFP-signal) channels. Cell 
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size, the integrated density and the mean grey values (MFI: mean fluorescence intensity) 
were determined for individual bacteria. 
The corrected total cell fluorescence (CTCF) was calculated in order to correlate intrinsic 
GFP-levels with intrinsic ColIb-HA, or with anti-GFP-signal, respectively.  
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The maximum value of MFI or CTCF value from S. Tmwt served as detection limit. 
 
 Live cell microscopy using CellASIC® ONIX Microfluidic Platform 3.2.5.3
For live cell microscopy bacterial strains were grown as previously described in section 
3.2.1.6.  
The medium/buffer reservoirs (wells 1-5) of the microfluidic plate for bacteria (B04) were 
filled with liquid LB medium (300 µl/well) and the cell outlet well 6 was emptied. Well 7 (for 
waste) was also emptied but a drop of solution was left over in the bottom whole. The plate 
was vacuum sealed to the manifold using the CellASIC® ONIX Microfluidic Perfusion System 
(model: EV262) and placed onto a Spinning disk confocal microscope (TE300 eclipse, Nikon 
Instruments, Düsseldorf) with Perkin Elmer UltraVIEW spinning disk system and Hamamatsu 
Orca ER CCD or Orca Flash 4.0 CMOS camera and surrounded by a climate chamber at 
37 °C. Subsequently, the plate was primed with LB medium of wells 1-5 simultaneously for 
5 psi for 5 min. After this, the plate was removed from the microscope and different liquid test 
media were loaded to the wells (1-5; 300 µl/ml) and 100 µl cell suspension (106 cells/ml) was 
loaded in the cell inlet well 8. The plate was again vacuum sealed to the manifold and placed 
onto the microscope. Bacterial cells were loaded with 4 psi for 6 sec from the cell inlet well 
following an additional priming step to wash out un-trapped bacterial cells. Using the 
CellASIC™ ONIX FG Software the protocol for the medium flow over time was set up 
(Table 3.20).  
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Table 3.20: Protocol for medium flow over time (example) 
Well Medium Pressure [psi] 
Time 
[min] 
1 LB 1 180 
2 LB+DTPA (100 µM) 2 1 
2 LB+DTPA (100 µM) 1 20 
3 LB+DTPA (100 µM) 
+ MitC (0.5 µg/ml) 
2 1 
3 LB+DTPA (100 µM) 
+ MitC (0.5 µg/ml) 
1 20 
4 LB+DTPA (100 µM) 2 1 
5 LB+DTPA (100 µM) 1 190 
 
Every 10 min images were taken with a Nikon 100×/1.40 Plan Apo oil objective. Image 
analysis was done using the Volocity 6.0.1 software (Perkin-Elmer) and the ImageJ software, 
version 1.48v (Wayne Rasband, National Institute of Health, USA) (Schneider et al., 2012). 
 
 Statistical analysis  3.2.6
For all statistical analysis the Graph Pad Prism Version 5.01 was used. As detailed in the 
results the following statistical tests were used:  
The 1-way ANOVA test followed by the Tukey’s post test. P-values less than 0.05 were 
considered as significant.  
The 1-way ANOVA test followed by the Kruskal-Wallis test with Dunn’s Multiple 
Comparison test. P-values less than 0.05 were considered as significant.  
The Spearman-rank correlation coefficient [ρ] was calculated on a regression to 
determine linear correlation. 
The 2-way-ANOVA was used followed by the Bonferroni posttest. P-values less than 0.05 
were considered as significant. 
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 Construction of plasmids and mutant strains  3.2.7
Bacterial mutant strains and bacterial plasmid generated and used in this study are listed in 
Table 3.1 and Table 3.2, respectively. 
 
 Construction of mutant strains by lambda Red recombination (Datsenko and 3.2.7.1
Wanner, 2000) 
Construction of S. Tm p2cib-HA (M1400): S. Tmwt was transformed with plasmid pKD46. As 
template for the amplification of the HA (Hemagglutinin)-epitope tag, including a kanamycin 
resistance cassette flanked by FRT-sites, plasmid pSU315 (Table 3.2) and the 
oligonucleotides Colicin-HA-fwd/Colicin-HA-rev (Table 3.3) were used. The correct insertion 
in the resulting strain M994-1 was confirmed by PCR using the oligonucleotides 
Col-ÜE-XbaI/ Col-ÜE-XhoI (Table 3.3). A clean S. Tmwt background strain was transduced 
with the cib-HA-aphT allele using P22-transduction. Correct insertion in S. Tm p2cib-HA was 
confirmed by PCR using oligonucleotides Col-ÜE-XbaI/ Col-ÜE-XhoI and the functional HA-
tag was assessed by immunoblot using HA probe (Y11) antiserum (Table 3.17). Additionally, 
functionality of ColIb-HA in S. Tm p2cib-HA was confirmed using a colicin killing-assay. 
Construction of Ec252R pColBMcba::cat (MAD4-1): Ec252R was transformed with pKD46 and 
pKD3 was used as template to amplify the chloramphenicol resistance cassette flanked by 
FRT-sites by PCR using the oligonucleotides cba-fwd-ko/cba-rev-ko (Table 3.3). The 
elimination of cba in Ec252R pColBMcba::cat (MAD4-1) was verified by PCR with the 
oligonucleotides cba-check-up/cba-check-down (Table 3.3) (Manuel Diehl). 
Construction of Ec252R pColBMcma::cat (MAD5-1): To generate Ec252R pColBMcma::cat (MAD5-
1) the lambda Red recombinase system was used as described. Plasmid pKD3 was used as 
template to amplify the chloramphenicol resistance cassette flanked by FRT-sites by PCR 
using the oligonucleotides cma-fwd-ko/cma-rev-ko (Table 3.3). The elimination of cma in 
Ec252R pColBMcma::cat (MAD5-1) was verified by PCR with the oligonucleotides cma-check-
up/cma-check-down (Table 3.3) and by a colicin killing-assay (Manuel Diehl). 
Construction of Ec252R pColBMcmaHA (SJB3): Ec252R was transformed with the recombinase 
including plasmid pKD46 (Table 3.1). Next, plasmid pSU314 (Table 3.2) was used as 
template to amplify the HA (hemagglutinin)-tag sequence, including a FRT-site-flanked 
kanamycin resistance gene, with the oligonucleotides cma-HA-fwd/cma-HA-rev (Table 3.3). 
Correct insertion was verified by PCR using the oligonucleotides cma-check-up/cma-check-
down (Table 3.3). The functionality of the cma-HA-tag was tested by immunoblot using HA 
probe (Y11) antiserum (Table 3.17). 
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Construction of Ec252R pColBMcmiHA (SJB4): Ec252R was transformed with plasmid pKD46 
(Table 3.2). Plasmid pSU314 (Table 3.2) was used as template to amplify the HA 
(hemagglutinin)-tag sequence, including a FRT-site-flanked kanamycin resistance gene, 
using oligonucleotides cmi-HA-fwd/cmi-HA-rev (Table 3.3). Correct insertion was verified by 
PCR using the oligonucleotides cmi check up forward/cmi check down rev (Table 3.3). The 
functionality of the cmi-HA-tag was checked by immunoblot using HA probe (Y11) antiserum 
(Table 3.17). 
Construction of EcBL21(DE3) ∆fhuA (SJB7): EcBL21(DE3) was transformed with plasmid pKD46 
(Table 3.2). Plasmid pKD3 (Table 3.2) served as template for the FRT-site flanked 
chloramphenicol resistance cassette. By PCR using the oligonucleotides FhuA-KO-
fwd/FhuA-KO-rev (Table 3.3) the chloramphenicol resistance cassette was amplified. Correct 
insertion was validated by PCR using oligonucleotides FhuA_seq-fwd1/FhuA_sequ-rev 
(Table 3.3). The functionality of the fhuA deletion was confirmed by a colicin M killing-assay 
(section 3.2.3.1).  
Construction of EcDH5α ∆fhuA (SJB8): EcDH5α was transformed with plasmid pKD46 
(Table 3.2). Plasmid pKD3 (Table 3.2) served as template for the FRT-site flanked 
chloramphenicol resistance cassette. By PCR using the oligonucleotides FhuA-KO-
fwd/FhuA-KO-rev (Table 3.3) the chloramphenicol resistance cassette was amplified. Correct 
insertion was validated by PCR using oligonucleotides FhuA_seq-fwd1/FhuA_sequ-rev 
(Table 3.3). The functionality of the fhuA deletion was confirmed by a colicin M killing-assay. 
Construction of S. Tm p2cib::sfgfp (SJB15-2): S. Tmwt was transformed with pKD46. The 
plasmid pWRG7 (Table 3.2) was used as template to amplify the sfgfp gene including a 
kanamycin resistance cassette flanked by FRT-sites with the oligonucleotides 
SFGFP_cib_fwd/SFGFP_cib_rev (Table 3.3) resulting in SJB11-14. Correct insertion was 
confirmed by PCR and sequencing using the oligonucleotides Check up_SFGFP_fwd/ 
Check up_SFGFP/RFP_rev (Table 3.3). Sequencing confirmed the correct sequence of the 
colicin Ib promoter (Pcib) and sfgfp gene for SJB11-14. The functionality of the sfgfp 
expression was assessed by FACS analysis (section 3.2.3.2). P22 transduction (section 
3.2.2.9) was used to transfer the allele cib imm::sfgfp-aphT from SJB11-14 in a clean S. Tmwt 
(SB300 pWKS30) background strain yielded in strain S. Tm p2cib::sfgfp. The correct insertion 
was verified by PCR using oligonucleotides Check up_SFGFP_fwd/ Check up_SFGFP/ 
RFP_rev (Table 3.3). The functionality of sfgfp expression was assessed by FACS analysis. 
Construction of EcMG1655 ∆fhuA (SJB20): EcMG165 was transformed with plasmid pKD46 
(Table 3.2). Plasmid pKD3 (Table 3.2) served as template for the FRT-site flanked 
chloramphenicol resistance cassette. By PCR using the oligonucleotides FhuA-KO-
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fwd/FhuA-KO-rev (Table 3.3) the chloramphenicol resistance cassette was amplified. Correct 
insertion was validated by PCR with the oligonucleotides FhuA_seq-fwd1/FhuA_sequ-rev 
(Table 3.3). The functionality of the fhuA deletion was confirmed by a colicin killing-assay. 
Construction of S. TmlysST::sfgfp p2cib-HA (SJB36-1): The ST64B lysis genes (SL1344_1955-
SL1344_1957=lysST) were replaced by the sfgfp reporter gene, with the assistance of the 
lambda Red recombination system. S. Tmwt was transformed with plasmid pKD46 (Table 3.2) 
and plasmid pWRG7 (Table 3.2) was used as template to amplify the sfgfp gene including a 
FRT-site-flanked kanamycin resistance cassette by PCR using the oligonucleotides ST64B-
sfgfp-fwd/ ST64B-sfgfp-rev (Table 3.3) resulting in SJB24-15. Correct insertion was validated 
by PCR with the oligonucleotides Check_ST64_for/Check_ST64_rev (Table 3.3). 
Functionality of the reporter was assessed by FACS analysis. P22 transduction was used to 
transfer the allele SL1344_1955-SL1344_1957::sfgfp-aphT of SJB24-15 in a clean S. Tmwt 
background strain. Correct insertion in the yielded strain S. Tm SJB26-2, was controlled by 
PCR with the oligonucleotides Check_ST64_for/Check_ST64_rev (Table 3.3) and 
functionality of the reporter was assessed using FACS analysis. Site specific-DNA 
recombination using Flp-recombinase was conducted to delete the FRT-site-flanked 
kanamycin resistance cassette of SJB26-2. The deletion of the kanamycin resistance 
cassette yielded in strain SJB35-1 and was confirmed by PCR using the oligonucleotides 
check_ST64_for/check_ST64_rev (Table 3.3). To transfer the plasmid p2cib-HA, total DNA 
was extracted of S. Tm p2cib-HA (M1400) (section 3.2.2.12) and transformed in SJB35-1 
resulting in strain SJB36-1. Transformants were selected on LB agar containing 30 µg/ml 
kanamycin. Plasmid transfer was verified by PCR using the oligonucleotides 
check_ST64_for/check_ST64_for and Col_lux_check_for/Col_lux_check_rev (Table 3.3).  
Construction S. TmlysST::T7 pol (SJB34): In order to replace the ST64B lysis genes 
(SL1344_1955-SL1344_1957) by the T7 RNA polymerase gene (T7 gene 1) the lambda Red 
recombinase system was used. Therefore, S. Tmwt was transformed at first with pKD46. The 
plasmid pJLG2 (Table 3.2) was used as template for the amplification of T7 gene 1 by PCR 
using the oligonucleotides T7_ST64B_fwd/ST64B-sfgfp-rev (Table 3.3).  
Successful recombination in SJB33 was verified by PCR using the oligonucleotides 
Check_ST64_for/Check_ST64_rev (Table 3.3). Correct sequence was controlled by 
sequencing using oligonucleotides Check_ST64_for/ T7 seq left 2/ T7 seq right2/ 
Check_ST64_rev (Table 3.3). P22 transduction was used to transfer the allele 
SL1344_1955-SL1344_1957::T7 gene 1 aphT of SJB33 into a new S. Tm background strain 
(S. Tmwt) resulting in S. TmlysST::T7 pol. Correct insertion was validated by PCR with the 
oligonucleotides Check_ST64_for/Check_ST64_rev (Table 3.3). To confirm functionality of 
the T7 RNA polymerase S. TmlysST::T7 pol was transformed with the plasmid pJLG1 (Table 3.2). 
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This plasmid encodes the T7 RNA polymerase promoter (PT7) fused to a sfgfp gene. 
Functionality of the reporter was assessed using FACS analysis. 
 
 Generation of mutant strains by other techniques 3.2.7.2
Generation of Ec252R pColBM∆cba (SJB5): Site specific-DNA recombination was used to 
delete the FRT-site-flanked chloramphenicol resistance cassette of Ec252R pColBMcba::cat. 
Therefore, Ec252R pColBMcba::cat was transformed with Flp-recombinase encoding plasmid 
pCP20. Deletion of the chloramphenicol resistance cassette was confirmed by PCR using 
the oligonucleotides cba-check-up/cba-check-down (Table 3.3). 
Generation of Ec252R pColBM∆cma (SJB6): Site specific-DNA recombination was used to 
delete the FRT-site-flanked chloramphenicol resistance cassette of Ec252R pColBMcma::cat. 
Therefore, Ec252R pColBMcma::cat was transformed with Flp-recombinase encoding plasmid 
pCP20. Deletion of the chloramphenicol resistance cassette was confirmed by PCR using 
the oligonucleotides cma-check-up/cma-check-down (Table 3.3). 
Generation of EcMG1655 pColBMB1144 (SJB21-2): To generate EcMG1655 pColBMB1144 (SJB21-
2) the plasmid pColBM of E. coli strain B1144 (Table 3.1) carrying an ampicillin resistance 
marker was transferred to EcMG1655 by conjugation. This was verified by PCR using the 
oligonucleotides CBA-CBI-For/CBA-complete rev and CBA-CBI-For/CBA-remnant rev 
(Table 3.3). Production of colicin BM was determined using colicin BM sensitive EcMG1655 and 
colicin M resistant EcMG1655 ∆fhuA as test strains.  
Generation of EcStx pColBMB1144 (SJB22-2):  To generate EcStx pColBMB1144 (SJB22-2) the 
plasmid pColBM of E. coli strain B1144 (Table 3.1) was transferred to EcStx (MBK13) by 
conjugation. This was verified by PCR using the oligonucleotides CBA-CBI-For/CBA-
complete rev and CBA-CBI-For/CBA-remnant rev (Table 3.3). Production of colicin BM was 
determined using colicin BM sensitive EcMG1655 and colicin M resistant EcMG1655 ∆fhuA as test 
strains.  
Generation of EcStx∆SR pColBMB1144 (SJB23-2): To generate EcStx∆SR pColBMB1144 (SJB23-2) 
the plasmid pColBM of E. coli strain B1144 (Table 3.1) was transferred to EcStx∆SR (MBK14) 
by conjugation. This was verified by PCR using the oligonucleotides CBA-CBI-For/CBA-
complete rev and CBA-CBI-For/CBA-remnant rev (Table 3.3). Production of colicin BM was 
determined using colicin BM sensitive EcMG1655 and colicin M resistant EcMG1655 ∆fhuA as test 
strains.  
Generation of Ec252R Tn10 (MAD3): Ec252R Tn10 (MAD3) was isolated from the Ec252R 
transposon mutagenesis assay (section 3.2.2.16). The strain harbors Tn10 at an unknown 
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location in the chromosome and does not exhibit a phenotype regarding colicin M production 
or sensitivity (Manuel Diehl). 
 
 Generation of plasmids 3.2.7.3
Generation of pempty (pM955): To generate pempty the gfpmut3b gene was deleted from 
plasmid pM946 (Table 3.2) by restriction hydrolysis with EcoRI, followed by a re-ligation 
step. 
Generation of pcmi 252R (pMAD7): The cmi promoter region (Pcmi) and the cmi gene were 
amplified from extracted total DNA of Ec252R. In order to this the oligonucleotides cmi-pro-fwd-
XbaI/cmi-pro-rev-BamHI (Table 3.3) with respective binding sites of 95 bp downstream of the 
cmi stop codon and 135 bp upstream of the promoter region of cmi. Pcmi-cmi of Ec252R was 
inserted into pempty via BamHI and XbaI. Correct sequence was confirmed by sequencing 
using the oligonucleotides cmi-pro-fwd-XbaI/cmi-pro-rev-BamHI (Manuel Diehl). 
Generation of pcmi Cl139 (pMAD8): The cmi promoter region (Pcmi) and the cmi gene were 
amplified from extracted total DNA of EcCl139 using the oligonucleotides cmi-pro-fwd-
XbaI/cmi-pro-rev-BamHI (Table 3.3) with respective binding sites of 95 bp downstream of the 
cmi stop codon and 135 bp upstream of the promoter region of cmi, respectively. Pcmi-cmi of 
EcCl139 was inserted into pempty via BamHI and XbaI. Correct sequence was confirmed by 
sequencing using the oligonucleotides cmi-pro-fwd-XbaI/cmi-pro-rev-BamHI (Manuel Diehl). 
Generation of pPT7 sfgfp (pJLG1): To construct plasmid pPT7 sfgfp the sfgfp gene of pWRG7 
was amplified using the oligonucleotides pJLG1 SFGFP SD BamHI Fw /pJLG1 SFGFP 
EcoRI Rev (Table 3.3). The amplicon was inserted into pempty (Table 3.2) using the enzymes 
BamHI and EcoRI. Correct sequence was confirmed by sequencing using the 
oligonucleotides pJLG1proof fwd/ pJLG1proof rev (Table 3.3) (Jana Glaser). 
Generation of pT7 Pol (pJLG2): To construct the plasmid pT7 Pol genomic DNA was extracted 
from EcBL21 (DE3) (Table 3.1) and used as template to amplify the T7 polymerase gene 
(T7 gene-1) using the oligonucleotides T7 pol FW NotI/T7 pol Rev XhoI (Table 3.3). 
Following restriction hydrolysis by NotI and XhoI the fragment was inserted into p2795 
(Table 3.2). Correct sequence in pJLG2 was verified by sequencing using the 
oligonucleotides pJLG2 seq Fw/T7 seq left 2/ T7 seq right2/pJLG2 seq Rev (Table 3.3) 
(Jana Glaser). 
Generation of pSJB4: To generate pSJB4 encoding for the c-terminal ColM-His(6x)-tag 
fusion, the open reading frame of cmaw/o stop codon was amplified of E. coli 252R genomic DNA by 
PCR using the oligonucleotides cma-histag_fwd/cma-histag_rev (Table 3.3). By restriction 
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hydrolysis with NheI and HindIII, cmaw/o stop codon was inserted into hydrolyzed pET24c 
(Novagen) to yield pSJB4 (Table 3.2). 
Generation of pPcib (pSJB16): To generate pPcib the gfpmut2 gene was deleted from plasmid 
pM1437 (Table 3.2) by restriction hydrolysis with EcoRI followed by a ligation step. Correct 
sequence of Pcib was checked by sequencing using oligonucleotide check up_pSJB16 
(Table 3.3). 
Generation of pcontrol (pSJB17): To generate pcontrol the gfpmut2 gene was deleted from 
plasmid pM968 (Table 3.2) by restriction hydrolysis with EcoRI, followed by a re-ligation 
step. 
Single cell analysis of cib expression in S. Tm                                                               Results 
4 Results 
4.1 Single cell analysis of colicin Ib (cib) gene expression in S. Tm 
S. TmSL1344 (S. Tmwt) harbors a large (86.9 kb) conjugative plasmid (p2) carrying the colicin Ib 
locus. Thus, S. Tmwt is able to produce colicin Ib (ColIb) and its immunity protein (ColIb Imm) 
to protect itself against self-killing. As previously shown, using western blot analysis and 
luciferase reporter constructs, ColIb (cib) is under the control of the SOS-response and is 
expressed in response to Fe2+-limiting conditions both in vitro and in the inflamed intestine 
(Nedialkova et al., 2014). In the same study it was additionally shown that cib expressing 
S. Tmwt can outcompete commensal E. coli in inflammation-dependent Enterobacterial 
blooms in the mouse gut (Nedialkova et al., 2014). In general it is known that colicins are 
produced only by small fraction of the (genetically identical) population and thus by individual 
bacteria (Mulec et al., 2003). This is of importance as colicin-release by the producing 
bacteria depends on cell lysis and thus on death of the producing bacteria (Cascales et al., 
2007) which is referred to as “division of labor”.  
Thus cell death of individual colicin producing bacteria (cooperative suicide) allows colicin-
release and serves as common good for the remaining population. As a consequence this 
may eventually increase the overall fitness of a strain in competition with a colicin sensitive 
Enterobacterial community. Therefore it is of interest to analyze cib expression at the single 
cell level, to determine the fraction of individual cib expressing bacteria of S. Tmwt. For this 
purpose, different gfp-reporters for cib expression were generated and characterized. Using 
these reporter tools it was possible to analyze cib expression of individual bacterial cells 
under different environmental conditions in a quantitative fashion.      
This work was published in (Spriewald et al., 2015).  
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4.1.1 Generation of gfp-reporters for the analysis of cib expression at the single 
cell level 
To analyze cib expression in S. TmSL1344 at the single cell level, at first the single-copy sfgfp-
reporter S. Tm p2cib::sfgfp was generated. In S. Tm p2cib::sfgfp the colicin Ib activity gene (cib) 
and the cib immunity gene (cib imm) on plasmid pColIB9 (further named as p2) 
(Figure 4.1A) were exchanged against a bright and photo stable superfolder GFP (sfgfp) 
(Pedelacq et al., 2006) (Figure 4.1B). Since p2 is only present in about one copy per 
S. Tm bacterial cell, the generated reporter is further termed as single-copy gfp-reporter. To 
characterize the reporter S. Tm p2cib::sfgfp was analyzed by FACS (section 3.2.3.2) under 
different environmental growth conditions (Figure 4.1C). Bacterial cells were grown for 4 h in 
liquid LB medium. To trigger the induction of the SOS-response only, bacteria were grown in 
liquid LB medium supplemented with 0.25 µg/ml MitC. For de-repression of cib promoter by 
Fe2+-limitation, LB medium was supplemented with 100 µM DTPA. For a full de-repression of 
cib promoter bacteria were cultured in liquid LB with both supplements at the same time. 
FACS data demonstrate that sfgfp expression of the single-copy reporter is slightly induced 
by induction of the SOS-response and Fe2+-limitation alone. Maximal expression was 
achieved by addition of both supplements simultaneously. These data are in accordance with 
results achieved by bulk assays using western blot analysis and luciferase reporter 
(Nedialkova et al., 2014). In conclusion, the single-copy reporter of S. Tm p2cib::sfgfp has the 
capacity of reporting cib expression, but the sfGFP signal intensity is fairly low due the low 
copy number of p2.   
To improve the signal intensity an additional multi-copy reporter (pPcib gfp) was generated, due 
to the overall low GFP fluorescence intensity of the single copy reporter. Therefore, gfpmut2 
was fused to the cib promoter region (Pcib) (Figure 4.1D) and this was inserted on a pBAD24 
backbone plasmid encoding the ori of pBR322 (Guzman et al., 1995) a derivative of the 
plasmid pMB1 (ColE1-type) (Bolivar et al., 1992). Hence, this gfp-reporter plasmid harbors 
the replication control mechanism of ColE1-type plasmids and derivatives. But interestingly, 
pBAD24 plasmids lack the gene encoding for the repressor of primer protein (ROP) (Cronan, 
2006). This RNA-binding protein negatively regulates the medium copy number characteristic 
for pBR322 by stabilizing the RNAI/RNAII complex, which inhibits primer formation and thus 
plasmid replication (Cesareni et al., 1982, Lacatena et al., 1984). The lack of ROP results in 
high copy numbers similar to the copy number of pUC plasmids (Cronan, 2006). Notably, 
pPcib gfp copy number is thus comparable to group A colicin plasmids, as these colicins are 
usually encoded on small high copy number plasmids (Cascales et al., 2007).   
S. Tmwt transformed with pPcib gfp has the advantage that, in addition to gfp expression, cib 
and imm are still intact and thus expressed from their native location. Additionally, the GFP 
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signal intensity is expected to be higher due to the multi-copy number plasmid. However, the 
high copy number may also affect gene regulation of cib by introducing “multi-copy-effects”, 
due to the additional copies of the repressor binding sites (FUR- and LexA-Box) on pPcib gfp 
(Figure 4.1D). 
Interestingly, FACS data show the same supplement-dependent cib expression pattern as it 
was observed for the single-copy reporter (Figure 4.1C). As expected, in contrast to the 
single-copy reporter the induction of cib resulted in overall higher GFP signal intensity 
(Figure 4.1E).  
 
 
Figure 4.1: Characterization of gfp expression by the single- and multi-copy gfp-reporter. (A) 
Organization of the ColIb locus encoded on the p2 plasmid in S. TmSL1344 and (B) on the single-copy 
reporter in S. Tm p2cib::sfgfp. (C) Flow cytometry analysis for sfGFP signal intensities of S. Tm p2cib::sfgfp. 
(D) Schematic view of the gene structure of the multi-copy reporter pPcib gfp. (E) Flow cytometry 
analysis for GFP signal intensities S. Tmwt pPcib gfp. (C and E) Bacterial strains were cultivated for 4 h in 
either liquid LB medium (grey), LB supplemented with 0.25 µg/ml MitC (red), LB supplemented with 
100 µM DTPA (blue), or in LB containing both inducer agents (purple). S. Tmwt grown for 4 h in liquid 
LB medium served as negative control to determine the fraction (%) of sfGFP+ and GFP+ bacteria. 
Adapted from (Spriewald et al., 2015).  
 
4.1.2 The influence of different inducer concentrations on cib expression 
pattern in S. Tmwt 
It was hypothesized that colicin production following the strategy of division of labor would be 
of advantage for the entire population. In this scenario a small fraction of colicin producing 
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bacteria would sacrifice itself to kill closely related environmental competitors. Consequently, 
this would result in a growth benefit for the majority of the colicin producing population, as 
this was shown for colicin-dependent growth benefit of S. Tm over commensal E. coli in the 
inflamed gut (Nedialkova et al., 2014). According to this hypothesis, a bimodal gene 
expression pattern of cib upon induction would be expected. So far I have not observed 
bimodal expression with the high supplement concentrations, applied before and in bulk 
assays to support maximal cib-induction (Nedialkova et al., 2014). Thus, gfp expression of 
the single-copy reporter was determined by FACS, using decreasing supplement 
concentrations. S. Tm p2cib::sfgfp was grown 4 h with either decreasing concentrations of DTPA 
(200 µM, 100 µM, 50 µM, 25 µM, 12 µM, 6 µM) or MitC (1 µg/ml, 0.5 µg/ml, 0.25 µg/ml, 
0.2 µg/ml, 0.1 µg/ml, 0.05 µg/ml, 0.01 µg/ml) and subsequently analyzed by FACS 
(Figure 4.2AB top). Again only a shift in the entire population of GFP+ bacteria was detected 
(unimodal gene expression) but no bimodal gene expression, which would have been 
characterized by two peaks of different fluorescence intensity. Nevertheless, as the promoter 
region of cib harbors two repressor binding sites (FUR- and LexA-box), both inducer 
compounds might be required simultaneously to favor a bimodal expression. Accordingly, 
S. Tm p2cib::sfgfp was grown 4 h in LB with both supplements but this time one supplement was 
kept at a constant concentration and the other one was titrated in a decreasing manner. 
However, no bimodal expression pattern was observed. To exclude, that the rather low 
sfGFP signal intensity of S. Tm p2cib::sfgfp is the reason for unimodal expression pattern the 
experiment was repeated with S. Tmwt pPcib gfp (Figure 4.2CD). FACS data of S. Tmwt pPcib gfp 
revealed higher GFP fluorescence intensity but a similar expression pattern compared to 
S. Tm p2cib::sfgfp. The influence of different time points of induction on sfgfp expression was 
also investigated and similar results were obtained (data not shown). Consequently, cib is 
expressed rather in a unimodal than bimodal fashion. 
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Figure 4.2: Impact of varying exogenous supplement concentrations on cib expression in 
S. Tm p2cib::sfgfp and S. Tmwt pPcib gfp. (A-B) GFP fluorescence intensity of S. Tm p2cib::sfgfp (single-copy 
reporter) was analyzed by flow cytometry after 4 h growth in liquid LB media supplemented with either 
(A) increasing concentrations of DTPA (0 µM, 6 µM, 12 µM, 25 µM, 50 µM, 100 µM and 200 µM) and 
addition of a constant MitC concentration (either 0 µg/ml, 0.01 µg/ml,  0.05 µg/ml, 0.1 µg/ml, 0.2 µg/ml, 
0.25 µg/ml, 0.5 µg/ml or 1 µg/ml) or (B) increasing MitC concentrations (0 µg/ml, 
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0.01 µg/ml,  0.05 µg/ml, 0.1 µg/ml, 0.2 µg/ml, 0.25 µg/ml, 0.5 µg/ml and 1 µg/m) while the DTPA was 
kept at a constant concentration (0 µM, 6 µM, 12 µM, 25 µM, 50 µM, or 100 µM). Underlined values 
highlight MitC and DTPA concentrations used before for the reporter characterization (Figure 4.1) and 
in bulk assays (Nedialkova et al., 2014). (C) S. Tmwt pPcib gfp was cultured 4 h in liquid LB medium 
supplemented with increasing DTPA concentrations (0 µM, 6 µM, 12 µM, 25 µM, 50 µM, 100 µM and 
200 µM) and a constant MitC concentration of 0.25 µg/ml and (D) with increasing MitC concentrations 
(0 µg/ml, 0.01 µg/ml,  0.05 µg/ml, 0.1 µg/ml, 0.2 µg/ml, 0.25 µg/ml, 0.5 µg/ml and 1 µg/m) and a 
constant DTPA concentrations of 100 µM. GFP fluorescence intensities were analyzed by FACS. To 
determine the fraction of GFP+ (%) bacteria S. Tmwt (no GFP) was grown as negative control in LB 
(grey) (Spriewald et al., 2015). 
 
 
 
4.1.3 Plasmid stability of pPcib gfp and its influence on intrinsic cib expression in 
S. Tmwt   
As the GFP signal intensity of the single-copy reporter S. Tm p2cib::sfgfp was overall quite low, 
the multi-copy reporter pPcib gfp, with its high GFP signal intensities, would be a useful tool for 
further analyses. For time course experiments as well as live cell microscopy or animal 
experiments it would be relevant to determine the plasmid stability of pPcib gfp, as the plasmid 
loss could lead to not reliable results. In order to investigate plasmid stability of the multi-
copy plasmid over time without selective pressure, S. Tmwt pPcib gfp was cultivated in liquid LB 
without antibiotics for 5 successive passages and thus for about 24 generations (section 
3.2.3.4). Furthermore, samples were taken, following replica plating to determine plasmid 
loss. Additionally, total DNA was extracted (section 3.2.2.11) and culture samples were 
analyzed by qPCR to determine plasmid copy number variations over time. Replica plating 
results exhibited an excellent plasmid stability of >99% which was also confirmed by qPCR 
analysis (Figure 4.3).   
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Figure 4.3: Quantitative PCR (qPCR) to determine plasmid stability and copy number of the 
reporter plasmid pPcib gfp. S. Tmwt pPcib gfp was grown in 5 successive passages in LB without 
antibiotics. After each passage, samples (1 ml for an OD600 of 1) were taken, total DNA was extracted 
and (A) plasmid (oligonucleotides Ampli4_Fwd/Rev) and (B) genome copy numbers (oligonucleotides 
PsicA_1_fwd/rev) were determined by qPCR. (C) Plasmid (pPcib gfp) copy numbers per genome as 
calculated from the values of (A) and (B). Bars represent the mean. Statistical analysis was done 
using 1-way ANOVA with Tukey’s post test and no significant difference was found (p>0.05). Adapted 
from (Spriewald et al., 2015). 
 
 
pPcib gfp reports cib expression through a Pcib gfpmut2 fusion on an external plasmid, and 
S. Tmwt pPcib gfp express intrinsic cib in addition to gfpmut2. This is a useful tool to correlate 
intrinsic cib expression with gfpmut2 expression from pPcib gfp in S. Tmwt. To this end a c-
terminal ColIb Hemagglutinin (HA) fusion was generated to detect ColIb-HA via intracellular 
immunostaining (Figure 4.4A). To exclude differences in production and/or functionality of 
ColIb-HA compared to the wildtype ColIb a halo-assay was conducted (section 3.2.3.1). 
S. Tm p2cib-HA and a wildtype control strain S. Tmwt were spotted on LB agar containing 
0.25 µg/ml MitC and overlayed with the colicin sensitive strain EcMG1655 to compared ColIb 
production and toxicity (Figure 4.4B). The halo-assay revealed no significant differences 
between ColIb-HA and wildtype ColIb production and functionality.    
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Figure 4.4: Verification of the ColIb-HA functionality in S. Tm p2cib-HA. (A) Organization of the 
ColIb-HA locus encoded on the p2 plasmid in S. Tm p2cib-HA. Adapted from (Spriewald et al., 2015). 
(B) Halo-assay to determine colicin production and functionality of ColIb-HA in S. Tm p2cib-HA 
compared to wildtype ColIb produced by S. Tmwt. O.n. cultures of S. Tmwt and S. Tm p2cib-HA as well as 
S. Tm p2∆cib lacking the entire cib locus were spotted on LB agar plates containing 0.25 µg/ml MitC. 
The next day, agar plates were overlayed with LB softagar mixed with o.n. culture of colicin sensitive 
EcMG1655. The experiment was done in triplicates and the halo sizes were measured 24 h after the 
overlay. Statistical analysis was done using 1-way ANOVA with Tukey’s post test (***p<0.001). Bars 
show mean and StD. Additional data not shown in (Spriewald et al., 2015). 
 
 
To detect intrabacterial ColIb-HA in S. Tm p2cib-HA, an immunofluorescent staining protocol for 
intrabacterial proteins (section 3.2.5.1) was employed (Schlumberger et al., 2005). For this 
purpose, the bacterial cell wall was permeabilized with lysozyme. The lysozyme 
permeabilization efficiency was optimized using a specific antibody (ADI-SPA-880 (Hsp 70)) 
against the conserved and ubiquitously expressed chaperon, DnaK (Figure 4.5). Besides 
this, specificity of the HA probe (Y11) antiserum was confirmed (Figure 4.6). 
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Figure 4.5: Intrabacterial detection of DnaK and ColIb-HA proteins in individual bacteria by 
immunofluorescence. S. Tm p2cib-HA was grown in LB for 12 h or 4 h or 4 h in LB supplemented with 
0.25 µg/ml MitC, 100 µM DTPA or both. Bacteria were fixed and either treated with lysozyme (A,B,C 
lower panels) or not (A,B,C upper panels). (A) Lysozyme permeabilization efficiency was validated 
through intrabacterial staining of the constitutively produced, cytosolic protein DnaK. (B-C) 
Intrabacterial ColIb-HA was detected using HA-specific antiserum (HA probe (Y11)). Depicted images 
show examples of intrabacterial staining of ColIb-HA in individual S. Tm p2cib-HA pcontrol bacteria, grown 
for 4 h in (B) LB medium, showing only a small fraction of ColIb-HA producing bacteria (arrow), and 
(C) in LB medium supplemented with MitC and DTPA, with maximal cib expression. Under these 
conditions ColIb-HA was also detected in a small fraction of S. Tm p2cib-HA without lysozyme treatment 
(C upper panel). Scale bar 25 µm. Adapted from (Spriewald et al., 2015). 
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Figure 4.6: Confirmation of binding specificity of HA probe (Y11) antiserum against ColIb-HA 
within individual bacteria. S. Tmwt pcontrol and S. Tm p2cib-HA pcontrol were grown in LB medium for 12 h 
or 4 h and for 4 h in LB supplemented with 0.25 µg/ml MitC, 100 µM DTPA (A) or both (B). Bacteria 
were fixed, lysozyme-permeabilized and stained with HA-specific antiserum (HA probe (Y11)) to detect 
intrabacterial ColIb-HA (red). Total DNA was stained with DAPI (grey). Scale bar 25 µm. Adapted from 
(Spriewald et al., 2015). 
 
 
As shown by qPCR (Figure 4.3), the multi-copy plasmid is present in >100 copies per cell, 
consequently each cell of S. Tmwt pPcib gfp harbors unnaturally more than 100 copies of the Pcib 
promoter and gfp. This may influence native cib regulation. For example, it has been shown, 
that eukaryotic GFP can be toxic for bacterial cells (Liu et al., 1999). Even if bacteria are only 
stressed by gfp expression, this could also lead to changes in intrinsic cib expression. To 
exclude any side effects on native cib expression by the colicin promoter (Pcib) or gfp of 
pPcib gfp, a variety of plasmid derivatives of the multi-copy reporter were constructed 
(Figure 4.7). These pPcib gfp derivatives are the plasmid pPcib lacking only gfp, pgfp lacking the 
promoter Pcib and pPrpsM gfp, a derivative expressing gfp constitutively under the control of the 
ribosomal rpsM promoter. The plasmid pcontrol, lacking the entire Pcib gfp fusion, was 
generated as negative control. 
 
  
Figure 4.7: Schematic view of multi-copy reporter pPcib gfp plasmid and its derivatives. The multi-
copy reporter plasmid pPcib gfp, the empty backbone vector pcontrol, pPcib lacking the gfp, pgfp lacking the 
cib promoter (Pcib) and plasmid pPrpsM gfp for constitutive gfp expression are shown (Spriewald et al., 
2015).  
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Each plasmid derivative was transformed into S. Tmwt p2cib-HA and cib-HA expression was 
examined by intrabacterial immunofluorescent staining. Bacteria were cultured for 4 h in 
liquid LB media containing 100 µg/ml ampicillin (LBA) without supplements or in LBA 
supplemented with 0.25 µg/ml MitC, or 100 µM DTPA or supplemented with even both 
inducing agents. As already mentioned, it was shown that induction of the SOS-response 
can take place spontaneously during a late logarithmic growth phase and colicins can also 
be induced in this growth phase in a small fraction of the population (e.g. 3%), as observed 
for ColK (Mulec et al., 2003, Mrak et al., 2007, Nanda et al., 2014). Thus, bacterial samples 
were also taken from cultures grown for 12 h (late logarithmic growth phase) in liquid LBA 
media. Subsequently, bacteria were stained for total DNA and intrabacterial ColIb-HA in 
individual bacteria (section 3.2.5.1). Microscopic images were taken by confocal microscopy 
and ColIb-HA fluorescence intensities (DyLightTM549), and GFP signal intensities were 
further analyzed using ImageJ software. S. Tmwt transformed with the control plasmid pcontrol 
served as negative control to quantify the fraction (%) of cib-HA- and gfp-expressing bacteria 
(Figure 4.8).  
Bacteria grown for 4 h  (logarithmic growth phase) without any supplements exhibit rather 
low ColIb-HA and GFP levels which were close to the detection limit. Overall, quantification 
of ColIb-HA levels showed no significant differences between strains transferred with the 
reporter pPcib gfp compared to the derivatives lacking the cib promoter (pgfp), gfp (pPcib) or both 
elements (pcontrol). Only control plasmid pPrpsM gfp, generating high intrabacterial GFP-levels, 
positively influenced the ColIb-HA levels.  
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Figure 4.8: Influence of reporter pPcib gfp and its derivative plasmids on intrinsic cib-HA-
expression in individual bacteria of S. Tm p2cib-HA. S. Tm p2cib-HA was transformed either with 
pPcib gfp or its derivatives (pcontrol, pPcib, pgfp, pPrpsM gfp) and grown over night for 12 h (stationary phase) in 
LBA (LB+ampicillin) or subcultured and grown for 4 h (late logarithmic phase) in LBA without or with 
supplements (0.25 µg/ml MitC, 100 µM DTPA) as indicated. Bacteria were fixed, immobilized on glass 
slides and lysozyme-permeabilized. Intrabacterial ColIb-HA was detected in individual bacterial using 
HA-specific antiserum (HA probe (Y11)) and a DyLightTM549-conjugated secondary antibody (anti-
rabbit IgG (DyLightTM549)). Bacterial DNA was stained with DAPI. By confocal microscopy bacteria 
were imaged and fluorescence of DAPI, GFP and DyLightTM549 (ColIb-HA) was recorded. Mean 
fluorescence intensities (MFI) (A, C, E, G, I) of ColIb-HA and (B, D, F, H, J) GFP ascertained using 
ImageJ. MFI of Individual bacteria are represented by dots. Bars represent the median and blue 
values represent the fraction above the detection limit (dotted line; background fluorescence of 
S. Tmwt pcontrol). Statistical analysis was done using Kruskal-Wallis test with Dunn's post test (* p < 
0.05). Adapted from (Spriewald et al., 2015). 
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4.1.4 Correlation of GFP- and intrinsic ColIb-HA- signal intensities of 
S. Tm p2cib-HA pPcib gfp  
Having ascertained that pPcib gfp does not have any major impact on intrinsic cib-HA 
expression, the correlation between gfp- and intrinsic cib-HA-expression in 
S. Tm p2cib-HA pPcib gfp was determined. This would demonstrate that the multi-copy reporter 
pPcib gfp is a reliable tool to report intrinsic cib-HA expression in individual bacterial cells. 
Using the intrabacterial immunofluorescence staining method, it is not possible to 
differentiate between folded (=functional) and unfolded ColIb-HA proteins. GFP fluorescence 
can only be detected when the GFP protein is correctly folded. A delayed GFP-maturation 
would lead to a bias in the correlation. To exclude this possibility the fluorescence signal 
intensities of mature folded GFP (GFPmature) was correlated with signal intensities of total 
GFP (GFPtotal) by intrabacterial staining against GFP using a GFP specific antiserum (anti-
GFP) and a DyLightTM649-conjugated secondary antibody (anti-rabbit IgG (DyLightTM649)). 
S. Tm p2cib-HA pPcib gfp was cultured under different environmental conditions and bacteria 
were stained for total bacterial DNA and intrabacterial GFP. Microscopic images were then 
taken and analyzed using the ImageJ software. Using S. Tmwt pcontrol as negative control it 
was now possible to show that under all tested conditions GFPmature and GFPtotal 
(DyLightTM649) signal intensities correlate well in S. Tm p2cib-HA pPcib gfp with an overall 
Spearman rank correlation coefficient of ρ=0.95 (Figure 4.9).    
To finally correlate the gfp expression gained by the multi-copy reporter pPcib gfp with intrinsic 
cib-HA expression (ColIb-HA; DyLightTM549) of individual S. Tm p2cib-HA pPcib gfp bacteria, the 
corrected total cell fluorescence (CTCF) values for GFP and anti-ColIb-HA were determined. 
The CTCF values of GFP and ColIb-HA (DyLightTM549) of individual S. Tm p2cib-HA pPcib gfp 
bacteria were plotted against each other. Results revealed a good correlation of mature GFP 
signal levels and ColIb-HA (DyLightTM549) signal intensities (overall Spearman-rank 
correlation coefficient ρ=0.87; Figure 4.10). 
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Figure 4.9: Correlation of the fluorescence signal of GFPmature with anti-GFPtotal 
immunofluorescent staining signal of pPcib gfp. S. Tmcib-HA p2Pcib gfp bacterial cells were cultured in LB 
medium supplemented with 100 µg/ml ampicillin (LBA) for (A) 12 h, (B) 4 h, and (C) for 4 h in LBA 
supplemented with 0.25 µg/ml MitC, (D) LBA supplemented with 100 µM DTPA and (E) LBA 
supplemented with both. Fixed bacteria were lysozyme-permeabilized and stained for intrabacterial 
total GFP (GFPtotal) with a GFP-specific antiserum and a DyLightTM649-conjugated secondary 
antibody. Confocal microscopic images were taken. Using ImageJ software the corrected total cell 
fluorescence signal intensity (CTCF) of maturated and fluorescent GFP (GFPmature) and intrabacterial 
stained total GFPtotal (DyLightTM649) was determined for each single bacterium. CTCF of GFPmature and 
GFPtotal were correlated using the Spearman-rank correlation (ρ). (F) The combination of all conditions 
presents a good correlation. The detection limit determined by S. Tmwt pcontrol is depicted as red line. 
(G-H) Examples of microscopic images (scale bar 25 µm). Adapted from (Spriewald et al., 2015). 
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Figure 4.10: Correlation of GFP-levels obtained by the reporter pPcib gfp with intrinsic ColIb-HA 
levels under different conditions in individual bacteria. Confocal microscopic images of S. Tm 
p2cib-HA pPcib gfp obtained in the experiment described in Figure 4.8 were used to calculate the corrected 
total cell fluorescence intensity (CTCF) of GFP- and ColIb-HA (DyLightTM549)-levels of each single 
cell. (A-D) CTCF values of GFP and ColIb-HA (DyLightTM549) of individual bacteria were analyzed by 
Spearman-rank correlation (ρ). The combined data of all conditions exhibit a high correlation 
coefficient (ρ=0.87). The detection limit determined by S. Tmwt pcontrol is depicted as red line. (E, F) 
Examples of microscopic images (scale bar 25 µm) are shown. Adapted from (Spriewald et al., 2015). 
 
 
Interaction of prophages and cib expression at the single cell level in S. Tm                Results 
4.2 Interaction of prophages and colicin Ib gene expression at the single 
cell level in S. Tm  
It has been previously shown, at the bulk level (Nedialkova et al., 2014) and at the single cell 
level (Spriewald et al., 2015), that cib is expressed by S. TmSL1344 (S. Tmwt) under SOS-
induced or Fe2+-limiting conditions and that maximal cib expression is seen by combined 
induction of the SOS-response and the Fe2+-limitation. In general, group B colicin loci (e.g. 
ColIb locus) do not encode a lysis gene for the colicin release as it is the case for group A 
colicins. Therefore it is unknown how group B colicins, including ColIb, are released. 
Recently, it was shown at the bulk level (using western blot analysis and luciferase reporters) 
that prophage lysis genes of S. Tmwt prophages  contribute to the release of ColIb 
(Nedialkova et al., 2015). In this part of the thesis these findings were analyzed at the single 
cell level to answer the question, if individual bacteria expressing cib also induce prophage 
lysis genes to release ColIb, and lyse to sacrifice themselves as common good for the whole 
bacterial population.  
 
4.2.1 Investigation of the fate of individual bacteria expressing cib 
It is known that S. TmSL1344 harbors four different temperate phages (the lambdoid phages 
Gifsy-1, Gifsy-2 and ST64B and the P2-like phage SopEφ) within its genome (Alonso et al., 
2005). Temperate phages can either follow the lytic life cycle as virulent phages or they 
permanently integrate their DNA into the host-chromosome as prophages, which can be then 
induced to enter the lytic life cycle. This prophage-induction is correlated with the induction of 
the SOS-response (Nanda et al., 2014). Recently, our work has been shown that among the 
four prophages of S. TmSL1344, the P27-like phage ST64B mainly contributes to ColIb release 
upon SOS-response, as tested by bulk assays using western blot analyses and luciferase 
reporters (Nedialkova et al., 2015).  
To uncover the fate of individual cib expressing bacteria with and without functional 
prophages the multi-copy reporter pPcib gfp was transformed into S. TmWT and in S. Tm∆Ph 
lacking all four prophages. As prophage-harboring S. Tmwt bacteria should lyse in the course 
of SOS-response induction, it was hypothesized that less GFP+ bacteria would be observed 
after inducing the culture with SOS-response inducer MitC compared to S. Tm∆Ph.  
To test this hypothesis strains were cultured under different environmental conditions and 
analyzed by flow cytometry. S. Tm∆Ph pPcib gfp and S. TmWT pPcib gfp were cultured in 96-well 
plates (section 3.2.1.5) for 4 h in LB medium or in LB medium supplemented with either 
0.5 µg/ml MitC or 100 µM DTPA or both agents. Every hour, the OD600 was determined to 
follow the growth and lysis of the strains (Figure 4.11A). Samples (106 cfu) were taken for 
Interaction of prophages and cib expression at the single cell level in S. Tm                Results 
 
74 
 
flow cytometry analysis (Figure 4.11BC and Figure 4.12). As controls S. TmWT and 
S. Tm∆Ph strains without the multi-copy gfp-reporter were also cultured under the same 
conditions. As shown previously (Nedialkova et al., 2015), all strains grew well and in a 
similar manner in LB medium and in LB medium supplemented with DTPA. With the addition 
of MitC to the growth medium the prophage-harboring strains S. TmWT and S. TmWT pPcib gfp 
start to lyse about 2 h after the SOS-response was induced by MitC whereas the strains 
S. Tm∆Ph and S. Tm∆Ph pPcib gfp lacking the prophages did not show any cell lysis 
(Figure 4.11A). 
FACS measurements revealed a time dependent increase in gfp expression for both reporter 
strains, S. TmWT pPcib gfp and S. Tm∆Ph pPcib gfp, under all cib-inducing conditions. Interestingly, 
after about 2 h the prophage deficient reporter strain S. Tm∆Ph pPcib gfp progressively exhibited 
higher GFP-signal levels compared to S. TmWT pPcib gfp. This effect was more pronounced 
when cultures were treated with MitC (Figure 4.11C and Figure 4.12).  
This confirmed the hypothesis that, preferentially, GFP+ bacteria lyse in case of S. TmWT but 
not in case of S. Tm∆Ph. 
 
Interaction of prophages and cib expression at the single cell level in S. Tm                Results 
 
75 
 
 
Figure 4.11: GFP- levels of S. TmWT pPcib gfp compared to prophage-deficient S. Tm∆Ph pPcib gfp. 
S. TmWT, S. Tm∆Ph, S. TmWT pPcib gfp and S. Tm∆Ph pPcib gfp were subcultured in a 96-well plate and 
grown for 4 h in LB or LB supplemented with 0.5 µg/ml MitC or 100 µM DTPA or both. Every hour 
OD600 was measured and samples (106 CFU) were taken for further flow cytometry measurements. (A) 
Growth curves of S. TmWT pPcib gfp and S. Tm∆Ph pPcib gfp and their respective negative control strains 
S. TmWT and S. Tm∆Ph without the gfp-reporter pPcib gfp (to exclude growth defects due to pPcib gfp) each 
curve represents three independent experiments. Bars shown mean and StD. Statistical analysis using 
2-way-ANOVA with Bonferroni post-test (***p<0.001) showed no significance in the growth in LB for all 
tested strains and in  LB+DTPA (except S. Tm∆Ph pPcib gfp at time point 4 h, due to one outlier). In the 
presence of MitC significance was observed between S. TmWT, S. Tm∆Ph at time point 4 h (***) and 
between S. TmWT pPcib gfp and S. Tm∆Ph pPcib gfp at time point 3 h (*) and 4 h (***). In the presence of 
MitC and DTPA significance was observed between S. TmWT, S. Tm∆Ph at timepoint 4 h (**) and 
between S. TmWT pPcib gfp and S. Tm∆Ph pPcib gfp at time point 3 h (*) and 4 h (***). (B) FACS plot 
examples of S. Tm∆Ph pPcib gfp at time point 4 h. Using FSC-SSC plots bacteria were gated and the 
mean fluorescence intensity (MFI) of the gated bacteria were plotted in (C). (C) MFI of the gfp-reporter 
strains S. TmWT pPcib gfp and S. Tm∆Ph pPcib gfp and their control strains S. TmWT and S. Tm∆Ph, 
respectively. Bars show means and StD. The experiment was performed in triplicates and analyzed by 
2-way-ANOVA with Bonferroni post-test (***p<0.001). 
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Figure 4.12: FACS plot examples of GFP-levels of S. TmWT pPcib gfp compared to S. Tm∆Ph pPcib gfp. 
MFI of S. TmWT pPcib gfp (grey) compared to S. Tm∆Ph pPcib gfp (black) are plotted against the cell size 
(FSC) of one experiment of Figure 4.11. showing size-independent higher GFP levels of 
S. Tm∆Ph pPcib gfp.  
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Using the CellASIC® ONIX Microfluidic Platform (Millipore) it is possible to follow cib 
expression in individual bacteria and their resulting cell fate over time during different 
environmental conditions. In contrast to methods were agar patches are used as growth 
medium, with this instrument bacteria are only able to grow in 2-dimensions, a flow of fresh 
liquid medium is applied, and the growth medium can be changed quickly, when necessary. 
S. TmWT pPcib gfp and S. Tm∆Ph pPcib gfp were grown individually in B04 plates (CellASIC® ONIX 
Microfluidic Platform, Millipore) with different supplements for a time course of about 6 h 
(Figure 4.13A). Initially, single bacteria were trapped in the cell chamber of the microfluidic 
system and grown for 3 h in liquid LB medium, to let bacteria adapt to the conditions. The 
microcolonies were exposed to Fe2+-limiting conditions by changing the growth medium to LB 
supplemented with 100 µM DTPA. Thereby, S. Tm would start producing high amounts of 
intracellular GFP while prophages remain inactive. About 20 min later, the medium was 
exchanged by liquid LB supplemented with 100 µM DTPA and 0.5 µg/ml MitC, leading to 
maximal induction of cib expression (gfp expression) and, concomitantly, the induction of 
prophages. As a consequence of prophage induction, lysis of individual bacteria is expected 
in S. TmWT pPcib gfp. In contrast, S. Tm∆Ph pPcib gfp strain lacking all prophages would fail in 
prophage-dependent cell lysis under these conditions (Nedialkova et al., 2015). 20 min later, 
the growth medium was changed back to LB supplemented with 100 µM DTPA and this 
condition was kept until the end of the experiment. The experimental protocol is depicted in 
Figure 4.13A. 
As expected, following the cell fate of individual cells of S. TmWT pPcib gfp lysis was observed 
~2 h after induction with MitC (Figure 4.13B; Movie S1). In contrast, no bacterial cell lysis 
was observed for S. Tm∆Ph pPcib gfp lacking all prophages (Figure 4.13C; Movie S2). 
Furthermore, live cell imaging revealed enhanced gfp expression in S. Tm∆Ph pPcib gfp 
compared to S. TmWT pPcib gfp, and pronounced elongation in S. Tm∆Ph pPcib gfp compared to 
S. TmWT pPcib gfp (Figure 4.13BC) in response to MitC treatment.  
Importantly, phage-dependent lysis was shown for the first time at the single cell level, 
confirming the results obtained at the population level, using western blot analysis and 
luciferase reporters (Nedialkova et al., 2015). 
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Figure 4.13: Live cell microscopy of S. TmWT pPcib gfp and S. Tm∆Ph pPcib gfp. (A) Timeline depicting 
the experimental protocol. First, microcolonies were grown for 3 h in LB, in the Onix microfluidic 
system (Millipore). Afterwards, media was switched first to LB medium supplemented with 100 µM 
DTPA (Fe2+-limiting conditions). After 20 min the SOS-response was induced by applying LB 
supplemented with 100 µM DTPA and 0.5 µg/ml MitC. Again after 20 min, media was switched back to 
LB supplemented with 100 µM DTPA only, for the remaining time. (B) Microscopic images (only GFP 
channel) of S. TmWT pPcib gfp microcolony, 2½ h-3½ h after SOS-response induction with MitC. Arrows 
highlight lysing bacterial cells (white: about to lyse; red: lysed). (C) Examples of microscopic images 
(only GFP channel) of growth of the prophage deficient strain S. Tm∆Ph pPcib gfp, 2½ h-3½ h after 
treatment with MitC. 
 
Live cell images also disclosed that bacterial cell length of S. Tm∆Ph pPcib gfp become longer 
over time compared to S. TmWT pPcib gfp, as observed in the FACS dot plots of Figure 4.12. It 
is known that, among other effects, bacteria as S. Tm respond with stopping cell division to 
the SOS-response induction. This is due to the expression sulA, which is also regulated by 
the SOS-response. SulA binds in the following to the FtsZ monomer of the dividing bacterial 
cell. This leads to the inhibition of the FtsZ-polymerization. As a consequence the formation 
of the FtsZ-ring and the final cell division is inhibited (Kamensek et al., 2010, Justice et al., 
2008). Therefore as only the pinching of mother and daughter cells is inhibited but not DNA 
replication or protein synthesis one can hypothesize that the longer the cell the more copy 
numbers of gfp and thus the higher the MFI of GFP signals. The hypothesis that differences 
in the GFP-signal intensity between both reporter strains rely only on the cell size was 
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excluded by gating bacteria of the same cell size and determining their GFP fluorescence 
intensities (data not shown).  
4.2.2 Only a fraction of cib expressing individual bacteria also express 
prophage lysis genes  
So far it could be shown at the single cell level that almost the entire S. Tm population 
expressed cib after SOS-response induction and/or Fe2+-limitation condition and not, as 
expected, in a bimodal fashion (section 4.1) (Spriewald et al., 2015). In addition, bacterial 
cell lysis could be observed upon induction of the SOS-response in individual, cib-expressing 
S. Tmwt bacteria and, furthermore, that this bacterial cell lysis is dependent on the presence 
of functional prophages (section 4.2.1). It was now important to determine the fraction of all 
cib expressing bacteria that would also lyse to release colicin. This could reveal the costs 
and benefits of ColIb production and explain how S. Tmwt gains a ColIb-dependent growth 
benefit over commensal E. coli in the inflamed gut (Nedialkova et al., 2014, Nedialkova et al., 
2015). Therefore, prophage-dependent lysis genes are assumed to be only induced in a 
fraction of cib expressing bacteria to release ColIb.  
To address this hypothesis, the reporter strain S. TmlysST::sfgfp p2cib-HA was generated in order 
to determine the fraction of cib expressing individual bacteria which also express ST64B 
prophage lysis genes to release ColIb. This strain encodes a sfgfp gene instead of the 
ST64B prophage lysis genes of S. Tmwt (SL1344_1955-SL1344_1957; lysST) for reporting 
lysis gene expression. Of note, in this reporter strain the ST64B lysis genes are inactive. 
Additionally, this strain carries cib-HA on the p2 plasmid to detect ColIb-HA by intrabacterial 
immunofluorescence staining and lysis gene (sfgfp) expression simultaneously. 
S. TmlysST::sfgfp p2cib-HA was cultured in 96-well plates for 2 h and 4 h, respectively, in liquid LB 
medium or LB supplemented with 0.5 µg/ml MitC, or 100 µM DTPA or both inducers. 
Bacteria samples were fixed, lysozyme-permeabilized and stained for intrabacterial ColIb-HA 
using HA-specific antiserum and a DyLightTM649 conjugated secondary antibody. Afterwards, 
images were taken by confocal microscopy and analyzed using ImageJ software. Mean 
fluorescence intensity above the detection limit, set by the background fluorescence of 
S. Tmwt (no sfGFP, no ColIbHA) grown under the same conditions, was determined for 
sfGFP- and ColIb-HA (DyLightTM649)-fluorescence signals of individual bacteria. In addition, 
the fraction (%) of cib-HA and sfgfp (lysis genes)-expressing individual bacteria were also 
determined (Figure 4.14).  
The experiment revealed that ST64B lysis genes are expressed only upon induction of the 
SOS-response by MitC, whereas DTPA had no influence. In addition, lysis gene expression 
increases over time in individual bacteria. These results are in accordance with the ST64B 
phage lysis gene expression pattern obtained in bulk experiments (Nedialkova et al., 2015). 
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By calculating the fraction (%) of sfgfp expressing bacteria, it was found that after 4 h only a 
fraction (~20-30%) of the whole population expressed the ST64B lysis genes (Figure 4.14B) 
whereas the entire population of S. TmlysST::sfgfp p2cib-HA responded to MitC or/and DTPA with 
cib-HA expression(Figure 4.14A).  
 
Figure 4.14: ST64B prophage lysis genes are only expressed in a fraction of S. Tm. 
S. TmlysST::sfgfp p2cib-HA was cultured in 96-well plates for 2 h and 4 h in liquid LB medium or liquid LB 
medium supplemented with 0.5 µg/ml MitC or 100 µM DTPA or both inducer compounds. Bacteria 
were fixed, lysozyme-permeabilized and stained for total DNA with DAPI and for intrabacterial ColIb-
HA. S. Tmwt (no sfGFP, no ColIbHA), grown under the same conditions, was used as detection limit. 
By confocal microscopy images were taken and analyzed for the MFI of sfGFP- and ColIb-HA 
(DyLightTM649)-levels upon the detection limit. The fraction (%) of cib-HA and sfgfp (lysis genes) 
expressing individual bacteria was determine using S. Tmwt bacteria as negative control. Each dot 
represents the measured MFI of an individual bacterium. Statistical analysis was done using Kruskal-
Wallis test with Dunn's post test (***p < 0.001). 
 
To investigate which fraction of the cib-HA expressing bacteria also express the ST64B 
prophage lysis genes the MFI values of sfGFP and ColIb-HA (DyLightTM649) of all conditions 
tested in the experiment represented in Figure 4.14 were plotted as XY-graph (Figure 4.15).  
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Figure 4.15:  Correlation of cib-HA expression of individual S. Tm cells with sfgfp expression of 
the prophage lysis gene reporter. The MFI values of sfGFP and ColIb-HA (DyLightTM649) given by 
individual S. TmlysST::sfgfp p2cib-HA under different conditions, determined in the experiment of Figure 
4.14AB were plotted as XY-graph. Each dot represents the MFI values of an individual object. (A) 2 h 
and (B) 4 h after treatment with or without supplements. The detection limit determined by no-
fluorescent S. Tmwt is depicted as dotted line.   
 
These results showed that the majority of sfgfp (lysST) expressing bacteria also express cib-
HA at the same time (Figure 4.15). However, only a fraction of cib-HA expressing 
S. TmlysST::sfgfp p2cib-HA also induces expression of prophage lysis genes (Table 4.1). 
 
Table 4.1: Fraction of cib expressing S. TmlysST::sfgfp p2cib-HA co-expressing ST64B lysis genes.   
Time MitC DTPA ColIb
+ 
[of total]  
ST64B lysis+ 
[of total]  
ColIb+ and ST64B lysis+          
[of total] 
ST64B lysis+ 
[of ColIb+] 
2 h - - 1.8% 0.1% 0% 0% 
4 h - - 2.9% 0.8% 0% 0% 
2 h + - 91.4% 6.5% 6% 5.5% 
4 h + - 97.3% 33.7% 32.8% 31.9% 
2 h - + 65.7% 0.2% 0.1% 0.1% 
4 h - + 67.6% 0.3% 0.2% 0.1% 
2 h + + 99.1% 11.3% 11% 10.9% 
4 h + + 98.6% 21.3% 21.3% 21% 
    
 
Due to the rather weak sfGFP signal intensity of S. TmlysST::sfgfp, a T7-polymerase based 
reporter strain (S. TmlysST::T7 pol pPT7 sfgfp) was constructed. Therefore, the ST64B prophage 
lysis genes (SL1344_1955-SL1344_1957) of S. Tmwt were exchanged against the gene 
encoding a T7-polymerase, using the lambda Red recombination. This strain was further 
transformed with a low copy plasmid encoding sfgfp under the control of a T7 promoter 
(pPT7 sfgfp). Thus, instead of lysST the T7-polymerase is expressed under inducing conditions. 
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This in turn leads to amplification of sfgfp expression from pPT7 sfgfp, which results in enhanced 
sfGFP signal intensity.  
To analyze the expression pattern of lysST compared to cib in S. Tm, the two reporter strains 
S. TmlysST::T7 pol pPT7 sfgfp and S. Tmwt pPcib gfp, were cultured in 96-well plates for 4 h in liquid LB 
medium or LB supplemented with 0.5 µg/ml MitC, or 100 µM DTPA or both. Flow cytometry 
analysis revealed that SOS-inducing and thus lysST-inducing conditions result in the 
emergence of two phenotypically different subpopulations in case of S. TmlysST::T7 pol pPT7 sfgfp. 
A sfGFP+ population and a sfGFP- subpopulation. In contrast, under the same conditions cib 
is expressed in the entire population (Figure 4.16) as shown previously (Spriewald et al., 
2015). In fact, this shows that in contrast to the overall unimodal expression of cib, upon 
SOS-inducing conditions lysST is expressed bimodally. 
 
 
Figure 4.16: In contrast to the unimodal expression of cib, lysST-expression is bimodal upon 
induction of the SOS-response. S. Tmwt pPcib gfp (grey) and S. TmlysST::T7 pol pPT7 sfgfp (black) were 
cultured in 96-well plates for 4 h in LB medium or LB medium supplemented with 0.5 µg/ml MitC or 
100 µM DTPA or both. GFP/sfGFP fluorescence signal intensities were analyzed by flow cytometry. 
S. Tmwt (grey; filled histogram) grown for 4 h under the same conditions was used as GFP negative 
control. 
  
In conclusion, although ColIb is produced in the entire S. Tm population by induction of the 
SOS-response and Fe2+-limitation, only a fraction of ColIb+ bacteria also induce ST64B 
prophage lysis genes and lyse to release ColIb. Therefore, bimodal gene expression of 
S. Tm prophage lysis genes secures survival of the overall population and is an explanation 
of how S. Tm gains a ColIb-dependent growth benefit over commensal E. coli in the inflamed 
gut (Nedialkova et al., 2015).  
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4.3 Adaptation of E. coli strains to auto-cytotoxic effects of colicin M 
production 
Upon screening for colicin producing E. coli strains, we identified a strain, E. coli 252R 
(Ec252R), which produced a bacteriocin against which it was not protected. This was 
surprising, as, in general, bacteriocin producers protect themselves against “self-killing” by 
the expression of cognate immunity factors. Using a transposon mutagenesis screen the 
bacteriocin colicin M was identified as the cause for this phenotype. The gene coding for 
colicin M (cma) is encoded together with the colicin B gene (cba) on the same locus on a 
large conjugative plasmid and is co-regulated from the same SOS-box upstream of cba. 
Usually bacteria are protected against colicin M (ColM)- or colicin B (ColB)-mediated self-
killing by the production of the respective immunity proteins. The immunity genes of ColB 
and ColM (cbi and cmi, respectively) are also encoded on the same locus, but transcribed in 
the reverse direction. In this thesis I have shown, that ColM immunity protein of Ec252R is 
produced and functional. However, production of ColM immunity protein generally only 
partially protects against self-killing by ColM. Further analysis of different E. coli strains, 
originally classified as ColM producers revealed two other E. coli strains (EcCl139, EcB195) 
which also showed a self-killing phenotype. Interestingly, I could also show that only strains 
which encode an intact cba gene are also able to express cma. This suggests that ColM 
producers might face an immense fitness cost due to high “self-toxicity” of ColM initially upon 
acquisition of a ColBM plasmid by conjugation. Thus, mutations which lead to resistance 
against ColM (e.g. by disrupting ColM production) are positively selected. Based on these 
data, it was hypothesized that Ec252R might represent an isolate which just had acquired a 
functional pColBM plasmid and has not yet “evolved” towards either ColM tolerance or 
downregulation of ColM production. This hypothesis was investigated how bacteria cope with 
the cytotoxic effect of ColM, by in vitro evolution experiments.  
 
4.3.1 Under stress conditions E. coli 252R (Ec252R) produces a colicin against 
which it susceptible  
E. coli 252R (Ec252R) is a mouse isolate which was identified to kill itself upon exposure to 
MitC. This phenotype was discovered using a halo-assay (section 3.2.1) where Ec252R was 
grown as a colony in the presence of the DNA-damaging antibiotic MitC (0.25 µg/ml). 
Overlayed with itself, Ec252R exhibited a lysis zone around the colony. Additionally, the 
compound released by Ec252R also killed other E. coli strains such as the commensal E. coli 
EcMG1655 (Figure 4.17). Interestingly, the self-killing phenomenon was only observed in the 
presence of MitC (Figure 4.17).   
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Figure 4.17: Halo-assay to determine bacteriocin release. Production and release of bacteriocin of 
Ec252R were tested in comparison to commensal EcMG1655. Additionally, each strain was tested for a 
suicidal behavior. Initially, Ec252R and EcMG1655 were spotted and incubated o.n. on LB agar plates 
supplemented with 0.25 µg/ml MitC, to induce stress-dependent toxin secretion, and on plain LB agar 
plates. Both strains were cultivated o.n. in liquid LB and the next day mixed with LB softagar and used 
to overlay the agar plates. After 24 h, the lysis-zone (halo) was measured (size of the overall diameter 
substracted by the colony size). The experiment was done in triplicates. Bars represent means and 
StD.        
 
To identify the bacteriocin in Ec252R leading to the self-killing phenotype, a transposon 
mutagenesis screen (section 3.2.2.16) was conducted. Ec252R was transformed with the 
plasmid pJA1 carrying Tn10 and a transposase under the control of the tac promoter 
(Badarinarayana et al., 2001). A library of 1536 mutants was generated in 96-well plates. 
Transconjugants were screened for the loss of the self-killing phenotype (similar to section 
3.3.1.1). The mutant EcP10A10 and EcP13C5 (Table 3.1) were found to be non-producers but still 
sensitive to Ec252R Tn10. Out of these 1536 mutants only two mutants (EcP10A10, EcP13C5) 
exhibited reduced self-killing (Figure 4.18A). Further analysis revealed that both mutants 
exhibit a reduction in toxicity against EcMG1655 but only EcP10A10 lost the self-killing phenotype. 
Mutant EcP13C5, however, showed only a reduction in the self-killing properties compared to 
the parental Ec252R strain (Figure 4.18B).     
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Figure 4.18: Characterization of the Ec252R transposon mutant strains. (A) To screen the Ec252R 
transposon mutant library (>1,500) for loss of self-killing-phenotype, strains were grown o.n. in LB 
medium in 96-well plates as described in section 3.2.2.17 and transferred using a replicator on LB 
agar plates supplemented with 0.016 µg/ml MitC and 100 µg/ml kanamycin. As control strain 
Ec252R Tn10 was cultivated and also spotted on each agar plate. The next day, an o.n culture of 
Ec252R Tn10 (carrying Tn10 in an unknown location) was mixed with LB softagar and agar plates were 
overlayed with this mix. After o.n. incubation two mutants (EcP10A10, EcP13C5) which showed robust 
growth but did not produce a halo against Ec252R Tn10 were identified. (B) Both bacterial mutant strains 
were tested with a halo-assay using LB agar plates containing 0.25 µg/ml MitC. 24 h after the overlay 
with the test strain EcMG1655 or Ec252R, the halo size of each strain was determined. The experiment 
was performed in triplicates. Bars represent means and StD. Statistical analysis was done using 1-way 
ANOVA with Tukey’s post test (***p<0.001). 
 
 
To identify the insertion site of Tn10 in EcP10A10 and EcP13C5, single primer PCR as described 
by Karlyshev et al. (Karlyshev et al., 2000) was employed (section 3.2.2.18). Single primer 
PCR products for each mutant were obtained and sent for sequencing. NCBI BLAST 
analysis revealed that Tn10 was inserted at the beginning of a colicin M gene (cma) in 
EcP10A10 (Figure 4.19).       
Usually cma is located together with its immunity gene (cmi), the colicin B gene (cba) and the 
colicin B immunity gene (cbi) at the same locus on a large conjugative plasmid (further 
named pColBM) (Christenson and Gordon, 2009). To confirm that Ec252R encodes cma and 
harbors a pColBM plasmid, the oligonucleotides cma-check-up/cma-check-down and cba-
check-up/cba-check-down (Table 3.3) were designed (binding 60 bp upstream and 
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downstream of the respective genes) based on nucleotide sequences published for pColBM 
plasmids (Accession no. NG_039430). PCR results, followed by sequencing of the amplicons 
for cma and cba, verified that Ec252R harbors a plasmid encoding the entire ColBM locus 
(Figure 4.19). In parallel, the entire genome of Ec252R was shotgun sequenced by the 
Wellcome Trust Sanger Institute (Cambridge, United Kingdom) by Illumina MiSeq 
sequencing, supporting these findings.  
 
 
Figure 4.19: Scheme of the colicin BM locus of Ec252R and location of the promoter. (A) Colicin B 
(cba) and colicin M activity gene (cma) are both regulated from the same promoter by two overlapping 
SOS-boxes upstream of cba, whereas, the respective immunity genes for ColM (cmi) and ColB (cbi) 
are transcribed in the opposite direction. The black triangle depicts the insertion site of Tn10 in 
EcP10A10.     
 
For the Ec252R mutant, EcP13C5 NCBI BLAST analysis showed that the transposon Tn10 was 
inserted in a putative prophage region (putative gene virE), which was excluded to be a 
prophage lysis gene. Notably, it was previously shown (also in section 4.2) that the group B 
colicin ColIb is released via prophage lysis (Nedialkova et al., 2015). Due to the reduced 
killing properties of the EcP13C5 mutant against itself and against sensitive EcMG1655, and the 
fact that the insertion of Tn10 in EcP13C5 is located in a prophage region of Ec252R, prophages 
may also play a role for ColM (at least) and/or ColB release.  
To investigate more precisely if ColB or ColM are responsible for the self-killing phenotype of 
Ec252R, targeted deletions for cba (Ec252R pColBMcba::cat) and cma (Ec252R pColBMcma::cat) were 
generated by gene replacement with a chloramphenicol resistance cassette (cat), 
respectively. To exclude any polar effect on gene expression compromised by the 
chloramphenicol resistance cassette (cat) in frame deletions of cba and cma 
(Ec252R pColBM∆cba and Ec252R pColBM∆cma) were also generated. All strains were tested in a 
halo-assay compared to the parental strain Ec252R for colicin production (overlayed by 
EcMG1655) and a self-killing phenotype (overlayed by themselves) both under normal 
conditions (LB; Figure 4.20A) and under SOS-response induced conditions 
(LB+0.25 µg/ml MitC; Figure 4.20B). FhuA is the outer membrane receptor for ColM and a 
fhuA mutant strain is resistant to ColM-dependent killing but still sensitive to ColB-dependent 
killing. To address ColB-dependent killing only, mutant strains were also overlayed with 
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EcMG1555 ∆fhuA. In addition, ColM production was detected by western blot analysis 
(Figure 4.20C) using an affinity-purified ColM specific antiserum (anti-ColM (rabbit 
polyclonal)) (section 3.2.4.4). To this end, Ec252R, its mutant derivatives and a different 
ColBM producer strain EcCl139 were grown o.n. and used to inoculate subcultures (1:20) of 
liquid LB or LB supplemented with 0.25 µg/ml MitC. After 4 h, incubation ColM was detected 
by the anti-ColM (rabbit polyclonal) antiserum in the cell lysates and culture supernatants.    
Mutant characterization in the halo-assay revealed, that under both conditions (LB and 
LB+MitC) the mutant strains Ec252R pColBMcba::cat and Ec252R pColBMcma::cat are reduced in 
total in colicin production compared to the wildtype strain Ec252R. This was expected, as both 
mutant strains only produce one of the two colicins present in Ec252R. Interestingly, the 
mutant Ec252R pColBMcba::cat killed EcMG1655 more efficiently compared to mutant Ec252R 
pColBMcma::cat in the overlay. As the in frame deletion strains Ec252R pColBM∆cba and Ec252R 
pColBM∆cma showed no significant differences in the halo-assay compared to the strains 
carrying the antibiotic resistance marker (Ec252R pColBMcba::cat and Ec252R pColBMcma::cat), polar 
effects of the cat gene in Ec252R pColBMcba::cat and Ec252R pColBMcma::cat could be excluded. By 
EcMG1555 ∆fhuA in the overlay it was possible to show that killing by ColM was abolished once 
the receptor for ColM (FhuA) was deleted. Moreover, equal ColB-dependent killing was 
observed under SOS-induced condition of the ColB-producing mutant strains 
Ec252R pColBMcma::cat and Ec252R pColBM∆cma. This assay could confirm the deletion of cba in 
Ec252R pColBM∆cba and Ec252R pColBMcba::cat as no killing of sensitive EcMG1655 or EcMG1655 ∆fhuA 
was detected. The deletion of cma Ec252R pColBMcma::cat and Ec252R pColBM∆cma could be 
confirmed by western blot analysis (Figure 4.20C). 
Interestingly, the halo-assays revealed that under SOS-induced conditions the self-killing 
phenotype was lost in the mutant strains Ec252R pColBMcma::cat and Ec252R pColBM∆cma, 
whereas in Ec252R pColBMcba::cat and its corresponding strain Ec252R pColBM∆cba the self-killing 
phenotype was only reduced compared to the wildtype Ec252R. Therefore, ColM is the 
responsible toxin leading to the self-killing phenotype of Ec252R and this ColM-mediated 
phenotype is pronounced in the presence of ColB.     
Interestingly, ColM was not detected in supernatant samples. Probably, the concentration of 
produced ColM is too low in the supernatant and is under the detection limit for western blot 
analysis.  
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Figure 4.20: Characterization of cma and cba mutant strains in an halo-assay. E. coli strains 
Ec252R wildtype (wt) and its mutant derivatives Ec252R pColBMcba::cat, Ec252R pColBMcma::cat, 
Ec252R pColBM∆cba and Ec252R pColBM∆cma. The bacterial strains were grown o.n. in media and spotted 
the following day on (A) LB agar plates and (B) LB agar plates supplemented with 0.25 µg/ml MitC to 
induce cba and cma expression. The next day the agar plates were overlayed with LB softagar mixed 
with o.n. culture of EcMG1655 (to analyze ColM- and ColB-dependent killing), or Ec252R wildtype (to 
analyze self-killing), or the ColM receptor-deficient strain EcMG1655 ∆fhuA (to analyze ColM-dependent 
killing), respectively. After 24h halo size was measured. The experiment was done in triplicates and 
statistical analysis was done using 1-way ANOVA with Tukey’s post test (***p<0.001), if not indicated 
differences were not statistically significant. Bars represent means and StD. (C) Western blot analysis 
for ColM production. Ec252R (wt) and its mutant derivative strains Ec252R pColBMcba::cat, 
Ec252R pColBMcma::cat, Ec252R pColBM∆cba and Ec252R pColBM∆cma as well as EcMG1655 (served as 
negative control= nctrl) and EcCl139 (Cl139) used as a second non-related ColM-producer, were grown 
4 h in subcultures (1:20 diluted from 12 h cultures) in LB or LB supplemented with 0.25 µg/ml MitC, as 
indicated. Samples from bacterial lysate (pellet) and culture supernatant were taken and ColM was 
detected using an affinity-purified anti-ColM (rabbit polyclonal) antiserum. An unknown protein 
recognized by the anti-ColM (rabbit polyclonal) antiserum was used as loading control.     
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4.3.2 The self-killing phenotype is not explained by the presence of a non-
functional immunity protein 
It is generally accepted that each colicin-producing strain produces a cognate colicin 
immunity protein which protects against self-intoxication (Cascales et al., 2007). Immunity 
genes are usually encoded on the same locus downstream of the colicin activity gene and 
transcribed in the same direction (enzymatic colicins) or in the opposite direction (pore-
forming colicins). For Colicin K and for other pore forming colicins the immunity protein is 
expressed constitutively (Cascales et al., 2007). Since ColM is responsible for the self-killing 
phenotype, we assumed that Ec252R might not express cmi or that the ColM immunity protein 
(CMI) is not functional. In order to investigate this, the mutant strains Ec252R pColBMcmaHA and 
Ec252R pColBMcmiHA, expressing either an HA-tagged cma or cmi, respectively, were 
generated to detect the ColM-HA and CMI-HA proteins using a HA-specific antiserum 
(Table 3.17). Initially, these mutants were tested for an altered self-killing phenotype and 
differences in ColM production using halo-assays (Figure 4.21A). Subsequently, 12 h 
cultures of wildtype Ec252R and the mutant strains were used to inoculate subcultures (1:20) 
in liquid LB or LB supplemented with 0.25 µg/ml MitC. As it was unknown under which 
conditions cmiHA would be expressed, additional subcultures in LB supplemented with 
100 µM DTPA or LB supplemented with 0.25 µg/ml MitC and 100 µM DTPA to test 
additionally for Fe2+-limitation conditions. Samples from bacterial lysate (OD600 of 1), as well 
as culture supernatant, were harvested and ColM-HA and CMI-HA were quantified by 
western blot using HA-specific antiserum (Table 3.17) (Figure 4.21B). In addition, ColM was 
also detected using an affinity-purified anti-ColM (rabbit polyclonal) antiserum 
(Figure 4.21C). 
As shown in the halo-assays in Figure 4.21A, the HA-tag of CMI-HA in Ec252R pColBMcmiHA 
does not influence the killing of sensitive EcMG1655 or the self-killing phenotype compared to 
the wildtype Ec252R. However, the HA-tag of ColM-HA in Ec252R pColBMcmaHA seems to 
interfere with the toxicity or the expression level of ColM, as this mutant is reduced in colicin 
killing of sensitive EcMG1655 and in its self-killing properties.  
Western blot analysis depicted in Figure 4.21B showed that ColM-HA is only produced in the 
presence of MitC. Iron limitation does not affect cmaHA expression. Levels of ColM-HA were 
reduced when detected with affinity-purified anti-ColM (rabbit polyclonal) antiserum in 
Ec252R pColBMcmaHA compared to Ec252R or Ec252R pColBMcmiHA (Figure 4.21C). In contrast to 
the cmaHA expression pattern, cmiHA was expressed at basal levels if grown in LB. 
Moreover in SOS-inducing conditions or under Fe2+-limitation, cmiHA-expression is 
increased compared to plain LB medium.  
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Figure 4.21: Analysis of cmaHA and cmiHA gene expression in Ec252R. (A) Standard halo-assay 
performed to analyze the interference of ColMB dependent killing of sensitive EcMG1655 and Ec252R self-
killing with the HA-tag of cma and cmi. Wildtype (wt) Ec252R, Ec252R pColBMcmaHA and 
Ec252R pColBMcmiHA were spotted on LB agar plates, containing 0.25 µg/ml MitC to induce colicin gene 
expression. The next day agar plates were overlayed with either Ec252R or EcMG1655 .24h later halo size 
was measured. The experiment was done in triplicates and statistical analysis was done using 1-way 
ANOVA with Tukey’s post test (***p<0.001). Bars represent means and StD. (B) Western blot analysis 
of ColM-HA and CMI-HA production in Ec252R, Ec252R pColBMcmaHA and Ec252R pColBMcmiHA under 
different environmental conditions. Samples of EcMG1655, grown under the same conditions, were used 
as negative control (nctrl). Bacterial strains were grown in LB media or LB supplemented with 
0.25 µg/ml MitC (SOS-response induction), or 100 µM DTPA (Fe2+-limitation), or supplemented with 
both. As loading control DnaK was detected. (C) Western blot analysis of ColM and ColM-HA under 
different environmental conditions. Samples of (B) were also detected by affinity-purified anti-ColM 
antiserum. As loading control an unknown protein detected by the ColM-specific antiserum is shown. 
 
These results showed that CMI of Ec252R is expressed. However, we could not rule out that 
the protein is non-functional. Thus, a comparative sequence analysis of Ec252R cmi with cmi 
sequence of EcCl139 and three other ColM resistant pColBM harboring E. coli strains (EcB203, 
EcB1011, EcB1144; Table 3.1) was performed and also compared with published cmi sequences 
of two other pColBM harboring E. coli strains from the database (E. coli R170 [Acc.no. 
FJ664740.1] and E. coli H354 [Acc.no. FJ664743.1]). The analysis revealed a single point 
mutation (G233T) in the cmi sequence of Ec252R leading to a D26Y conversion in the protein 
sequence compared to the other CMI sequences (Figure 4.22A). This mutation is located in 
the part connecting the membrane anchor and head (hinge region) of ColM immunity protein 
(Figure 4.22B).  
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Figure 4.22: Protein sequence of CMI in Ec252R compared to other E. coli strains. (A) CMI protein 
sequence of Ec252R was aligned with sequences of EcCl139, EcB203, EcB1011, EcB1144 (Table 3.1) and with 
published CMI sequences of EcH354 and EcR170 (Acc.no. FJ664740.1 and FJ664743.1, respectively). 
The alignment reveals an amino acid exchange (D26Y marked by *) in the protein sequence of CMI. 
(B) Protein structure of a CMI dimer (monomers are shown in orange and blue, respectively; PDB-
entry: 2XGL) (Usón et al., 2012). CMI dimer is anchored in the inner membrane (IM) with the N-
terminal helices (tail) and the head structure is directed in the periplasm. The position of the mutation 
in CMI of Ec252R is highlighted with a red circle.    
 
In order to test if the mutation affects cmi functionality ColBM producer strain EcCl139 
(Figure 4.20C) was used and characterized by halo-assays for ColB and ColM production in 
comparison to Ec252R under normal (LB) and stressed (LB with 0.25 µg/ml MitC) conditions 
and also tested for the presence of a self-killing phenotype (Figure 4.23A-D). 
Characterization of EcCl139 revealed a reduced killing capacity against EcMG1655 compared to 
Ec252R, but this was not due to ColB production, as killing of EcMG1655 ∆fhuA was similar between 
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Ec252R and EcCl139. Moreover, according to the western blot results of the experiment, shown 
in Figure 4.20C, ColM production is enhanced in EcCl139 compared to Ec252R. Furthermore, 
EcCl139 is partially resistant to its ColM toxicity (Figure 4.23). To investigate, if the mutation in 
cmi of Ec252R leads to loss of impairment of ColM immunity, the sequence of Ec252R cmi and 
from a ColM immune strain (EcCl139) was cloned in a plasmid, yielding in p252R cmi (encodes 
cmi of Ec252R) and pCl139 cmi (encodes cmi of EcCl139) respectively. Notably, both cmi 
sequences were cloned together with their putative promoter region, to ensure that each cmi 
is under the control of its own and native promoter. ColM sensitive strain EcMG1655 was then 
transformed with either p252R cmi, pCl139 cmi or the control plasmid pempty (lacking any cmi gene) 
and tested by a halo-assay for ColM-susceptibility using Ec252R pColBMcba::cat as ColM 
producer strain (Figure 4.23E). The results revealed that both CMI of Ec252R and CMI of 
EcCl139 confer protection and no significant difference was observed. This demonstrated that 
the point mutation in cmi of Ec252R has no effect on its protective function and we thus 
concluded that other mechanisms, besides non functional ColM immunity must be underlying 
the self-killing phenotype of Ec252R. Notably, expression of cmi from a plasmid was 
insufficient to protect EcMG1655 against ColM-dependent killing. Therefore, I concluded that 
expression of the ColM immunity protein is generally insufficient to completely protect a 
ColM-producer against self-killing.   
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Figure 4.23: Characterization of ColM and ColB production of Ec252R and EcCl139 and protection 
by CMI. Halo assays to determine (A) colicin production, (B) killing by Ec252R, (C) killing by EcCl139 and 
(D) ColB-dependent killing. (E) Halo-assay using LB agar plates supplemented with 0.25 µg/ml MitC to 
determine the protection capacity of the ColM immunity protein (cmi) of Ec252R compared to the cmi of 
EcCl139. Ec252R pColBMcba::cat was grown o.n. in LB media and spotted as ColM producer on LB agar 
plates containing 0.25 µg/ml MitC to induce ColM production. The next day, plates were overlayed 
with LB softagar mixed with o.n. cultures of either EcMG1655 pempty, EcMG1655 pcmi 252R or EcMG1655 pcmi Cl139. 
The first served as control for a ColM sensitive strain. Both halo-assays were done in triplicates and 
statistical analysis was performed using 1-way ANOVA with Tukey’s post test (***p<0.001).Bars 
represent means and StD. 
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4.3.3 Characterization of a collection of cmi-positive E. coli strains with respect 
to ColM-dependent self-killing  
A literature research revealed that mutations in the ColBM locus occur rather frequently 
(Christenson and Gordon, 2009). Christenson and Gordon (2009) found that, out of 128 
E. coli strains tested positive for cma and cba genes, 69% encoded both colicin genes, 3% 
lost the entire cba locus  and about 28% encoded a full length cma but different truncated 
versions of cba (named as cba-remnant) (Figure 4.24).  
 
 
Figure 4.24.: Scheme of the gene structure for colicin BM strains and its colicin B remnant 
derivatives (adapted from Christenson et al., 2009). The arrows indicate the binding sites and 
direction of the oligonucleotides used to identify full length cba (CBA complete Rev ( ) and CBA CBI 
Primer For ( )) or cma (Colicin M Start Rev ( ) and Colicin M Start For ( )) and the cba-remnant 
type I and II versions (CBA remnant Pri. Rev ( ) and CBA CBI Primer For ( )). Hp is a conserved 
hypothetical protein found upstream of strains encoding the short cba-remnant type I gene. Strains 
carrying a longer cba-remnant version are classified as cba-remnant type II.  
     
In this thesis 35 different E. coli strains (human isolates from Czech Republic; Table 4.2.) 
tested positive for cma by PCR, were characterized by halo-assays for colicin production and 
a self-killing phenotype. Moreover, strains were analyzed for ColM production by western blot 
analysis (Figure 4.25 and Table 4.2). PCR was used to validate full length cma and/or cba 
genes and the presence of the hp gene (conserved hypothetical protein) as described 
(Christenson and Gordon, 2009). All results are summarized in Table 4.2.          
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Figure 4.25: Characterization of the 35 E. coli human isolates (selection). (A) Examples of the 
halo-assay to determine colicin production. O.n cultures of the strains were spotted on LB agar plates 
supplemented with 0.25 µg/ml MitC. The next day strains were overlayed with LB softagar mixed with 
o.n. cultures of EcMG1655 or EcMG1655 ∆fhuA. Halo sizes were measured after 24 h incubation. (B) 
Examples of western blot analysis of the tested strains. (C) Halo-assay showing the suicidal 
phenotype of EcB195 in comparison to Ec252R. O.n. cultures of both bacterial strains together with the 
negative control strain EcMG1655 were spotted on LB agar plates containing 0.25 µg/ml MitC. The next 
day, plates were overlayed with LB softagar mixed with o.n. cultures of the spotted strains. 
Subsequently, each spotted bacteria was overlayed with itself. After an incubation of 24 h halo sizes 
were measured. All halo-assays in the course of the characterization were done in triplicates and 
statistical analysis was performed using 1-way ANOVA with Tukey’s post test (***p<0.001).Bars 
represent means and StD. Colicin BM producer strains are marked by *. 
 
 
Out of the 35 tested strains, only EcB195 strain was found to exhibit a selfkilling phenotype 
(Figure 4.25C). Only 10 strains out of the 35 E. coli strains harbor intact cba and cma genes. 
In three strains the cba gene was absent but a full-length cma was detected, while three 
other strains lack the cma gene but encode the cba-remnant gene version and the hp gene. 
Majority (18 strains) were cma-positive but carried the cba-remnant gene version together 
with the hp gene and are classified as cba-remnant type I. EcB1218 was the only exception as 
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this strain was tested positive by PCR for a full length cma gene and a long cba-remnant 
version (<1000 kb) compared to the other strains and is classified as cba-remnant type II 
(Figure 4.24). This was revealed using oligonucleotides binding upstream and downstream 
cba adjacent region (CBA check up/CBA check down; Table 3.3).  
Overall, the characterization of the 35 strains revealed an interesting correlation: only 
bacteria with full length cma and cba genes were able to produce ColM in response to MitC. 
Examples of the characterization by halo-assay and western blot analysis are depicted in 
Figure 4.25B.  
 
4.3.4 Evolutionary experiment to monitor the course of ColM production and 
resistance after uptake of pColBM by a colicin sensitive E. coli strain 
The characterization of Ec252R revealed, so far, that ColM production is the reason for its self-
killing phenotype. Although Ec252R also produces the corresponding ColM immunity protein, it 
is not sufficiently protected against ColM-mediated killing. In contrast, other ColM producers 
are protected against self-killing although they harbor the same immunity protein gene 
(Figure 4.23E). This raised the question whether ColM-producing bacteria need to adapt to 
the high toxicity of produced ColM. In particular, a colicin sensitive strain can acquire the 
colicin BM plasmid (pColBM) from a colicin producer strain by conjugation. This new colicin 
producer then needs to adapt to the toxicity of ColM production, as the CMI is not sufficient 
to fully protect the strain against self-killing. The new pColBM producer strain might develop 
during an evolutionary process into a fully evolved, and thus fully protected, ColM producer. 
Adaptation to ColM toxicity might occur subsequently, e.g. by mutations in the ColM uptake 
machinery for instance by mutations in ColM receptor (fhuA), or by mutations at the ColBM 
locus (Figure 4.26). 
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Figure 4.26: Scheme of pColBM uptake and adaptation. According to the literature group B colicin 
plasmids as pColBM can be transferred by conjugation from a colicin producer to a colicin sensitive 
bacterial strain. Due to the insufficient protection against ColM by its immunity protein, the pColBM 
transconjugant strain needs now to adapt to the colicin-dependent toxicity e.g. (1.) by accumulating 
mutations in the uptake machinery components (e.g. fhuA) or the colicin receptor or (2.) by mutations 
interfering with colicin gene expression resulting in a new colicin producer which is fully protected 
against ColM.    
 
To confirm the hypothesis that originally colicin sensitive bacterial strains, which have 
recently acquired a pColBM plasmid, adapt successfully to the toxicity of ColM, an in vitro 
evolution assay was devised. The idea was to transfer a pColBM plasmid from an E. coli 
donor strain, which produces ColM and ColB and is, at the same time, fully protected against 
toxicity of both colicins, to a “naive” colicin BM sensitive E. coli strain (e.g. EcMG1655) 
(Figure 4.27). This transconjugant strain would be passaged several times under SOS-
induced condition, to trigger ColM production and to initiate the putative “evolution process”.  
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Figure 4.27: Scheme of evolution experiment. As a colicin group B plasmid, pColBM can be 
transferred by conjugation to a colicin sensitive E. coli strain (EcMG1655, EcStx or EcStx ∆SR) resulting in 
pColMB transconjugant E. coli strains. These transconjugant strains will be exposed to SOS-inducing 
conditions to trigger a possible evolution process.  
 
To test the hypothesis that ColM producers become resistant to ColM after new acquisition of 
a ColM plasmid, the pColBM plasmid of the donor EcB1144 was transferred into the colicin 
sensitive strain EcMG1655 by conjugation. This plasmid harbored a resistance to ampicillin (as 
tested by a standard antibiotic disc test) and thereby it was possible to select for pColBM 
plasmid transformants. Since prophages contribute to the release of ColIb (Nedialkova et al., 
2015), the adaptation to ColM toxicity might be more pronounced or eventually faster in a 
strain containing a functional prophage. Thus, pColBM of EcB1144 was also transferred into 
EcStx and EcStx ∆SR (Table 3.1). These strains are variants of EcMG1655. EcStx is a lysogen for 
the functional lambdoid temperate phage 933W and was shown to be able to lyse EcStx upon 
induction of the SOS-response and thus release colicin Ib (Nedialkova et al., 2015). EcStx ∆SR 
is a derivate of EcStx with disrupted lysis genes of prophage 933W and was shown to be 
deficient in prophage-dependent cell lysis and thus colicin Ib release (Nedialkova et al., 
2015). As described in section 3.2.3.3, the in vitro evolution assay was conducted as 
follows. Transconjugant strains were grown in liquid LB media in a flask, and plated the next 
day in appropriate dilutions on LB agar plates supplemented with 0.25 µg/ml MitC to induce 
the SOS-response, and therefore induction of colicin production, to direct the adaption 
process towards a less ColM sensitive strain. Afterwards, single colonies (10 in the first 
experiment and one in the second experiment) were transferred in a flask containing LB 
media, grown over night and plated the next day on LB agar plates supplemented with 
0.25 µg/µl MitC. This procedure was performed for five times in series. Subsequently, 
transconjugants were tested for ColB and ColM production and sensitivity (Figure 4.28 and 
Figure 4.29).  
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Figure 4.28: Halo-assay to determine ColBM production in newly pColBM transconjugant 
E. coli strains and their mutants. Bacterial strains were cultivated o.n. and spotted on LB agar plates 
supplemented with 0.25 µg/ml MitC. The next day agar plates were overlayed with LB softagar mixed 
with o.n. culture of (A) EcMG1655 or (B) EcMG1655 ∆fhuA, respectively. Following an incubation time of 24 h, 
the halo size was measured. The experiment was performed in triplicates. Statistical analysis was 
performed using 1-way ANOVA with Tukey’s post test (***p<0.001). If not indicated, differences were 
not statistically significant. Bars represent means and StD.   
 
All transconjugants produced functional ColM and ColB before passaging (Figure 4.28). 
Interestingly, it was shown that prophage-harboring strain EcStx pColBMB1144 releases more 
colicin compared to prophage-deficient strain EcMG1655 pColMBMB1144. By the overlay with 
only ColB-sensitive mutant strain EcMG1655 ∆fhuA it was shown, that this was due to 
differences in ColM release. The prophage lysis gene deficient EcStx ∆SR pColBMB1144 
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transconjugant strain secretes less ColBM than its equivalent strain EcStx pColBMB1144 with 
the intact prophage lysis genes, as expected. This is in line with published results on the 
release of ColIb, where prophage lysis genes are needed to release ColIb (Nedialkova et al., 
2015), together by the fact that EcStx pColBMB1144 releases more ColM than its equivalent 
EcMG1655 pColBMB1144 strain. Notably, ColBM release of EcStx ∆SR pColBMB1144 is even more 
decreased compared to the prophage-deficient strain EcMG1655 pColBMB1144.  
The mutants EcMG1655 pColMBMB1144 S6 and EcStx pColBMB1144 S6 generated during the first 
set of the in vitro evolution did not show a difference in ColBM production or secretion 
compared to the parental strains, respectively. Although mutant strain 
EcStx ∆SR pColBMB1144 S6 shows no differences in total ColBM secretion, when overlayed with 
the sensitive strain EcMG1655, it exhibit a decrease of ColB release compared to the parental 
strain. 
The mutants EcMG1655 pColBMB1144 G5 and EcStx pColBMB1144 G5, generated during the 
second set of the in vitro evolution did not exhibit a difference in ColBM production or 
secretion, respectively, compared to the respective parental strains. Mutant strain 
EcStx ∆SR pColBMB1144 G5 showed no colicin production at all (Figure 4.28). Further 
investigations by PCR and halo-assay confirmed the assumption that this mutant lost the 
pColBM plasmid (data not shown). 
All strains were also tested for suicidal properties (Figure 4.29). All tested pColBM 
transconjugant E. coli strains were able to kill themselves. The majority of the “evolved” 
pColBM transconjugant strains did not exhibit a difference in their suicidal phenotype 
compared to their parental strain. The exception was EcMG1655 pColBMB1144 S6, which 
revealed a slightly reduced sensitivity against its produced colicins. This strain is now under 
further investigation to decipher the genetic basis for this phenotype. In addition EcStx ∆SR 
pColBMB1144 S6 will be further characterized due to its decreased ColB release. 
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Figure 4.29: Halo-assay to characterize the suicidal phenotypes. pColMB transduced E. coli 
strains, their mutants, as well as the control strains EcMG1655 and EcB1144 (negative controls) and Ec252R 
(positive control) were analyzed for their self-killing properties. O.n. cultures of these E. coli strains 
were spotted on LB agar plates containing 0.25 µg/ml MitC. The next day, agar plates were overlayed 
with LB softagar mixed with o.n. cultures of the spotted strain. Afterwards each strain could be 
overlayed by itself. Halos were measured 24 h later. The experiment was done in triplicates and 
statistical analysis was performed using 1-way ANOVA with Tukey’s post test (***p<0.001), if not 
indicated differences were not statistically significant. Bars represent means and StD.   
    
 
In conclusion, the hypothesis that new ColBM producers quickly adapt to ColM production 
could not be verified by the “evolution experiments” under the chosen experimental 
conditions. Only one “evolved” strain showed a slightly reduced self-killing and another 
“evolved” strain showed a decrease in ColB release. These “evolved” strains will be 
characterized further.  
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5 Discussion 
5.1 Single cell analysis of colicin Ib (cib) gene expression in S. Tm 
Colicin Ib production confers a competitive benefit to S. TmSL1344 against commensal E. coli 
in the inflamed gut (Nedialkova et al., 2014, Stecher et al., 2012b, Stecher et al., 2013). 
Notably, colicin-producing bacteria usually lyse, and thus die, in order to release colicins. 
According to this it was speculated that S. Tm gains its fitness benefit over colicin-sensitive 
E. coli by bimodal cib expression, thus by division of labor. Colicin production would be taken 
over, by a sub-fraction of the S. Tm population and thus, their lysis served as a “common 
good” for the entire population. To address this hypothesis, different reporter strains 
(S. Tm p2cib::sfgfp, S. Tmwt pPcib gfp) were generated and comprehensively characterized. In 
contrast to the hypothesis, results of this thesis revealed that cib expression is rather 
unimodal than bimodal. Thus, other mechanisms must ensure that release only occurs in a 
subfraction of S. Tm population in order that S. Tm can benefit from ColIb production.  
 
5.1.1 Analysis of group B colicin gene expression and its characteristics 
In contrast to group A colicins, which are mainly encoded by multi-copy (15-20 copies/cell) 
type I colicinogenic plasmids, group B colicins are encoded by single-copy type II 
colicinogenic plasmids (Clewell and Helinski, 1970, Hardy et al., 1973). Therefore, the direct 
exchange of the group B colicin Ib gene against the gene of a fluorescent protein results in 
rather low fluorescent signal intensities (Figure 4.1C). This confirms that pColIB9 (p2) of 
S. TmSL1344 exists in low copy numbers per bacterium, like it was shown before for pColIB9 in 
E. coli (Clewell and Helinski, 1970).  
To overcome the limitations of low signal intensities, the multi-copy reporter pPcib gfp was 
constructed. Notably, multi-copy reporter pPcib gfp is based on plasmid pBAD24 (Guzman et 
al., 1995). This backbone plasmid contains the ori pBR322, thus it is a derivative of pColE1-
type plasmid pMB1 and owns the same replication control mechanism of ColE1 and relatives 
(Bolivar et al., 1992, Guzman et al., 1995). In E. coli, pBR322 was shown to exist at about 
15-20 copies per bacterium (Lin-Chao and Bremer, 1986). This copy number is negatively 
regulated by the repressor of primer (ROP) protein (Cesareni et al., 1982). This small RNA-
binding protein stabilizes the RNAI/RNAII complex, which inhibits primer formation and 
consequently plasmid replication (Cesareni et al., 1982, Lacatena et al., 1984). In contrast to 
plasmid pBR322, plasmids based on pBAD24, such as multi-copy reporter pPcib gfp, lack rop 
(Cronan, 2006). Furthermore it was shown, that a deletion of rop results in an increase of 
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copy numbers, similar to that of pUC plasmids (Cronan, 2006, Cesareni et al., 1982, Twigg 
and Sherratt, 1980). Notably, Pcib regulated gfp expression by pPcib gfp would thus resemble 
colicin expression of group A colicins rather than of group B colicins. 
Colicin expression is generally repressed by LexA which is the global regulator of the SOS-
response. Upon DNA damage (e.g. double strand breaks) the protease RecA is activated. 
This induces auto-cleavage of free LexA dimers and leads to the dissociation of LexA from 
the SOS-box. Consequently, this is followed by the de-repression of SOS-inducible 
promoters (Baharoglu and Mazel, 2014). The SOS-response it is responsible for the 
regulation of more than 50 genes (Zgur-Bertok, 2013). According to this, it essential for 
bacteria to provide a sufficient quantity of LexA repressor proteins in the cell, to bind all LexA 
binding sites and secure repression of all SOS-response regulated genes.  
In 1983 Anthony P. Pugsley assumed that the introduction of additional LexA binding sites 
provided by multi copies of a group A colicin plasmid (15-20 copies per cell), could interfere 
with the SOS-response regulation (Clewell and Helinski, 1970, Hardy et al., 1973, Pugsley, 
1983). Consequently, the SOS-response would be induced and this in turn would lead to the 
expression of the colicin (Pugsley, 1983). However, he could disprove his hypothesis, but 
only for group A colicins. So far it has never been addressed whether an artificial introduction 
of multi copies of LexA binding sites has an effect on group B colicin expression. According 
to this, it was investigated during this thesis, whether an artificial increase of LexA binding 
sites provided by the multi-copy gfp-reporter, interferes with expression of group B colicin cib. 
Construction of different derivatives of pPcib gfp (Figure 4.7) and their transformation in 
S. Tm p2cib-HA allowed quantification of intrinsic ColIb-HA-levels as well as multi-copy reporter 
derived GFP-levels by immunofluorescence microscopy. The results confirmed that the 
introduction of additional copies of the colicin Ib promoter region (Pcib) and thus additional 
repressor binding sites by pPcib gfp does not affect intrinsic cib-HA expression (section 4.1.3). 
Concerning the quantification of cib expression at the single cell level, it is very important to 
ensure that the chosen fluorescent protein does not affect cell viability and reports indeed the 
expression of the gene of interest. Recent studies support this concern as they showed that 
fluorescent proteins can additionally stress bacteria leading to an erroneous up-regulation of 
the reporter gene (Hebisch et al., 2013, Liu et al., 1999). Using S. Tm p2cib-HA pPcib gfp I 
showed that intrinsic ColIb-HA levels correlate well (ρ=0.87) with GFP-levels (Figure 4.10). 
Additionally, analysis of the multi-copy reporter plasmid pPcib gfp revealed plasmid stability of 
>99% after about 24 generations, grown for 5 successive passages in LB medium without 
selective pressure. This was also true for the copy numbers of pPcib gfp in S. Tmwt, which 
stayed stable over the entire time. As expected, pPcib gfp exhibited high copy numbers 
(passage 1: 169±91 StD; passage 2: 84±18 StD; passage 3: 147±57 StD; passage 4: 
198±100 StD; passage 5:127±67 StD).  
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Taken together, this data verifies that pPcib gfp is a useful and powerful tool to report and 
analyse cib expression in further experiments (e.g. live cell microscopy). 
So far the majority of studies on group A colicin expression was performed under non-
inducing conditions in the late logarithmic or stationary growth phase. Bacteria were grown in 
batch cultures in standard nutrient broth (e.g. Luria Bertani), at 37°C until the stationary 
growth phase, where colicin expression was determined (Kamensek et al., 2010, Hol et al., 
2014). These studies revealed that in early stationary phase colicins are only expressed at 
low rates, for instance ColA, ColN and ColE1 are expressed in about 0.5%, ColE7 in about 
1.5% and ColK in about 3% of the population (Kamensek et al., 2010, Mulec et al., 2003). In 
a different study, the expression of ColE7 was detected in 2.3% of the population in the 
exponential growth phase. Moreover this study showed a slight increase in gfp expression 
upon early stationary phase, although the same reporter plasmid was used (as in (Kamensek 
et al., 2010)) (Majeed et al., 2015). Differences in gfp expression might be explained by 
different media composition or growth conditions or by the sensitivity of the fluorescent 
protein used as reporter tool. Additionally, the detection limit can vary between different 
analysis methods in different laboratories. This is supported by the different results of the 
multi-copy (pPcib gfp) and single-copy (S. Tm p2cib::sfgfp) gfp-reporter used in this thesis. For 
instance, using the multi-copy reporter pPcib gfp 0.93% of the S. Tm population was detected 
as GFP+, whereas only 0.01% GFP+ bacteria were detected using the single-copy reporter 
strain S. Tm p2cib::sfgfp by FACS  in the exponential growth phase (Figure 4.1C-E). These 
results revealed that, quantification of gfp expression can be biased by reporter sensitivity. 
As a consequence, comparison on relative expression rates between different reporter tools 
and analysis methods must be interpreted with care.    
 
5.1.2 Colicin produciton: an extreme form of division of labor?  
For the majority of group A colicins it was shown that DNA-damage and, thus induction of the 
SOS-response is the main trigger of colicin expression which is negatively regulated by two 
overlapping LexA binding sites located downstream of the -10 box in the promoter region 
(Gillor et al., 2008, Ghazaryan et al., 2014). When triggered by DNA double strand brakes, 
the SOS-response can be induced and LexA is removed from its binding site (Pennington 
and Rosenberg, 2007). This de-represses colicin expression in a small fraction of the 
bacterial population (Mrak et al., 2007). This bistable gene expression is abrogated in a recA-
deficient strain or if the LexA binding sites in the colicin promoter region are modified (Mrak 
et al., 2007). Since bacteria lyse to release intracellular colicin and this results in the 
eradiation of the entire population of colicin producers. This underlines the strong need for a 
tight regulation of colicin expression to ensure the survival of a sufficiently high fraction so 
that colicin production remains beneficial for the bacterial fitness. 
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To ensure tight control of colicin expression, several colicins are under negative control by 
other regulators besides LexA. For instance, colicin K expression is growth-phase 
dependent, as it is only induced upon nutrient starvation by the stringent response alarmone 
(p)ppGpp (guanosine pentaphosphate) (Kuhar and Žgur-Bertok, 1999). Furthermore, colicin 
K synthesis can also be regulated by the transcription regulator IscR (iron-sulfur cluster 
regulator), which is suggested to stabilize LexA at the promoter and is de-repressed upon 
nutrient starvation (Butala et al., 2012). Other colicins are also found to be regulated by 
transcription regulator IscR e.g. ColE1 and ColN (Butala et al., 2012) or by transcription 
regulator AsnC, e.g. ColE2, ColE6, ColE8 (Kamenšek et al., 2015). Interestingly, colicin Ib as 
well as colicin Ia, harbour only one single LexA binding site located downstream of the -10 
box (Gillor et al., 2008). Additionally, colicin Ib is negatively regulated by Fur which binds 
upstream of the -35 region and mediates Fe2+-dependent repression of Pcib (Figure 4.1A) 
(Nedialkova et al., 2014). Thus, it is likely that Fur- and LexA-mediated repression together 
fulfil a “double-locking” function, to reduce suicidal colicin production (Butala et al., 2012). 
In this thesis, cib expression in S. TmSL1344 was analysed and quantified in individual bacteria 
in response to SOS-induction (by MitC) and Fe2+-limitation (by DTPA). If applied individually, 
both supplements de-repress Pcib, which in turn leads to a significant increase in gfp 
expression. Compared to conditions were both inducers are supplemented at the same time, 
single application leads to rather small increase in fluorescence signal intensity. This could 
also be confirmed at the level of intrabacterial ColIb-HA protein (Figure 4.8). These results 
demonstrated that, upon full induction, cib is unimodally expressed rather than bimodally. 
Inducer titration experiments confirmed these expression patterns (Figure 4.2).  
Recently it has been shown that, although the colicin Ib locus does not encode a cognate 
lysis gene, bacteria lyse to release colicin by prophage-mediated cell lysis (Nedialkova et al., 
2015). Assuming that all colicin producing bacteria lyse, under inducing conditions unimodal 
cib expression observed in S. Tm would lead to the death of almost the entire population. 
Similar to this observation, single cell analysis of colicin E2 (cea) expression revealed that 
only upon non-inducing conditions, cea is expressed in a small fraction of the population. In 
contrast to this, upon SOS-induction cea expression was observed in almost each bacterium 
(Mader et al., 2015).  
As colicin producers lyse to release colicin, the question arises: how could colicin Ib 
expression confer a growth benefit to S. Tm over E. coli in the inflamed gut, if >90% of the 
population produced ColIb and thus eventually died to release colicin?  
Using the intrabacterial staining protocol for ColIb-HA it was observed that without lysozyme 
treatment, ColIb-HA was detectable in a small fraction of bacteria grown under inducing 
conditions (LB+MitC+DTPA) (Figure 4.5C). This suggests that bacteria of this small fraction 
are undergoing lysis. Based on this data it was assumed that upon induction of cib 
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expression only a small fraction would lyse and thus die to release colicin. Therefore, under 
colicin and lysis gene inducing conditions, division of labor might not be the case at the level 
of colicin expression but rather at the level of colicin release by cell lysis. This forms a new 
scenario of how colicin Ib production could increase the fitness of a bacterial population.  
 
 
5.2 Analysis of group B colicin release at the single cell level 
It is known, that the release mechanisms of group A and B colicin are different. The operons 
of group A colicins in general encode for small cognate lysis protein, which is, like the colicin, 
expressed upon prolonged and severe DNA damage (Cavard, 1997). Anchored within the 
periplasmic leaflet of the IM the lysis protein confers perturbation of the IM and activates the 
outer membrane phospholipase A (OmpLA). Activated OmpLA leads to the permeabilization 
of the OM and thus results in the release of colicins (Pugsley and Schwartz, 1984, Snijder 
and Dijkstra, 2000). The operons of group B colicins do not encode for a cognate lysis gene, 
and it has been unclear, how group B colicins are released (Cascales et al., 2007). Recently, 
it has been discovered that group B colicin Ib is released by prophage-mediated lysis in 
S. Tm and E. coli (Nedialkova et al., 2015). Furthermore, this study showed that the major 
contributors for phage-mediated cell lysis in S. TmSL1344, and thus release of ColIb, are the 
lysis genes of the lambdoid prophage ST64B (SL1344_1955-SL1344_1957). Thus, colicin Ib 
does not only hijack host receptor proteins for their entry into the target cell, but also phage 
lysis proteins to be released by the producer cell.  
In the second part of this thesis, interaction of ColIb and prophage was investigated at the 
single cell level (section 4.2). Comparative single cell analysis of S. TmWT pPcib gfp and 
S. Tm∆Ph pPcib gfp using live cell microscopy and FACS revealed that induction of the SOS-
response resulted only in case of S. TmWT pPcib gfp in bacterial lysis and, thus, in colicin 
release. Under the same conditions, bacteria of S. Tm∆Ph pPcib gfp did not lyse and showed 
higher GFP signal intensity levels and extreme long cell shapes compared to S. TmWT pPcib gfp 
bacteria. Importantly, the differences in GFP signal intensity levels are not only caused by 
differences in the cell size. Therefore, as shown in bulk assays (Nedialkova et al., 2015), 
single cell analysis revealed that only in the presence of prophages, S. Tm lyses and thus 
release ColIb. Prophage-mediated lysis starts after sufficient amounts of ColIb have been 
synthesized intracellularly. Furthermore this indicates that, upon SOS-induction, the amounts 
of produced colicin released into the environment is not dependent on intracellular colicin 
concentrations but is regulated by the prophage-lysis genes. Similar observations were 
recently published for group A colicin E2 (ColE2) and its cognate lysis gene (Mader et al., 
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2015). This study showed that upon SOS-induction, ColE2 is only produced until a certain 
saturation level caused by ColE2 release through cell lysis. In contrast to this, in a lysis gene-
deficient strain, ColE2 production is significantly increased above this saturation level (Mader 
et al., 2015). 
 
5.2.1 Co-regulation of colicin gene expression and phage-mediated lysis 
It has been previously shown, that the majority of colicins are negatively regulated by LexA 
and additionally co-regulated by other transcription regulators such as IscR (ColE1, ColK, 
ColN) (Butala et al., 2012), Fur (ColIb) (Nedialkova et al., 2014) or AsnC (ColE2, ColE6, 
ColE8) (Kamenšek et al., 2015). Such “double locking” mechanisms might protect the 
bacterium against a premature colicin production, under conditions where DNA damage 
could be overcome by cellular repair mechanisms (Butala et al., 2012). Lysis genes of group 
A colicins are located downstream of their cognate colicin gene and thus are regulated by the 
same “double locking” mechanism (Cascales et al., 2007). In addition it has been shown that 
some group A colicin lysis genes (ColE2 and ColE7) are also post-transcriptional regulated 
by the RNA binding protein CsrA (Hol et al., 2014). This suggests, at least for group A 
colicins, a co-regulation of colicin and cognate lysis gene expression. Indeed, single cell 
analysis tools revealed that group A colicin E2 lysis gene (cel) is co-regulated with colicin E2 
(cea) and both genes showed similar, if not identical, gene expression patterns, with the 
difference that cea is expressed at higher intensity levels compared to cel (Mader et al., 
2015).  
Is such co-regulation also possible for group B colicins and prophage lysis genes? In 
particular, is ColIb production co-regulated with prophage-mediated cell lysis? And 
furthermore, do all colicin producing bacteria lyse and release colicins? 
Single cell analysis revealed that upon non-induced conditions (only LB medium), during the 
exponential growth phase, prophage lysis genes are expressed only in a small fraction of the 
population (0.1% or 0.8%, respectively) (section 4.2.2). Interestingly, this fraction did not co-
expressed colicin Ib. This might be due to spontaneous induction of the ST64B prophage in 
S. Tm as shown for CGP3 prophage of Corynebacterium glutamicum. Under similar 
conditions (as in this work) CGP3 prophage was spontaneously induced in about 0.01% to 
0.08% of the bacterial population measured by FACS (Nanda et al., 2014). It was also shown 
for CGP3 in Corynebacterium glutamicum, that spontaneous prophage induction is not solely 
caused by spontaneous SOS-induction but also by other so far unknown factors (Helfrich et 
al., 2015). This would explain the small fraction of LysST+ but ColIb- bacteria in non-inducing 
conditions (Figure 4.15). Additionally this would also explain small fraction of LysST+ but 
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ColIb- bacteria observed in induced conditions (Figure 4.15). Interestingly, the fraction of 
lysST-expressing bacteria increased significantly by induction of the SOS-response using 
MitC only, or MitC and DTPA. However, as before, under these conditions only a fraction of 
the population induced the prophage lysis genes (6.5% to 33.7%), whereas almost the entire 
population responded with cib expression (91.4% to 99.1%) (Table 4.1). This reflects a 
bimodality in the prophage-decision between lysogenic and lytic state.  
However, upon Fe2+-limiting condition only a slight induction of cib expression was observed. 
This was expected since, in contrast to prophage lysis genes, ColIb is also negatively 
regulated by Fur. According to this, Fur-mediated repression of cib expression can protect 
the cell against premature colicin production under conditions where DNA damage could be 
overcome by cellular repair mechanisms. In this scenario prophage-mediated cell lysis and 
thus colicin release is prevented and cib expression would not be required.  
Interestingly, it was previously shown in bulk assays that induction of prophage-lysis genes is 
delayed compared to cib expression (Nedialkova et al., 2015). This was also supported by 
live cell microscopy (done in this work). Results showed that cib expressing bacteria start to 
lyse ~2 h after induction of the SOS-response (Figure 4.11B and Movie S1). In conclusion, 
results showed that production of ColIb is co-regulated with prophage-mediated cell lysis 
~2 h after induction of the SOS-response.  
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Figure 5.1:Colicin warfare: an extreme form of “division of labor”. Upon conditions which trigger 
the bacterial SOS-response and Fe2+-limitation, colicinogenic bacteria (light blue) start to express 
colicin Ib (purple). Depending on the environmental conditions colicins are expressed in a small 
fraction or the majority of the population. Upon prolonged and severe DNA-damage colicins are then 
only released by a small fraction of the population by prophage-mediated cell lysis. This leads to 
colicin-depending killing of colicin sensitive competitors (blue). Sacrificing only a small fraction of the 
population the remaining (majority) of the population can benefit from colicin-mediated killing and gain 
a fitness increase over colicin sensitive competitors. 
 
Taken together, it can be assumed that under colicin and lysis gene-inducing conditions, 
division of labor is a strategy of S. Tm for colicin release by cell lysis rather than for cib 
expression (see section 5.1.2). Furthermore, growth in the inflamed intestine provides S. Tm 
an excellent environment for ColIb-dependent competition against ColIb-sensitive E. coli. As 
under these conditions not only production of ColIb but also the production of its receptor and 
translocator CirA is maximally induced. In addition, the delayed ColIb release, due to the 
delayed induction of prophage lysis gene expression would provide the possibility to 
accumulate sufficient amounts of intracellular ColIb before the start of prophage-mediated 
cell lysis.  
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5.2.2 Benefits conferred by prophage-mediated release of ColIb   
The fact that, in contrast to group A, group B colicins are released by prophage-mediated 
lysis raised the question, what is the benefit of the genetic un-coupling of release process 
from colicin production and immunity?  
With respect to protection against premature cell lysis, it might be favorable to induce cell 
lysis only, if sufficient amounts of colicin have been produced to guarantee the killing of the 
surrounding competing bacteria by the toxin. That means, if cell lysis, and thus the colicin 
release mechanism, was under the control of a different system (e.g. prophages) this would 
confer a “double locking” mechanism which secures premature lysis eventually better than 
the double locking system of lysis gene regulation of group A colicins (e.g. E2 and E7) or at 
least to similar extent. However, in case of ColE2 (cea) its cognate lysis gene (cel) is post-
transcriptionally regulated by CsrA, thus CsrA prevents premature lysis. This is important as 
it has been recently shown, that induction of cel expression is similar, if not identical to cea 
expression (Mader et al., 2015). Thus if post-transcriptional regulation by CsrA is not 
sufficient it would lead to cell lysis even if only little amounts of colicin are produced. 
Furthermore, based on the results from the same study, it is likely that upon induction, all 
group A colicin producing bacteria also produce lysis proteins and thus die to release colicin, 
especially if lysis gene regulation failed. Thus colicinogenic bacteria would suffer from the 
cost of colicin and immunity production as well as cell lysis, therefore being unable to 
compete with other bacteria. Notably, MitC concentrations used before (Nedialkova et al., 
2014), in this study but also in other studies e.g. (Mader et al., 2015) are rather high and thus 
might be un-physiological. In the gut, DNA damaging agents might be present at 
concentrations which only locally trigger the SOS-response in a small part of the population. 
Therefore, it can not be excluded, that colicin gene expression is bimodal under in vivo 
conditions. This will be addressed in the future. 
In contrast to lysis genes of group A colicins, lysis genes of group B colicin Ib are un-coupled 
from the colicin plasmid and under the control of S. Tm prophages, in particular prophage 
ST64B. In S. TmSL1344 it has been recently shown that expression of prophage ST64B (lysST) 
lysis genes is delayed (~60 min) compared to cib expression (Nedialkova et al., 2015). The 
difference in timing of expression was also supported by single cell analysis in this study. It 
was shown that 2 h after SOS-induction, the majority of bacteria were already ColIb+ (MitC 
only: 91.4%) but out of these bacteria only a very small fraction was LysST+ (MitC only: 
5.5%), with rather weak signal intensity compared to induction for 4 h (Figure 4.15 and 
Table 4.1). Furthermore, it was shown that full induction of cib expression was achieved by 
MitC and DTPA with the highest signal intensities at 2 h post induction, whereas 4 h post 
induction the ColIb signal intensity levels were significantly decreased, due to cell lysis. In 
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contrast to this, lysis genes were slightly expressed after 2 h of induction, but were 
significantly increased after 4 h, which supports the delay in induction of expression. With 
this delay bacteria might have time enough to produce sufficient amounts of ColIb before 
lysis genes are also expressed, followed by the lysis of the cell.  
Recently, it was also shown for Corynebacterium glutamicum that the induction of the SOS-
response can be transient and those bacteria which are switched to the “ON” state can also 
switch back to the “OFF” state, if DNA-damage can be repaired by the bacterium (Helfrich et 
al., 2015). This study also demonstrated that only upon severe DNA damage SOS-response 
stays in the “ON” state and results in CPG3 prophage induction always leading to cell lysis.  
Therefore, upon SOS-induction S. TmSL1344 is switched to the “ON” state and start to express 
cib. If the SOS-inducer is gone and it was possible to repair the DNA-damage, before 
induction of ST64B prophage lysis genes, bacteria might switch back to the “OFF” state 
(regarding the SOS-response). If ColIb production was only induced by the SOS-response 
induction ColIb production would be inhibited. Intracellular ColIb might be degraded by 
produced proteases, as it is known that expression of proteases is also induced upon cell 
stress. It might also be the case that colicins are just out-diluted over the next generations 
due to cell division. This behavior might be more likely if bacteria show a delay in lysis gene 
induction due to prophage induction, as this confers the bacterium enough time to repair the 
DNA-damage and to outlast a short period of cellular stress. In this scenario Fur-mediated 
repression would prevent the cell against high concentrations of intracellular ColIb. This 
simplifies elimination of small amounts of intracellular ColIb.    
Furthermore, as the exploitation of prophage lysis genes for colicin release is not restricted to 
a specific colicin it can also release all types of colicins. This is of advantage as colicinogenic 
plasmids can harbor more than one colicin, as e.g. pColBM encodes genes for colicin B and 
M. Prophage-mediated release of both colicins would save costs as instead of two lysis 
genes only prophage lysis genes would have to be expressed. This leads also to the 
question, if other group B colicins without cognate lysis genes are also released by 
prophage-mediated cell lysis as for instance ColB and ColM (section 5.3.3). Generation of 
bacterial mutants with and without prophages as well as generation of reporter tools would 
be required to address this question. 
Group B colicin plasmids can be easily transferred into colicin sensitive strains by 
conjugation. These strains would pay the cost for colicin production and its cognate immunity 
protein but would not gain ColIb dependent growth benefit as the colicin remains intracellular. 
Thus only if the plasmid acceptor strain carries prophages, it can benefit from colicin 
production. This circumstance would serve as selective pressure on maintenance of intact 
prophages or cryptic prophages with intact lysis function. Therefore, outsourcing colicin lysis 
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genes to prophages would also enable the use of a colicin plasmid directly as “weapon”. For 
instance, it was shown that upon gut inflammation colicin Ib plasmid p2 of S. TmSL1344 can be 
transferred by conjugation with an efficiency of about 100% (Stecher et al., 2012b). Under 
such conditions, plasmid p2 could be conjugated into ColIb-sensitive E. coli lacking functional 
prophages. This E. coli strain would suffer from the cost of ColIb production (i.e metabolic 
load of protein synthesis) but would not benefit from ColIb production as this strain lacks the 
ColIb release mechanism (Nedialkova et al., 2015). Furthermore, the requirement of 
prophages for colicin release secures the co-occurrence of colicin plasmids and prophages 
and thus provides the simultaneous release of two different weapons: the toxin colicin and 
infectious phage progenies. According to this, outsourcing colicin lysis genes from the colicin 
plasmid would broaden the range of targeted competitors. Competitors might be killed either 
by the bactericidal activity of colicins, by the increased metabolic load of colicin production 
provided by the colicin plasmid, or by phage-dependent lysis.  
 
5.2.2.1 Does prophage-mediated release of ColIb provide an evolutionary stable 
strategy to prevent the emergence of cheaters?   
Furthermore, uncoupling of colicin production and immunity from cell lysis may lead to 
evolutionary stabilization of the ColIb production phenotype and may prevent the emergence 
of cheaters (e.g. lysis-deficient mutants). Therefore it may form an evolutionary stable 
strategy (ESS) even in a well-mixed environment. Colicin production is highly costly, since 
the producer lyses to release colicin. Thus, the emergence of cheaters, e.g. defective in cell 
lysis, is very likely. As a consequence, cheaters do not contribute to the provision of the 
public good (=colicin) but benefit from its production by the cooperators. In case, the genes 
for colicin, immunity and lysis are encoded on the same location (plasmid or chromosome) 
cheaters usually have a fitness benefit over the cooperators. In well-mixed environments 
(e.g. in batch cultures) cheaters can arise and outcompete cooperators, which bear the 
burden of colicin release. The emergence and spread of cheaters can only be prevented if 
counteracting mechanisms exist such as bottlenecks, which promote group selection 
(Ackermann et al., 2008). In contrast to this, in spatially structured environments (e.g. growth 
on agar plates or in biofilms), cooperators which produce and release the common good 
(colicin) will have a benefit over cheaters, as only those can invade other territories of colicin 
sensitive populations (Chao and Levin, 1981, Kerr, 2007).     
Temperate phages only have a fitness benefit if their lysis genes are functional, to secure the 
release of infectious phage particles and the infection of a new host to propagate. This 
fitness benefit would be lost, if phage lysis genes were disrupted. Furthermore, this would 
lead to extinction of the phage. Thus, the selective pressure for phages to maintain functional 
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lysis genes is very high. According to this outsourcing costly lysis from colicin production and 
immunity would evolutionary stabilize the colicin production phenotype. Moreover, a single 
bacterium can harbor several prophages. Thus, if a bacterium harbored a prophage with 
disrupted lysis genes, infection with a new functional phage could restore prophage-
mediated cell lysis. This presumes that not a particular prophage is required for colicin 
release. Interestingly, it was shown, ColIb is released by prophage ST64B-mediated cell lysis 
in S. Tm but also by prophage 933W-mediated lysis in E. coli (Nedialkova et al., 2015). This 
suggests that not a particular prophage is required for ColIb release. Additionally, a future 
work objective will be, to investigate if prophage-mediated colicin release provides an ESS to 
stabilize the ColIb production phenotype and prevent the emergence of cheaters. This will be 
analyzed by mathematical modeling (e.g. by adaptive dynamics) as well as suitable in vitro 
studies.                   
 
5.2.3 Colicin production and release by prophage-mediated cell lysis in vivo  
It was shown that S. Tm can colonize the mammalian intestine and induce inflammation 
(Stecher et al., 2007). This inflammation is primarily characterized by transmigration of 
neutrophils into the gut lumen, which produce antibacterial proteins like lipocalin-2, elastase, 
calprotectin and antibacterial effectors like reactive oxygen and nitrogen species (ROS, 
RNS). These neutrophil effectors induce iron-starvation or DNA damage in bacteria and thus 
lead to induction of the SOS-response (Winter et al., 2010b, Loetscher et al., 2012). 
Furthermore, it was shown that inflammation leads to a bloom of Enterobacteriaceae, which 
are usually found at low densities (<108 cfu/g) in a healthy gut (Stecher et al., 2012a). Under 
these stressful environmental conditions S. Tm upregulates expression of the colicin Ib gene 
which, in turn, enables S. Tm to outcompete commensal E. coli (Nedialkova et al., 2014). 
Furthermore, a recent in vitro study from our lab elucidated the release mechanism of ColIb 
(Nedialkova et al., 2015). Like the majority of colicins, prophages are activated by the SOS-
response to induce the lytic cycle (Oppenheim et al., 2005). Interestingly, it has been 
reported recently that IBD (inflammatory bowel disease) patients exhibit increased fecal 
phage titer compared to healthy controls (Norman et al., 2015). Therefore, it is likely that gut 
inflammation leads to induction of prophages, which in turn mediate cell lysis and release of 
phage particles and colicin Ib, explaining the ColIb-dependent fitness benefit of S. Tm over 
E. coli. After all, the relative importance of iron-starvation and induction of the SOS-response 
for cib expression and thus prophage mediated lysis was not elucidated in detail in vivo. Due 
to the high costs of colicin production (death of the producer) it is important to keep a 
balance between the colicin-mediated fitness loss and the fitness gain. Therefore colicin 
production and its release should be tightly regulated and restricted to environmental niches 
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with high frequencies of potential competitors such as in Enterobacterial blooms. Further 
studies will be directed to define the optimal rate for cib expression and prophage-mediated 
lysis in vivo to explore the conditions how ColIb production and the release by prophage-
mediated lysis has evolved as cooperative phenotype in Enterobacteriaceae.  
 
 
5.3 How do colicin producers become immune to their own colicin?  
Ec252R shows a self-killing phenotype under SOS-response conditions. By performing 
transposon library screens the Ec252R mutant strains EcP10A10 (no self-killing) and EcP13C5 
(reduced self-killing) could be isolated. Further analysis revealed that Ec252R harbors a 
pColBM plasmid and in case of EcP10A10 the transposon Tn10 was inserted at the beginning 
of the gene encoded for colicin M (cma). Generation and analysis of mutant strains with 
deletion either of cma or cba (colicin B) revealed that cma expression is responsible for the 
self-killing phenotype of Ec252R (Figure 4.20). Colicin M-mediated self-killing of Ec252R was 
surprising, as generally, colicinogenic bacteria are protected against their own colicins by 
simultaneous production of a cognate immunity protein, which is usually encoded on the 
same locus (Cascales et al., 2007). Further investigations showed that pColBM of Ec252R also 
encodes a ColM immunity protein (cmi), which is expressed constitutively at low levels and 
increased by MitC (Stayrook et al., 2008) and Fe2+-limitation (DTPA) (Figure 4.21B). 
Furthermore, although cmi of Ec252R exhibits a point mutation (G233T), which results in an 
amino acid exchange (D26Y) in the hinge region of CMI (Figure 4.22), it is as functional as 
other ColM immunity proteins of immune ColM producers (Figure 4.23E). Interestingly, the 
same experiment revealed that, in general, the ColM immunity protein does not fully protect 
bacteria against ColM, suggesting that full ColM-immunity is not only mediated by ColM 
immunity protein. Nuclease colicins are directly active after synthesis and thus have to be 
inactivated by their cognate immunity protein already in the cytosol of the producing strain. In 
contrast, the immunity protein of ColM is integrated in the periplasmic leaflet of the IM as it is 
the case for pore-forming colicins (Usón et al., 2012). According to the literature, this should 
sufficiently protect bacteria from ColM toxicity. In the course of this thesis two other E. coli 
strains which harbor the pColBM plasmid (EcCl139 and EcB195) were also found to be only 
partially immune against their own colicins. Thus this seems to be a property of ColM 
producers that can be encountered occasionally.      
Taken all data together I hypothesized that bacteria which have just taken up a pColBM 
plasmid by conjugation need to adapt to ColM production and its cytotoxicity. Thus Ec252R 
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might be a candidate for an evolutionary “early” ColBM producer that needs to adapt to 
become fully ColM resistant.    
 
5.3.1 Adaptation to colicin M production   
Is there evidence that colicin M producers, in general, have to adapt to become fully ColM 
resistant? Interestingly, immunity proteins of nuclease-type colicins form tight complexes with 
their cognate colicins. In fact, the interaction of Im9 to its ColE9 has been shown to be a very 
strong protein-protein interaction (Wallis et al., 1995). In contrast, the interaction between 
ColM immunity protein and the enzymatically active ColM is very weak (Usón et al., 2012). 
Additionally, it was shown that immunity can be overcome by high colicin concentrations 
(Levisohn et al., 1968, Šmajs et al., 2006). Considering this and with the finding, that cmi 
expression alone is not sufficient to protect bacteria against ColM (Figure 4.23E) additional 
resistance mechanisms besides CMI-mediated immunity may have evolved.  
To test the hypothesis, an in vitro evolution experiment was carried out. As ColM is usually 
encoded together with ColB on the same conjugative plasmid (Cascales et al., 2007) a 
pColBM plasmid was transferred in a ColBM sensitive E. coli strain. Indeed, this “new” 
ColBM producer was not completely immune to ColM and exhibited a “self-killing” phenotype 
in the presence of MitC. This strain was passaged several times on LB agar plates 
containing MitC. Results however showed that only one strain (EcMG1655 pColBMB1144 S6) 
showed a slightly decreased self-killing phenotype compared to its parental strain 
(EcMG1655 pColBMB1144) (Figure 4.29). All other strains exhibited the same ColM sensitivity 
after five rounds of passaging.  
It was shown that prophage-mediated cell lysis contributes to ColIb release in S. Tm 
(Nedialkova et al., 2015). This was not only restricted to a S. Tm strain but also shown for 
ColIb release by E. coli strains harboring a ColIb plasmid and a functional prophage 933W 
(EcStx). In contrast, ColIb release was not observed in a derivative of EcStx with disrupted 
933W prophage lysis genes (EcStx∆S R). Thus only EcStx with intact lysis genes released ColIb 
in the supernatant (Nedialkova et al., 2015). According to this, we assumed that prophage-
mediated cell lysis may also contribute to ColM release and the prophage may thus be 
required for the adaptation process. Therefore, pColBM was also transferred in EcStx and in 
the derivative EcStx∆S R. These strains were also passaged several times. As expected, results 
confirmed that the prophage-harboring strain (EcStx pColBMB1144) released higher amounts of 
ColBM compared to its derivative lacking the prophage lysis genes (EcStx∆S R pColBMB1144) 
and compared to E. coli lacking the entire prophage (EcMG1655 pColBMB1144) (Figure 4.28). 
Interestingly, it seems that only release of ColM is increased in the presence of a functional 
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prophage compared to a strain lacking the entire prophage, whereas the release of ColB was 
similar in these strains (Figure 4.28). Comparing colicin release of the strain harboring the 
intact prophage and its derivative lacking the prophage lysis genes, the results showed 
expression of 933W prophage lysis genes increased ColM and also slightly ColB release 
(Figure 4.28). Therefore, prophage-mediated lysis mainly contributes to the release of ColM 
and this might explain the slightly decreased self-killing phenotype of a ColBM producer 
strain lacking the 933W prophage lysis genes compared to the strain harboring the intact 
prophage (Figure 4.29). However, 933W prophage-mediated ColM release did not alter the 
adaption process to a fully ColM resistant strain under the tested conditions.  
In the course of this experiment passaging of the strain lysogenic for temperate 933W but 
lacking the prophage lysis genes, resulted in the mutant strain EcStx∆S R pColBMB1144 S6. This 
mutant showed a decrease in ColB-dependent killing compared to its parental strain (Figure 
4.28B).      
In conclusion, only two mutant strains were identified showing either a slight decreased self-
killing phenotype (EcMG1655 pColBMB1144 S6) or a phenotype with decreased ColB-dependent 
killing (EcStx∆S R pColBMB1144 S6). This suggests that the in vitro evolution experiment was 
insufficient to select for mutants which become fully immune to ColM production. A possible 
explanation for this could be that the selective pressure by growth on LB agar plates 
containing the antibiotic MitC was too low. Future in vitro evolution experiments should be 
performed for instance encompassing more rounds of passaging. Or passaging of the strains 
could be done in liquid medium containing MitC. This may create increased selective 
pressure for ColM resistant mutants, as bacteria are all exposed to the same concentration 
of MitC. The use of recombinant ColM as selective pressure could also be a useful tool to 
select for ColM resistant strains, especially because purified ColM can be applied in defined 
concentrations.  
Further future tasks will be to analyze the mutant strains EcMG1655 pColBMB1144 S6 (decreased 
self-killing phenotype) and EcStx∆S R pColBMB1144 S6 (decreased ColB release). Therefore, 
genomes of both mutant strains will be sequenced to identify localization of the mutations. 
Western blot analysis of EcMG1655 pColBMB1144 S6 using ColM specific antiserum will give 
insights whether colicin production is decreased or only ColM-release. The generation of a 
specific ColB antiserum would be of advantage to study ColB production as well. This would 
allow us to investigate if the observed phenotype of EcStx∆S R pColBMB1144 S6 is due to 
decreased cba expression, or if ColB release is defective. The in vitro evolution experiment 
could also be repeated with other ColM sensitive E. coli strains.    
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5.3.2 Is the self-killing phenotype also found in other “new” colicin producers? 
Mutations in the cba gene appear to be frequent (Christenson and Gordon, 2009). 
Christenson and Gordon showed that the majority (~90%) of E. coli strains harboring the 
pColBM plasmid encode, instead of full length cba, only a truncated version (cba-remnant). 
Interestingly, these strains exhibit only a rather low cma expression (Christenson and 
Gordon, 2009). Such a “polar” effect on cma expression has also been shown before 
(Ölschläger et al., 1984). It was demonstrated that a transposon insertion in cba reduces 
cma expression (Ölschläger et al., 1984). This is reasonable, since cba is encoded upstream 
of cma and both are regulated by the same promoter (Figure 4.19A).  
In the course of this study, a collection of 35 E. coli strains identified as ColM-producers was 
characterized. Our results revealed that the majority of these strains (63%) encode a cba-
remnant version instead of a full length cba (Table 4.2). As noted above, this mutation leads 
to downregulation of ColM production in these strains (Table 4.2 and Figure 4.25). In this 
case a derivative of a ColBM plasmid might have become positively selected and spread in 
the E. coli population, on which both, cba and cma expression is non-functional. Truncation 
of cba also leads to deletion of the common promoter, and thus to massive reduction of cma 
expression. It can be speculated that the ancestor ColBM producer strain experienced a 
benefit from this mutation as it alleviated self-killing. Why has this plasmid spread so 
successfully in the E. coli population? It can be assumed that the plasmid harbors other 
fitness factors besides cba and cma that lead to positive selection of this plasmid(s), such as 
virulence factors like siderophore receptors, iron transport systems, antibiotic resistances or 
pili (Christenson and Gordon, 2009, Kröger et al., 2012). Interestingly a different study 
observed that the majority of E. coli isolates from wild mice (50-98%) are resistant against 
different colicins (Riley and Wertz, 2002a). This supports the idea that, besides exhibiting 
immunity to self-produced colicins, colicin producers, in general, may benefit from mutations 
rendering them colicin resistant. This is actually in contrast to the concept “rock-paper-
scissors”, where a colicin sensitive strain would beat a resistant strain as it does not suffer 
from costs arising by mutations in the import pathway (Hibbing et al., 2010). This suggests 
that immunity to colicins alone is generally insufficient to protect colicin producers against 
self-killing. As a consequence all strains which just have become colicin-producers would 
show a (more or less pronounced) self-killing phenotype and hence may accumulate 
mutations and become fully resistant to their produced colicins.  
It was shown that the ColIb-producer S.TmSL1344 is resistant to its own colicin even after the 
strain was cured from the colicin plasmid p2 (Stecher, unpublished data). To test if ColIb 
immunity protein does sufficiently protect the strain against self-killing, the ColIb plasmid p2 
was transferred in a colicin-sensitive strain (EcMG1655) by conjugation. However, this strain 
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was highly immune to ColIb. After curing the strain of p2 it became sensitive to ColIb as 
before (data not shown). In conclusion, production of the ColIb immunity protein is apparently 
sufficient to protect E. coli against self-killing. Based on these first results, other colicin 
producers also should be tested to further support our hypothesis. However, the self-killing 
phenotype may also only be restricted to ColM producers. This might be explained by the 
fact that ColM has a unique mode of action among all colicins (El Ghachi et al., 2006). In 
addition, its immunity protein is (in contrast to other enzymatic colicins) inserted in the inner 
membrane of the bacterium (similar to immunity proteins pore-forming colicins) and forms a 
dimer to protect against ColM toxicity (Olschläger and Braun, 1987, Cascales et al., 2007, 
Usón et al., 2012).          
 
5.3.3 Is prophage-mediated release also true for group B colicins ColB and 
ColM? 
ColB and ColM are classified as group B colicins, thus they do not encode cognate lysis 
genes and their release mechanism is still unclear. Recently, it has been shown that the 
pore-forming group B colicin Ib (ColIb) is released by prophage-mediated cell lysis 
(Nedialkova et al., 2015). Interestingly, the transposon library screen conducted in this thesis 
yielded a mutant strain (EcP13C5) which showed a reduced self-killing phenotype (Figure 
4.18). The insertion of Tn10 in EcP13C5 was located in a gene for a putative prophage protein 
of Ec252R. However, this prophage gene was excluded to be a lysis gene. Interestingly, the 
self-killing phenotype was almost lost but this mutant was still able to kill sensitive EcMG1655 as 
efficiently as ColM-deficient EcP10A10. This suggests, that mainly ColM is released by 
prophages, or at least, by this prophage. This hypothesis was also supported by the 
observation that increased ColM release was observed in EcMG1655 when transduced with 
intact prophage 933W. Further analysis is required, for instance identification of all Ec252R 
prophages followed by generation and analysis of Ec252R mutant strains lacking prophage 
lysis genes or cured from all prophages, and additionally carrying deletions in either cba or 
cma. Furthermore, generation of a fepA mutant strain, the gene encoding the ColB receptor 
(FepA), would be necessary. Using this fepA mutant as test strain in the overlay of a halo-
assay, ColM-dependent killing and thus ColM-release could be investigate.  
In fact, ColB and ColM might be released by different mechanisms. It was shown that 
although ColM is detected as clear band in the cell pellet by western blot analysis, it is 
released only in small amounts by a fraction of the population (1%) (Ölschläger, 1991). 
Surprisingly, this small amount is sufficient to inhibit growth of sensitive bacteria (Ölschläger, 
1991). Interestingly, in the course of this work, western blot analysis for ColM production and 
release by 13 ColM-producing E. coli strains (including Ec252R) revealed that in half of the 
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strains, ColM was only detected in the cell pellet but not or in rather low amounts, in the 
supernatant. This suggests that ColM concentration in the supernatant is rather low and 
under the detection limit of a western blot analysis. Ölschläger (1991) assumed that 
according to the low amounts of released ColM, ColM might be secreted without cell lysis 
(Ölschläger, 1991). Intriguingly, it was shown that ColM (one of the smallest colicins 
(~30 kDa) is able to enter the cell from the outside by osmotic shock in a strain lacking the 
ColM-receptor (Harkness and Braun, 1990). This suggests that ColM is small enough to 
enter the cell and possibly to exit the cell without an active transport machinery. Whether 
ColM-producing (of an immune ColM producer) bacteria do not lyse during colicin production 
and colicin release could be tested by single cell analysis using the CellASIC® ONIX 
Microfluidic Platform (Millipore).  
Although ColB has a higher molecular mass (~55 kDa) compared to ColM, it is assumed that 
ColB is released by cell leakage, since it was also only detected in low amounts in the 
supernatant similar to ColM (Mende and Braun, 1990, Ölschläger, 1991, Ölschläger et al., 
1984). Mende et al. could also show in their study that ColB can enter the cell from the 
outside by osmotic shock in a strain lacking the ColB receptor FepA (Mende and Braun, 
1990). This suggests that ColB might also exit the cell without an active transport machinery 
or cell lysis. Secretion of ColB might also explain the phenotype of EcP13C5 which was 
observed to kill sensitive EcMG1655 as efficiently as the ColM-deficient strain EcP10A10. 
Furthermore, our results showed that ColB release was not increased in EcMG1655 when 
transduced with intact prophage 933W. 
Taken together, our data supports the hypothesis that ColB is secreted by its producer by a 
so far unknown mechanism not involving phage-mediated cell lysis. Whether ColB-producing 
(of an immune ColB producer) bacteria do not lyse during colicin production and colicin 
release could be tested by single cell analysis using the CellASIC® ONIX Microfluidic 
Platform (Millipore). 
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Supplementary Data 
Movie S1: Live cell microscopy of S. TmWT pPcib gfp. First, microcolonies of S. TmWT pPcib gfp were 
grown for 3 h in LB, in the Onix microfluidic system (Millipore). Afterwards, media was switched first to 
LB medium supplemented with 100 µM DTPA (Fe2+-limiting conditions). After 20 min the SOS-
response was induced by applying LB supplemented with 100 µM DTPA and 0.5 µg/ml MitC. Again 
after 20 min, media was switched back to LB supplemented with 100 µM DTPA only, for the remaining 
time. (A) Merge of brightfield and GFP-channel and (B) GFP-channel only.  
 
Movie S2: Live cell microscopy of S. Tm∆Ph pPcib gfp. First, microcolonies of S. Tm∆Ph pPcib gfp were 
grown for 3 h in LB, in the Onix microfluidic system (Millipore). Afterwards, media was switched first to 
LB medium supplemented with 100 µM DTPA (Fe2+-limiting conditions). After 20 min the SOS-
response was induced by applying LB supplemented with 100 µM DTPA and 0.5 µg/ml MitC. Again 
after 20 min, media was switched back to LB supplemented with 100 µM DTPA only, for the remaining 
time. (A) Merge of brightfield and GFP-channel and (B) GFP-channel only.  
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